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Abbreviations and definitions 
 
 
List of abbreviations: 
 
AHO   Albright hereditary osteodystrophy 
ALP   alkaline phosphatase 
AMP   adenosine monophosphate 
BCP   biphasic calcium phosphate 
BET   Brunauer, Emett and Teller 
BMP   bone morphogenetic protein 
BSP   bone sialoprotein 
CA   carbonated apatite 
CaP   calcium phosphate 
CG   calcein green 
Coll   collagen 
DBM   demineralized bone matrix 
EDX   energy dispersive x-ray 
ESC   embryonic stem cell 
ESEM   environmental scanning electron microscope 
FGF   fibroblast growth factor 
FOP   fybrodisplasia ossificans progressiva 
FTIR   fourier transform infra red 
G-CSF   granulocyte colony-stimulating factor 
GM-CSF  granulocyte-macrophage colony-stimulating factor 
HA   hydroxyapatite 
IGF   insuline-derived growth factor 
IL   interleukin 
LM   light microscope 
MP   mercury porosimetry 
OC   osteocalcin 
OCP   octacalcium phosphate 
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ON   osteonectin 
OP   osteopontin 
OSF2   osteoblast-specific factor 2 
Osx   osterix 
OTC   oxytetracycline 
PDGF   platelet-derived growth factor 
PEO   poly(ethylene glycol)- terephtalate 
PBT   poly(butylene terephtalate) 
PGE   prostaglandin 
(P)MMA   (poly)methylmethacrylate 
POH   progressive osseous heteroplasia 
(Poly)HEMA  (poly)hydroxyethylmethacrylate 
PS   plasma-spraying 
PTH   parathyroid hormone 
PTH-r   parathyroid hormone receptor 
PU   polyurethane 
Q-PCR   quantitative polymerase chain reaction 
RBMC   rat bone marrow cell 
RF   radio-frequency 
RT-PCR   reverse transcription-polymerase chain reaction 
SBF   simulated body fluid 
SCS   simulated calcifying solution 
Ta   tantalum 
TE   tissue-engineering 
TGA   thermogravimetry analysis 
TGF-β   transforming growth factor beta 
Ti6Al4V   titanium6aluminum4vanadium alloy 
vol.%   volume percent 
wt.%   weight percent 
XRD   x-ray diffraction 
XO   xylenol orange 
β-TCP   beta tricalcium phosphate 
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List of relevant definitions as used in this thesis: 
 
Biomaterial A non-viable material used in a medical device, intended to 
interact with biological systems. 
Material intended to interface with biological systems to 
evaluate, treat, augment or replace any tissue, organ or 
function of the body. 
Biomimetic material any material that is structurally or chemically analogous to a 
component of plant or animal tissue and which can be 
incorporated into any product whose use is based on the 
characteristics of that tissue component. 
Bone the hard, rigid form of connective tissue constituting most of 
the skeleton of vertebrates, composed chiefly of calcium salts 
embedded in collagen fibers. 
Ceramic type of material chemically derived from the combination of 
one or more metallic elements with one or more non-metallic 
elements, usually ionically bound but with a contribution from 
covalent bonding, characterized in the solid state by extreme 
brittleness. 
Coating deposited layer or covering on a biomaterial or 
medical/dental device which is intended to protect or enhance 
the performance of the device or biomaterial. 
Ectopic   located away from normal position. 
Femur   the thigh bone. 
Graft piece of viable tissue or collection of viable cells transferred 
from a donor site to a recipient site for the purpose of 
reconstruction of the recipient site. Bone grafts can be 
substituted by biomaterials. 
Illiac wing  the upper and largest part of bony pelvic girdle.  
Implant medical device made from one or more biomaterials that is 
intentionally placed within the body, either totally or partially 
buried beneath the epithelial surface. 
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Interconnectivity the degree to which a single phase within a medium is joined 
to form continuous paths. 
Macropore  pore with the diameter larger than 10 micrometers. 
Micropore  pore with the diameter smaller than 10 micrometers. 
Orthotopic  occurring at the normal place. 
Osteoconduction 
• The process through which bone is directed into material 
structures such as pores, channels and pipes. 
• Spreading of bone over the surface proceeded by ordered 
migration of differentiating osteogenic cells. 
Osteogenesis bone formation by determined osteoprogenitor cells (DOPCs). 
Osteogenic relating to or derived from the tissue from which bone is 
developed. 
Osteoinduction 
• The mechanism of cellular differentiation towards bone of one 
tissue due to the physicochemical effect or contact with 
another tissue.  
• The induction of undifferentiated inducible osteoprogenitor 
cells (IOPCs) that are not yet committed to the osteogenic 
lineage to form osteoprogenitor cells. 
Osteointegration the concept of a clinically asymptomatic attachment of a 
biomaterial to bone, under conditions of functional loading.  
Pore small space between solid parts or particles within a material. 
Porosity the collection of pores making up the void space within a 
porous material. 
Specific surface area category unit in m2/kg. 
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Chapter 1 
 
General introduction 
 
Pamela Habibovic, Clemens A. van Blitterswijk and Klaas de Groot 
 
University of Twente, Institute for Biomedical Technology,  
Professor Bronkhorstlaan 10D, 3723 MB, Bilthoven, The Netherlands 
 
 
1.1 Biomineralization 
 
Some 540 million years ago, within a period of a few million years, a multitude of 
primarily multicellular organisms began to produce mineralized skeletal structures. 
During this crucial period in the evolution of biomineralization, the basic structural 
patterns for skeletal formation were fixed, although it has been suggested that some of 
the underlying principles used for mineralization itself were acquired from ancestral 
organisms [1]. 
Today the phenomenon of biomineralization is widespread. Almost all living organisms 
can deposit minerals that serve a wide variety of functions: magnetotactic bacteria 
deposit iron oxide enclosed in organic sheaths, mollusks form calcite crystals in their 
shells, and vertebrates generate the apatite crystals found in bones and teeth. More 
than sixty different minerals are known to be formed by living organisms, including 
amorphous minerals, inorganic crystals and crystals including organic compounds. 
Calcium minerals represent some 50% of all known biogenic minerals and the two major 
skeleton-reinforcing minerals are calcium carbonate and calcium phosphate [2]. 
The most common use of crystals is in the form of multicrystalline arrays, primarily to 
form skeletal structures. The order of the crystals in these arrays can largely differ 
between different organisms. In the next paragraphs, an overview of the known facts 
regarding the development of crystalline mineral deposition is given [2]. 
The current understanding of biomineralization in vivo is still very limited and the 
underlying principles involved are for the most part derived from observations in vitro. 
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Understanding how a whole ordered array of macromolecules and crystals can make 
biological materials is still far beyond our knowledge. However, there are some well 
known and generally accepted facts that can help in understanding the mechanism of 
biomineralization and potentially using this knowledge for purposes of developing 
intelligent synthetic biomaterials. 
It is generally accepted that physiologic mineral, i.e. the formation of mineral in an 
organized fashion in shells, teeth and bones, does not occur without a matrix. The matrix 
provides an oriented support for mineral deposition, and may participate directly in the 
mineralization process by serving as nucleator, or holding and orienting ions which 
become incorporated into the mineral crystals [3]. 
The matrix is not the same in all mineralized tissues. Even in vertebrates where type I 
collagen is the predominant component of dentin, cementum and bone, the calcified 
cartilage matrix is distinct, containing types II, IX and X collagen as well as 
proteoglycans, and the enamel matrix is even more unique. The matrices which contain 
type I collagen also show individual variations. For example, dentin contains dentin 
phosphoprotein, dentin phosphophoryn and dentin sialoprotein, while none of these exist 
in bone [4]. 
The mineral itself is also not the same in all mineralized tissues. For example, calcium 
carbonates, silicates and oxalates are found in invertebrates, while calcium phosphate 
apatitic minerals are found in enamel, dentin and bone. The formation of the stable 
apatitic structure which comprises physiologic mineral of i.e. bone is preceded by a less 
stable calcium-phosphate phase. There are reports suggesting that this phase is 
amorphous calcium-phosphate. In addition, dicalcium phosphate and octacalcium 
phosphate have been proposed as possible precursors of the final bone mineral [1]. 
The mechanisms underlying mineral deposition can be different too. A key step in the 
control of mineralization employed by almost all organisms is the initial isolation of a 
space. Then, under controlled conditions minerals are induced to form within the space. 
The space is usually delineated by cellular membranes and vesicles [2]. In the case of 
bone, minerals start to nucleate in the spaces isolated by the collagen fibrils. This 
heterogeneous nucleation is catalyzed by the phosphated ester- and carboxylate 
groups present in collagen fibrils. The growth of the crystals consequently takes place 
along the collagen fibrils, interconnecting them [5, 6]. However, in turkey tendons for 
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example, matrix vesicle and collagen mineralization start simultaneously at different 
sites. In other tissues, sulphate-rich proteins, such as bone sialoproteins or proteoglycans, 
appear to be sites of initial mineralization [4]. In many invertebrates, and in enamel, 
there are no extracellular matrix vesicles, suggesting that other processes are involved 
in enamel mineralization. Recently, it was proposed that during mineralization of 
enamel, linear aggregates of polarized, self-assembled amelogenin nanospheres form 
a negatively charged template that induces apatite formation [3]. 
Biomineralization is thus a complex and only partially understood phenomenon. Further 
research into mechanisms of biomineralization, which probably needs to be conducted 
at micro- and even nanolevel, will be of great importance for the development of 
successful synthetic bone grafts. 
  
 
1.2 Bone 
 
Bone is a highly specialized form of connective tissue that is nature’s provision for an 
internal support system in most higher vertebrates. Bone provides for the attachment of 
the muscles and tendons essential for locomotion, protects the vital organs of the cranial 
and thoracic cavities, and it encloses the bloodforming elements of the bone marrow. In 
addition to these mechanical functions, bone plays an important metabolic role as a 
mobilizable store of calcium and phosphate, which can be drawn upon when needed in 
the homeostatic regulation of the calcium and phosphate in blood and other fluids of the 
body [7]. 
By weight, bone contains approximately 60% mineral, 10% water and about 30% 
organic matrix. Type I collagen constitutes approximately 90% of the organic matrix; 
the remaining 10% is composed of proteoglycans and numerous noncallogeneous 
proteins, such as osteocalcin, osteopontin, osteonectin, bone sialoprotein, decorin and 
biglycan [8, 9]. Bone mineral has a structure similar to type AB carbonated calcium-
phosphate apatite. In addition, bone mineral apatite contains non-apatitic carbonate 
and phosphate groups, which are, from the structural and physical point of view, 
unstable and very reactive. The high reactivity potential of these groups plays an 
important role in the formation and degradation of the bone tissue [10-12]. 
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Morphologically there are two forms of bone: cortical (compact) bone and cancellous 
(trabecular) bone. Compact bone, which is rigid and dense, is found mainly in the 
middle shaft of long bones or shells of other bones. Found predominantly in epiphysis, 
ribs and spine, cancellous bone has a highly porous structure (>75%), with numerous 
small bone trusses or trabeculae interconnected with each other, and tends to orient 
along the principal directions in adaptation to the external loading environment.  
Bone is composed of four different cell types. Osteoblasts, osteoclasts and bone lining 
cells are present on bone surface, whereas osteocytes permeate the mineralized 
interior. Osteoblasts, osteoclasts and bone lining cells originate from local 
osteoprogenitor cells, whereas osteoclasts arise from the fusion of mononuclear 
precursors, which originate in the various hemapoietic tissues. Osteoblasts are the fully 
differentiated cells responsible for the production of the bone matrix and regulation of 
its mineralization. The osteocyte is a mature osteoblast within the bone matrix and is 
responsible for the matrix maintenance. Bone lining cells are flat, elongated cells that 
cover bone surfaces that are undergoing neither bone formation nor resorption. Little is 
known regarding the function of these cells, however, it has been speculated that bone 
lining cells can be precursors for osteoblasts. Osteoclasts are large, multinucleated cells, 
which are able of resorbing bone mineral. 
 
 
1.3 Current methods of bone repair 
 
The improvement of the quality of life and consequent increase of life expectancy are 
accompanied by the expanding demand for the repair of damaged and degraded 
organs and tissues. Bone tissue regeneration remains an important challenge in the field 
of orthopaedic- and maxillofacial surgery. Spinal fusions and repairs of bone defects 
caused by traumas, tumors, infections, biochemical disorders and abnormal skeletal 
development, are some examples of the frequently performed surgeries in the clinic. For 
most of these surgeries, there is a great need for grafting materials. Below, an overview 
of the existing bone graft substitutes is given. 
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1.3.1 Natural bone grafts 
 
Autologous bone is still considered the golden standard for bone repair and 
regeneration, in particular because of the absence of immunogenic reaction after the 
surgery [13-17]. In addition, autologous bone grafts possess a great biological 
performance in terms of osteogenicity (supply of bone forming cells by the bone 
marrow) [18], osteoinductivity (initiation of the differentiation of mesenchymal stem cells 
towards the osteogenic lineage by e.g. bone morphogenetic proteins (BMPs) present in 
the graft) [14, 17-19] and osteoconductivity (facilitation of cell- en nutrient infiltration 
through the 3D porous structure) [17, 18, 20]. Although autologous bone grafting meets 
many requirements for bone regeneration, its use is also associated with some important 
drawbacks. The harvest of the graft requires an additional invasive surgical procedure 
that may lead to donor site morbidity [14, 16-18], chronic post-operative pain [17, 21-
23], hypersensitivity [17] and infection [18, 23, 24]. Another important drawback of the 
use of autograft is the limited availability. Unlike autologous bone, allogeneic and 
xenogeneic grafts are widely available and do not require an additional surgery on 
the patient. However, allogeneic bone has to undergo processing techniques such as 
lyophilization, irradiation or freeze-drying to remove all immunogenic proteins in order 
to avoid any risk of immunogenic reaction [25, 26]. In turn, these processing techniques 
have a negative effect on osteoinductive and osteoconductive potential of the allografts 
[27], which consequently decreases their biological performance as compared to 
autografts [21, 28-30]. 
 
 
1.3.2 Synthetic bone graft substitutes  
 
Because of the above-mentioned drawbacks of natural bone grafts, a large number of 
synthetic graft substitutes have been developed. Synthetic bone graft substitutes are 
largely available, they do not cause antigenic response and can easily be tailored 
depending on the intended application. Synthetic bone graft substitutes are based on 
the biomaterials, which are defined as “non-viable materials used in a medical device, 
intended to interact with biological systems” [31].  
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As shown in the chart in figure 1, based on their chemical composition, biomaterials can 
be divided into four groups: 
• Metallic implants, such as titanium and its alloys, stainless steel and cobalt-
chromium alloys, 
• Ceramics, such as calcium-phosphate-, alumina-, carbon- and glass ceramic, 
• Polymers like poly (methyl methacrylate), poly (urethane), ultra high molecular 
weight poly ethylene, silicon and polylactide, 
• Composites of first three groups such as calcium-phosphate ceramic coatings on 
metallic implants or polymer-ceramic composites. 
Diverse calcium-phosphate containing biomaterials and metals, as well as the 
combinations of the two are most frequently used for bone repair and replacement. 
 
 
1.3.2.1Calcium phosphate biomaterials 
 
Calcium-phosphate (CaP) biomaterials, with the chemical composition similar to that of 
bone and teeth mineral, are the most widely used synthetic bone graft substitutes. In 
addition to an excellent biocompatibility, their bioactivity is remarkable.  
As reviewed by Damien and Parsons [17], various CaP biomaterials have shown some 
distinct clinical successes. Both hydroxyapatites of natural origin (coral- and bovine bone 
derived) and synthetic hydroxyapatites have widely been tested and successfully used 
for clinical applications. Due to its low resorption rate, hydroxyapatite has proven to be 
a good material for alveolar ridge augmentation, pulp capping, and filling of 
periodontal defects, where the use of autologous bone has been found to be less than 
optimal. In orthopaedics, porous hydroxyapatite blocks have been used for filling 
defects remaining after tumor excision, for spinal fusion of vertebral bodies and for the 
canine defects. Dental applications of tricalcium phosphate ceramics include the filling of 
defects due to periodontal loss, as well as repairing cleft palates. In orthopaedics, 
tricalcium phosphate remains an implant material for defect filling where a resorbable 
material is indicated. A ceramic receiving much attention is biphasic calcium phosphate, 
consisting of hydroxyapatite and tricalcium phosphate. This ceramic is clearly 
biocompatible and osteoconductive, while having a resorption rate between that of 
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pure hydroxyapatite and pure tricalcium phosphate. By altering the ratio of 
hydroxyapatite to tricalcium phosphate, variable rates of degradation can be 
achieved. Clinically, biphasic calcium phosphate has been tested for treatment of 
patient with scoliosis and for filling defects after tumor removal. 
 
 
Figure 1: an overview of bone grafts and bone graft substitutes. 
 
 
The concept of developing CaP cement was introduced by LeGeros et.al. and Chow 
et.al. CaP cements consist of solid and liquid components, and the product obtained 
after the setting of the cement is dependent on the reaction between these two 
components. A great advantage of the cements above other CaP materials is that they 
are injectable [32]. 
Investigations of the biological performances of glass ceramics and bioactive glass have 
also shown favorable bone-bonding characteristics, due to their ability to form a CaP 
rich layer on their surface. However, their inherent weakness limits their use to non-
loadbearing sites and alveolar ridge reconstruction [17, 33, 34].  
 
 
1.3.2.2 Metals 
 
Metallic implants like titanium and its alloys are biocompatible [35, 36] and have 
excellent mechanical properties, which makes them suitable for load-bearing 
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applications [37]. However, high stiffness of the metals often leads to stress-shielding 
from residual bone, which may result in detrimental resorptive bone remodeling [38], 
and consequently to a poor fixation of the implant. Recent developments in metallic 
implant designs therefore focus on adapting the mechanical properties of metals to 
those of biological systems, by e.g. introduction of a porous structure.  Although they are 
widely used in load-bearing application, the ability of metals to bond to bone and to 
guide new bone formation are distinctly smaller as compared to the earlier described 
CaP materials.  
Heat-, acidic and alkaline treatments of metals, and sputtering of their surfaces with 
e.g. corundum are all meant to increase the surface roughness of and even to introduce 
microporosity into their structures. By doing so, the surface of metallic implant harbors 
nucleation sites for the formation of calcium-phosphate crystals in a saturated 
environment, which in turn, can significantly influence the metal’s bioactivity. Similarly, 
aluminum oxide powder can be used to make highly macro- and microporous metallic 
ceramics, with improved bioactivity as compared to other metals. 
 
 
1.3.2.3 Composites 
 
Composites consist of two or more different biomaterials which are combined with the 
aim to improve their properties in terms of mechanical strength, osteoconductivity, etc. 
For example, in order to decrease stiffness of CaP ceramics without losing their 
osteoconductive properties, composites of collagens [39] and synthetic polymers [40, 
41] with CaPs are made.  
Another example of composites are CaP ceramic coatings that have been developed in 
order to be combined with e.g. metallic implants. Thereby, mechanical properties of 
metals are combined with the osteoconductivity of CaPs. Plasma sprayed coatings, 
mainly hydroxyapatite, on titanium alloy (Ti6Al4V) prostheses have widely been used in 
orthopaedic surgery to reconstruct hip and knee joints. Earlier investigations have shown 
that these coatings can successfully enhance clinical success to less than 2% failures after 
10 years [42]. Despite excellent clinical performances, the plasma spray process is 
limited by intrinsic drawbacks. For instance, this line-of-sight process takes place at high 
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temperatures. The process is, therefore, limited to thermally stable phases like 
hydroxyapatite, and the incorporation of growth factors that stimulate bone healing is 
impossible. Furthermore, the process of plasma-spraying cannot provide even coatings 
on porous metal surfaces. Recently, other techniques have been studied to improve the 
quality of coatings, such as electrophoretic deposition [43], sputter deposition [44] , and 
sol-gel [45]. Nevertheless, the deposition of apatite coatings from simulated body fluids 
offers the most promising alternative to plasma-spraying and other coating methods. 
The biomimetic approach has four main advantages: it is a low temperature process 
applicable to, besides metals, any heat-sensitive substrate including polymers [46], it 
forms bone-like apatite or octacalcium phosphate crystals having high bioactivity and 
good resorption characteristics [47], it is evenly deposited on or even into porous or 
complex implant geometries and it can incorporate bone growth stimulating factors [48, 
49]. 
 
 
1.3.3 Tissue-engineered hybrids 
 
Despite intensive research and continuous improvements of synthetic biomaterials, so far 
these materials do not perform as good as autologous bone grafts. Bone conduction 
over the material surface and the replacement by bone as well as their mechanical 
properties are usually inferior to autologous bone grafts [17, 29, 50-52]. In order to 
bring the biological performance of synthetic biomaterials closer to that of autologous 
bone, a new interdisciplinary research field has developed: tissue engineering. In 1993 
Langer and Vacanti defined tissue engineering as an: “interdisciplinary field that 
applies principles of engineering and life sciences toward the development of 
biological substitutes that restore, maintain, or improve tissue function” [53]. With 
regard to bone regeneration, mainly two strategies have been implemented to 
generate new tissue: 1) chemical stimulation of bone formation through the use of bone 
inducing substances and 2) the construction of hybrid implants composed of osteogenic 
cells/tissue and a biomaterial scaffold [53].  
To date numerous growth factors have been identified and subsequently produced by 
recombinant gene technology, such as bone morphogenetic proteins (BMPs) and other 
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members of the transforming growth factor β (TGFs-β) family, fibroblast growth factors 
(FGFs), plateled-derived growth factors (PDGFs) and insuline derived growth factors 
(IGFs). Various studies have shown that bone growth factors have several regulating 
effects on cells from the osteoblastic lineage and in vivo studies have demonstrated that 
some factors can induce bone formation and/or stimulate bone healing. Kirker-Head 
has reviewed the application of BMPs in a number of animal models at various 
orthotopic sites, such as spinal fusion, long bone defects, mandibular and cranial bone 
defects, fracture healing, as well as in periodontal regeneration, alveolar ridge 
augmentation and osteointegration of dental implants [54]. In addition, various 
preclinical and clinical studies have shown positive effects of BMP in nonunions and 
segmental defects, like traumatic tibial defect [55, 56] and femoral defects [57]. 
The combination of autologous cells with carriers is another way to produce tissue-
engineered hybrids. Various cell types such as calvarial [58, 59] and periostal [60, 61] 
cells, osteoblasts of trabecular bone [62, 63], chondrocytes [64] and vascular pericytes 
[65] have been tested as potential sources of bone forming cells. Nevertheless, the most 
widely used source of osteogenic cells is bone marrow. Bone marrow has been 
recognized as a source of osteoprogenitor cells that can differentiate towards bone 
forming cells when cultured under adequate conditions [66-69]. In addition, bone 
marrow has been shown to be the most abundant source of osteoprogenitors, which 
possess high proliferative ability and great capacity for differentiation [70, 71]. Studies 
in rodents have shown the feasibility of the tissue-engineered hybrids, consisting of a 
carrier and bone marrow stromal cells, after ectopic [72, 73] and orthotopic 
implantation [72-76]. In larger animals, there are a few studies showing the biological 
performance of the TE hybrids, in ectopic [77-80] and orthotopic sites [80-82]. 
Although both growth factors-based and cell-based tissue-engineered constructs have 
shown the capability to enhance bone formation when implanted orthotopically, their 
biological performance is for a big part dependent on the construct carrier. For 
example, when BMPs are implanted without a carrier, they are reported to diffuse too 
rapidly to be able to induce or to enhance new bone formation. Furthermore, the 
amount of BMP necessary to achieve a certain dose in vivo is also carrier dependent 
[83-85].  Similarly, a suitable carrier is a prerequisite for the success of a cell-based 
tissue-engineered construct. For instance, recent studies have shown that bone formation 
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in tissue-engineered constructs is restricted to confined areas of the scaffold. 
Furthermore, bone bridging between individual tissue-engineered material granules is 
exceptional. In addition, the findings of the clinically relevant studies suggest that the 
effect of tissue engineering is moderate and may be irrelevant at long-term 
implantation intervals [86]. The tissue engineering technique is also associated with some 
drawbacks. The production of recombinant growth factors, collection and transport of 
the biopsies, culture of autologous cells are some of the factors that make tissue 
engineering time-, money- and labor-consuming.  
The real challenge of the bone regeneration research field still lies in the development 
of synthetic bone graft substitutes. Further improvement of biomaterials is needed in 
order to make tissue engineering more successful, and ideally, even unnecessary. Fully 
synthetic “intelligent” biomaterials should be able to perform at least as good as 
autologous bone graft. A group of potentially “intelligent” biomaterials are 
osteoinductive biomaterials. 
 
 
1.4 Backgrounds on osteoinduction 
 
Bone and cartilage formation has been found in extraskeletal tissues after implantation 
of devitalized tissue and tissue extracts as early as in the beginning of the 20th century 
[87-91]. At that time however, consistent results have rarely been obtained and little 
was known about elements involved in this process.  
In 1958 Bridges and Pritchard performed a screening study in rabbits in order to 
examine the fate of a variety of devitalized tissues and other substances introduced in 
the rabbit soft tissue and to study the histological changes occurring after procedures 
which consistently resulted in bone or cartilage formation [92]. The results of this study 
showed that tissues containing hypertrophic cartilage consistently induced bone if 
devitalized with alcohol, acetone, hydrochloric acid or heating to 55 °C, while skeletal 
and cardiac muscle and tissues containing smooth muscle, which were devitalized with 
alcohol and acetone, consistently induced cartilage followed by bone. It was concluded 
that induction was due to liberation of chemical substances, possibly of protein nature, 
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from the implants, and that these substances may be identical in hypertrophic cartilage 
and muscle. 
In 1965 Urist set a landmark in the research into osteoinduction by publishing a report 
in which osteoinduction by hydrochloric acid-decalcified diaphyseal bone was 
consistently shown in muscles of rabbits, rats, mice and guinea pigs [19]. Urist illustrated 
that bone formation in extraskeletal implants of decalcified bone matrix occurs in the 
interior of cavities, and that new osteoblasts are not derived from elements of the donor 
tissue, but from proliferating pluripotent, ingrowing cells of the host. 
Another highly valuable report in osteoinduction was published by Friedenstein in 1968 
in which bone induction by transitional epithelium was described [93]. The author 
defined osteoinduction as “the induction of undifferentiated inducible osteoprogenitor 
cells (IOPCs) that are not yet committed to the osteogenic lineage to form 
osteoprogenitor cells”. This induction only takes place in the presence of inducing 
substances, such as transitional epithelium or demineralized bone. 
Later work by Urist and coworkers led to the conclusion that a discrete protein within the 
demineralized bone matrix (DBM) was the sole inducer of bone formation. This finding 
was published in 1971 and this protein was named Bone Morphogenetic Protein (BMP) 
[94]. BMP was shown to be involved in the bone formation cascade of chemotaxis, 
mitosis, differentiation, callus formation and finally bone formation. Different groups 
showed that BMPs have the ability to induce de novo endochondral bone formation 
when implanted in ectopic sites of different experimental animals. Proof that BMP could 
be extracted from demineralized bone matrix and still retain its ability to form bone 
came in 1977 [95]. 
 
 
1.4.1 Osteoinduction by Bone Morphogenetic Proteins 
 
To date 15 BMPs are known (BMP1-15) [96]. Besides BMP-1, which is a 
metalloprotease [97], BMPs belong to the Transforming Growth Factor beta (TGF-β) 
superfamily [98, 99]. When DBM (or BMPs) are implanted ectopically in rodents, a 
cascade of events, similar to embryonic bone formation and fracture healing is initiated. 
First, the chemotaxis of undifferentiated mesenchymal cells occurs, followed by cell 
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proliferation. Then, these cells differentiate into chondroblasts and chondrocytes, 
followed by the formation of cartilaginous extracellular matrix including type II collagen 
and proteoglycans. The chondrocytes mature and become hypertrophic, and cartilage 
starts to mineralize. Following the period of chondrogenesis, blood vessels appear at 
the implantation site. Bone-forming cells are consequently observed, and while calcified 
cartilage is removed by osteoclasts, bone matrix is produced. Once bone has been 
formed, hemopoietic bone marrow appears within the bone. Finally, bone undergoes 
remodeling [100]. In figure 2, a sequence of events during osteoinduction by BMPs is 
illustrated. 
Although it is generally thought that BMP-induced bone formation is endochondral 
[101], recent reports have shown that, depending on the carrier on which BMPs are 
implanted in the body, osteoinduction by BMPs can be either endochondral or 
intramembranous. For example, fibrous collagen membrane [102], hydroxyapatite 
[103] and biomimetic CaP coatings [104] in combination with BMP have shown 
intramembranous bone induction. In contrast, BMPs on fibrous glass membrane and 
insoluble bone matrix showed that ectopic bone was formed following the process of 
endochondral ossification [102, 103]. The exact reason for the observed difference 
between different carriers is not completely understood yet. It has been proposed that 
differences in vascularization as well as differences in local oxygen concentrations might 
be of importance in the process of differentiation of the undifferentiated cells into either 
chondroblasts or directly into osteoblasts [105]. For both optimal vascularization and 
oxygen levels, the ultrastructure of the carrier has been proposed to be relevant [106]. 
Osteoinductive capacity of BMPs has mostly been tested in rodents, either 
subcutaneously or intramuscularly. In comparative studies, more bone was induced 
intramuscularly than subcutaneously or intra-fatty, suggesting again the importance of 
vascularization in ectopic bone formation, as it is generally accepted that the level of 
vascularization is higher in the muscle as compared to other investigated soft tissues 
[107, 108]. Only a few reports describe osteoinduction by BMPs in higher animals, 
namely in monkeys and baboons [109-112]. Besides the observations of the differences 
in response to BMPs between different species [112], there are reports showing 
differences in response to ectopically implanted BMPs, between individuals of the same 
species, probably due to genetic differences [113].  
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Figure 2: the sequence of events in endochondral bone formation. 
 
 
1.4.2 Osteoinduction by biomaterials 
 
Soon after Urist’s description of osteoinduction by DBM and the suggestion that BMPs 
are responsible for the process of osteoinduction, Winter and Simpson described an 
observation of bone induction by a sponge made of polyhydroxyethylmethacrylate 
(poly-HEMA), that was at that time used for e.g. breast augmentations, in soft tissue of 
pigs [114]. The authors observed that the implanted sponge became calcified prior to 
bone formation. Calcification of the used sponge was also observed after subcutaneous 
implantation in rats. The observed phenomenon of bone induction by the polymeric 
sponge could not be explained by the Urist’s theory, as the sponge neither contained 
nor produced BMPs. Interestingly, in earlier reports it was observed that bone was 
induced by tendons and arteries only if they were first calcified in vivo, as reviewed by 
de Groot [115]. Although the exact underlying phenomenon was not known, these 
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observations suggested that calcification, and hence calcium-phosphates might play an 
important role in the process of osteoinduction. 
In the last decade, a large number of publications illustrated osteoinduction by diverse 
CaP biomaterials, such as synthetic hydroxyapatite ceramic in dogs [116-120], coral 
derived hydroxyapatite ceramic in dogs, monkeys and baboons [117, 121-123], α-
tricalcium phosphate, β- tricalcium phosphate-, biphasic calcium phosphate-, α-
pyrophosphate- and β-pyrophosphate ceramics [122, 124-130]. In addition, CaP 
cements [124, 131] and coatings [132, 133] were shown to be osteoinductive in various 
animal models. Besides CaP containing biomaterials, osteoinduction was also observed 
in alumina ceramic [134], titanium [135, 136] and glass ceramics [137]. The last group 
of materials was shown to be able to precipitate a CaP layer on their surface in a Ca- 
and P-rich environment, and their in vivo ectopic bone formation was preceded by the 
process of calcification.  
Until now the exact mechanism of osteoinduction by biomaterials is still largely unknown. 
It is furthermore questionable whether the mechanisms of osteoinduction by BMPs and 
osteoinduction by biomaterials are the same. In some reports by Ripamonti and 
coworkers it is hypothesized that endogenous BMPs are collected in the biomaterial 
post-implantation and that they consequently induce bone formation ectopically [138, 
139]. The authors, however, failed in giving a conclusive evidence for their hypothesis. In 
the pilot study by Yuan and coworkers it was suggested that BMPs do play a role in 
osteoinduction by biomaterials, although this role does not seem to be essential [140]. 
The limited number of animals used in this pilot study limited the reliability of its results. 
The three apparent differences in osteoinduction by BMPs and biomaterials are that 1) 
bone induced by biomaterials is always intramembranous [121, 129] while BMP-
induced bone is mostly formed via the endochondral pathway [101], 2) in small animals 
such as rodents bone is very rarely induced by biomaterials [116, 141-144], but easily 
by BMPs [145-147] and 3) while bone is never observed on the periphery of the 
biomaterials and it is always formed inside their pores, bone formation by BMPs is 
regularly seen on the  outside of the carrier and even in the soft tissue distant from the 
carrier surface [104, 148]. 
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The exact processes involved in the mechanism of osteoinduction by biomaterials are still 
largely unknown. The work by many groups has, however, shown that biomaterials need 
to meet very specific requirements in terms of (Ι) macro-, (ΙΙ) microstructure and (ΙΙΙ) 
chemical composition in order to be osteoinductive. 
From the literature, the following is known about the relevance of the above material 
characteristics in the process of osteoinduction: 
 
(Ι) Macrostructure: 
• CaP ceramics: Bone induction by CaP ceramics was never observed on flat 
ceramic surfaces. All osteoinductive ceramics had either a porous 
macrostructure [116, 118, 119, 121, 122, 124-126, 128, 149] or a 
macrostructure that contained well-defined concavities [138]. Bone formation 
was never observed on the peripheries of porous implants, and was always 
found inside the pores or concavities, aligning the surface. 
• CaP cements: Bone induction in CaP cements was only observed in the pores 
and surface crevices formed due to degradation of cements [124, 131]. Bone 
formation was never observed on the flat cement surfaces. 
• CaP coatings: Bone induction by the biomimetically produced octacalcium 
phosphate was only observed when the coating was applied on porous 
scaffolds and solely in their center [132, 133]. Similarly, bone formation was 
observed inside the octacalcium phosphate coated hollow titanium cylinders, 
contrary to the dense coated titanium cylinders [132]. 
• Glass ceramic [137], alumina ceramic [134], polymeric sponge [114] and 
titanium [135, 136]: osteoinductive glass ceramic, alumina ceramic and 
synthetic poly-HEMA sponge all possessed a porous macrostructure. 
Osteoinductive titanium was macroporous having a complex macrostructure 
produced by sputter technique. The same porous metal, produced in the form 
of fibrous mesh, i.e. with a more simple porous structure, was not osteoinductive 
[135]. 
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(ΙΙ) Microstructure: 
• Unfortunately, in many reports on osteoinduction, microstructures of the used 
materials were poorly characterized. The following reports gave an indication 
of the importance of microstructure:  
• CaP cements: pores and surface crevices in which the bone induction took place 
had a rough microstructure [124, 131]. 
• CaP coatings: bone induction was observed on the octacalcium phosphate 
coated porous Ta implants, in contrast to the carbonated apatite coated ones 
[132]. Apart from the chemical composition difference between the two CaP 
phases, the two coatings differed significantly in their surface morphologies. 
Octacalcium phosphate coating had a rough morphology, due to its large 
crystals perpendicularly grown on the substrate surface, in contrast to a more 
smooth morphology of carbonated apatite. 
• Glass ceramic, alumina ceramic, titanium and glass [134, 137]: all materials 
possessed a rough surface due to the used production techniques. Only 
chemically/thermally treated titanium implants induced bone [135, 136]. The 
result of such a treatment was the formation of micropores on the metal surface, 
which was absent on the untreated implants. 
 
(ΙΙΙ) Chemical composition (presence of CaP): 
• CaP ceramics, cements and coatings and glass ceramic all contained CaP. Poly-
HEMA sponge, alumina ceramic and titanium did not contain CaPs initially. 
Nevertheless, all these materials are known to be able to calcify in vitro when 
immersed in SBF [135]. A similar process of calcification, that is possibly a 
precursor of bone formation, is expected to take place in vivo [114, 134, 135, 
137].  
 
Based on the knowledge of the importance of structural and physico-chemical 
properties of the material in the process of osteoinduction, a hypothesis of the 
mechanism of osteoinduction by biomaterials is given in a flowchart (figure 3). 
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Figure 3: flowchart of the proposed mechanism of osteoinduction by biomaterials. 
 
 
The interest in osteoinductive biomaterials is based on the hypothesis that a material 
that is able to induce bone ectopically will also perform better at orthotopic sites. 
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However, because of the lack of understanding of the mechanism of osteoinduction by 
biomaterials, at present, many studies still focus on ectopic implantations, as this is the 
only way to give the evidence of osteoinductive potential of a biomaterial.  
Therefore, the number of studies in which osteoinductive potential of a material is 
directly linked to its performance orthotopically is very limited, and even more limited is 
the number of studies in which osteoinductive materials are tested in clinically relevant 
orthotopic defects. 
 
 
1.5 Heterotopic ossification 
 
The phenomenon of osteoinduction cannot be discussed without shedding light upon a 
frequently observed clinical problem which closely resembles osteoinduction: heterotopic 
ossification. Heterotopic ossification, sometimes also called pathological ossification is 
often simply defined as the presence of bone in soft tissue, where bone normally does 
not exist. This condition should not be confused with metastatic calcification, such as 
observed with hypercalcemia, and dystrophic calcification, which occurs in morbid tissues 
such as tumors. 
Heterotopic ossification can roughly be divided into two forms. The first, acquired form 
is often associated with trauma (fracture, total hip arthroplasty, muscular trauma) or has 
a neurogenic cause (spinal cord or central nervous system injuries) and is most common. 
In addition, there is the rare hereditary form, including fybrodisplasia ossificans 
progressiva (also known as myositis ossificans progressiva), progressive osseous 
heteroplasia and Albright hereditary osteodistrophy [150]. 
 
 
1.5.1 Acquired heterotopic ossification 
 
The most common, acquired form of heterotopic ossification may occur after virtually 
any type of musculoskeletal trauma. For example, heterotopic ossification may occur 
after orthopaedic procedures such as hip-, knee-, elbow- or shoulder arthroplasty, 
fractures, joint dislocations, or soft-tissue trauma, with the musculus quadriceps femoris 
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and musculus brachialis often involved. Heterotopic ossification includes the specific 
posttraumatic variant myositis ossificans, in which patients often have soft-tissue 
ossification at sites of trauma adjacent to long bones. Less commonly encountered sites 
of posttraumatic heterotopic ossification are abdominal incisions, wounds, the kidneys, 
the uterus, the cardiac valves, the corpora cavernosa and gastrointestinal tract. The 
other common traumatic form of heterotopic ossification occurs after injury to the 
nervous system, usually without direct injury to the soft tissue where bone formation will 
occur, and is therefore known as posttraumatic neurogenic heterotopic ossification. 
Heterotopic ossification often occurs among patients with recent spinal cord injury and it 
develops only in sites distal to the level of the injury. Closed head injuries, strokes and 
brain tumors also may lead to heterotopic ossification. Notable, but more rare, are the 
cases of heterotopic ossification after burns, sickle cell anemia, hemophilia, tetanus, 
poliomyelitis, multiple sclerosis and toxic epidermal necrolysis. 
The clinical signs and symptoms of heterotopic ossification may appear as early as 
three weeks or as late as twelve weeks after the musculoskeletal trauma, spinal cord 
injury or other. Loss of joint mobility and resulting loss of function are the most important 
complications of heterotopic ossification. Other complications include peripheral nerve 
entrapment and pressure ulcers. 
The transformation of mesenchymal cells, present in the connective tissue septa within 
muscle, into osteogenic cells is thought to be the pathogenesis of heterotopic ossification. 
The differentiation of the mesenchymal cells into the osteogenic lineage is postulated to 
be induced by the bone morphogenetic protein that is liberated from normal bone in 
response to venous stasis, inflammation, or diseases of connective tissue attachments to 
bone, conditions that often accompany immobilization or trauma. Some investigators 
proposed the involvement of a centrally mediated factor. The role of prostaglandin E2 
(PGE2) has also been suggested as a mediator in the differentiation of the 
mesenchymal cells of the soft tissue into the osteogenic lineage. Observations showed 
that the heterotopic bone formation often starts at some distance from normal bone, 
later moving towards it [150-152]. 
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1.5.2 Pathological heterotopic ossification 
 
Hereditary forms of heterotopic ossification, such as fybrodisplasia ossificans 
progressiva, progressive osseous heteroplasia and Albright hereditary osteodistrophy 
do not go accompanied with traumas and severe injuries. 
Fybrodisplasia ossificans progressiva (FOP) is a severely disabling, autosomal dominant 
disorder that is characterized by congenital malformation of the great toes and by 
postnatal progressive heterotopic ossification of tendon, ligament, fascia and skeletal 
muscle. FOP has three distinguished features: (Ι) congenital malformation of the great 
toes, (ΙΙ) heterotopic ossification of soft connective tissues and (ΙΙΙ) temporal progression 
of osteogenesis in characteristic anatomic patterns. Patients who have FOP have two 
skeletons: a normotopic one formed during embryogenesis and heterotopic one formed 
after birth. Although heterotopic bone forms independently of the skeleton, maturing 
heterotopic bone generally forms rigid synostoses with the normotopic skeleton, thus 
further restricting motion and exacerbating disability.  
Congenital malformation of the great toes along with postnatal heterotopic 
endochondral osteogenesis strongly suggests that FOP is a disorder of defective 
induction of endochondral osteogenesis. The earliest histopathological finding is an 
intense perivascular lymphocytic infiltration, followed by death of skeletal muscle and 
replacement by highly vascular fibroproliferative soft tissue. The soft tissue rapidly 
matures through an endochondral process to form heterotopic bone. 
The autosomal dominant inheritance of FOP has been documented, but the gene or 
genes responsible for this disorder are unknown. BMP-4 is overexpressed in 
lymphocytes and lesional cells of patients who have FOP, but mutations have not been 
detected in the FOP genes, and recent linkage studies exclude the BMP-4 locus. The 
molecular cause of FOP may be in a component of the BMP signaling pathway or in 
some other gene whose product controls BMP-4 production [152, 153].  
Albright hereditary osteodystrophy (AHO) is an autosomal dominant disorder of the 
skin, skeletal and endocrine system, with variable features that may include 
pseudohypoparathyroidism, multiple hormone resistance, obesity, short stature, round 
facies and cutaneous and subcutaneous ossification. In most patients with AHO, the 
disease is caused by heterozygous mutations in GNAS1, a gene of human chromosome 
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20 encoding the α-subunit of the stimulatory G protein of adenylyl cyclase. This genetic 
defect leads to the impaired activation of adenylyl cyclase and impaired cyclic 
adenosine monophosphate (AMP)-mediated signal transduction [154]. 
Progressive osseous heteroplasia (POH) is a developmental disorder of mesenchymal 
differentiation characterized by dermal ossification during infancy and by progressive 
heterotopic ossification of cutaneous, subcutaneous and deep connective tissue during 
childhood. The disorder can be distinguished from FOP by the presence of cutaneous 
ossification, by the absence of congenital skeletal malformations, by the asymmetric 
mosaic distributions of lesions, by the absence of predictable regional patterns of 
heterotopic ossification and by the predominance of intramembranous rather than 
endochondral ossification. POH can be distinguished from AHO by the progression of 
heterotopic ossification from skin and subcutaneous tissue into skeletal muscle, by the 
absence of morphological features associated with AHO and by the presence of normal 
endocrine function. As already mentioned, heterotopic ossification in POH occurs 
predominantly through an intramembranous pathway, although there are few reports 
describing observed islands of endochondral ossification. 
Although it is still largely unknown what the pathogenesis of POH is, the involvement of 
the presence of a mutant gene in mesenchymal stem cells destined for widespread 
distribution has been suggested. Observations in patients with POH suggest that such 
mesenchymal stem cells or more committed osteogenic precursors are present in skin, 
subcutaneous fat, muscle, tendon and ligament tissue [154]. 
In summary, heterotopic ossification, as a general name for the bone formation in 
extraskeletal sites often observed in the clinic, can be divided into two forms: acquired 
and hereditary. The first, acquired form of heterotopic ossification, is most often caused 
by traumas and severe injuries, and is most probably induced by BMPs released from 
the surrounding bone as a reaction to inflammation and other consequences of the 
trauma. This form of heterotopic ossification should therefore not get the label 
pathological. Hereditary form of heterotopic ossification involves diseases. In the case 
of FOP, the involvement of BMP-4 is suggested, while AHO and POH most probably 
have other underlying mechanisms. 
Obviously, the involvement of BMPs in some types of heterotopic ossification suggests 
close resemblance with osteoinduction by BMPs. In the basis, osteoinduction and 
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heterotopic or pathological ossification are two names for the same phenomenon, but 
used in a different manner. While the word osteoinduction is used to express the ability 
of a substance to induce new bone formation, the word pathological ossification is used 
to refer to the problem that bone growth at abnormal sites can cause. Whether 
osteoinduction by biomaterials also represents the same phenomenon is, as discussed 
earlier, not completely understood yet. Bone formation in osteoinductive materials is 
found in soft tissue far away from the skeleton, which excludes release of BMPs from the 
surrounding bone as in the case of a trauma or a spinal cord injury. That endogenous 
BMPs are locally produced as the reaction of the body to the surgery is possible, but 
does not explain the fact that one type of the materials does and another type does not 
induce bone formation. Besides, the lack of bone induction on the periphery of the 
materials, lack of bone induction in small animals and consistent intramembranous 
ossification all suggest that osteoinduction by biomaterials is (partially) different from 
osteoinduction by either added or locally produced BMPs. 
 
 
1.6 Aims and approach of the thesis 
 
The full understanding of the phenomenon of osteoinduction should help us developing 
better bone graft substitutes by teaching us the parameters that nature needs in order 
to start producing bone. It is thereby important to use the knowledge of fundamental 
biological processes and to combine it with materials science knowledge. In this thesis, 
we have attempted to come a step closer to the unraveling of the mechanism of 
osteoinduction.  
This thesis manly focuses on achieving two goals: (Ι) gathering relevant information on 
the parameters which are important in the process of osteoinduction by biomaterials in 
order to unravel this, so far largely not understood, phenomenon and (ΙΙ) investigating 
the relevance of osteoinductive biomaterials orthotopically in order to get more insight 
into their potential use in the clinic. 
In order to achieve these goals, the following questions need to be answered: 
• What is the influence of chemical composition, microstructure and surface 
morphology on the osteoinductive properties of materials? The dynamics of the 
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interaction between a material and the in vivo surrounding can be influenced 
by either changing its chemical compositions (e.g. addition of a more soluble 
compound) or by changing its specific surface area (e.g. by introducing 
micropores or by coating the surface with a highly crystalline phase). Changes 
of the interaction between the material and its in vivo environment are 
hypothesized to be of influence on the material’s osteoinductive properties. 
• Is there an influence of implant size and implantation site on the relative 
amount of induced bone? Osteoinduction by biomaterials always takes place 
inside the implant and never on its periphery. A smaller implant has relatively 
more periphery than a larger implant, which could be a reason for more 
micromotion in the center of the smaller implant. Besides, there is relatively 
more surface available for infiltration of cells and nutrients within a large 
implant as compared to a small implant. A larger implant is therefore 
hypothesized to induce relatively more bone ectopically than a smaller implant 
of the same type. Vascularization is hypothesized to be of great importance in 
osteoinduction by biomaterials. It is therefore expected that the implantation of 
a material intramuscularly will result in more bone formation than the 
implantation of the same material subcutaneously.  
• What occurs on or near the surface of an osteoinductive material during ectopic 
implantation? After implantation, on the surface of a CaP-containing material, 
release of calcium and phosphate ions takes place, followed by the 
reprecipitation of a more stable carbonated apatite layer. During the 
formation of the apatite layer, endogenous proteins are coprecipitated into the 
layer. These events lead to the initiation of the differentiation of the 
undifferentiated cells into the osteogenic lineage. It is hypothesized that on the 
surface of a material with a high specific surface area, the process of 
dissolution-reprecipitation/coprecipitation will take place faster and will be 
more pronounced that on the similar material with a lower specific surface 
area. 
• What is the performance of osteoinductive biomaterials at orthotopic 
implantation sites? It is hypothesized that a material that is able to induce bone 
formation ectopically, i.e. an osteoinductive material, has the ability to increase 
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the amount of bone formed orthotopically, in comparison with a non-
osteoinductive material. 
In order to answer the above questions, two material types are used as a model: 
biomimetically produced octacalcium phosphate coating applied on surfaces of porous 
metals, polymers and ceramics and sintered porous ceramics based on hydroxyapatite.  
The phenomenon of osteoinduction by biomaterials is complex and still largely unknown, 
which makes it difficult to use simplified in vitro models to study its mechanism. 
Uncontrollable interactions between the material and the cell culture medium, difficulties 
in choosing the right cell sort and culture conditions are only few examples of the 
problems one is confronted with when trying to study a complex phenomenon such as 
osteoinduction in vitro. 
Because of the above shortcomings on the in vitro systems, in this thesis, the in vivo model 
in goats is chosen. As previously mentioned, osteoinduction by biomaterials is rarely 
observed in rodents and other small animals, which was a reason to chose a large 
animal as a model. In addition, a large animal model is needed to be able to test 
osteoinductive materials in clinically relevant critical-sized orthotopic defects. The choice 
of goat as a model was made because of the large availability in The Netherlands. 
Chapter 2 of this thesis is a review on limitations of different in vitro models to study 
bone repair by biomaterials and complex biological phenomena involving bone 
formation such as osteoconduction and osteoinduction. 
Chapters 3, 4 and 5 deal with physico-chemical parameters which are of importance in 
the mechanism of osteoinduction. In Chapter 3, it is investigated whether a relatively 
simple application of biomimetic octacalcium phosphate coating can improve 
osteoinductive properties of a range of different porous biomaterials. In Chapters 4 
and 5, influence of chemical composition (pure hydroxyapatite and biphasic calcium 
phosphate ceramic in Chapter 4 and different hydroxyapatite to β-tricalcium 
phosphate weight ratios in biphasic calcium phosphate ceramic and carbonated apatite 
ceramics in Chapter 5) and microstructure (and hence specific surface area) on 
osteoinductivity of biomaterials are investigated. In addition, Chapter 5 deals with 
implant size and implantation site effect on the amount of induced bone and with 
changes occurring on the surface of osteoinductive biomaterials after intramuscular 
implantation. 
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In Chapters 6 and 7 the performance of osteoinductive biomaterials at orthotopic 
implantation sites is investigated. In Chapter 6, uncoated and octacalcium-phosphate 
coated porous titanium alloy scaffolds as well as porous biphasic calcium-phosphate 
ceramic scaffolds are implanted in diaphyseal femur of goats. In Chapter 7, 
implantations of osteoinductive and non-osteoinductive biphasic calcium phosphate 
ceramic are performed in critical-sized iliac wing defects.  
In Chapter 8 the results of all studies are discussed. 
In Chapter 9 some general conclusions and recommendations for future research are 
given. 
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2.1 Abstract 
 
Increasing demand for synthetic scaffolds and matrices that can be used in bone repair 
and regeneration raises the need for fast and reliable preclinical screening tests. In vitro 
organ culture- and cell culture systems, originally developed as tools to study the effects 
of hormones and cytokines on the attachment, proliferation and differentiation of cells, 
are also attractive for screening of biomaterials, because they are relatively simple, 
and allow for work in a controlled environment. Besides, in vitro assays are preferred 
above the in vivo ones from an ethical and financial point of view. 
However, as the established in vitro bone formation assays have been developed for a 
different purpose, they do not take into account possible effects of the presence of a 
biomaterial in the in vitro system. An important question that needs to be answered is, 
therefore, whether the established in vitro systems as such are suitable for the 
biomaterials research and to which extent the results from in vitro studies are predictive 
for the final performance of the material in vivo and in the clinic. 
In this paper, we review a number of studies in which potential synthetic bone grafts 
have been tested in vitro and consequently in vivo in order to investigate to which 
extent their results correlate with each other.  
Today’s in vitro assays in which potential synthetic bone graft substitutes are tested 
often give inconclusive results and their predictive value for the in vivo performance of 
the graft is limited, which may be caused by a number of reasons such as a biomaterial-
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cell culture medium interaction, which is absent in vivo and a wrong cell- and assay 
choice.  
The increasing number of new synthetic bone grafts will demand more fast and reliable 
in vitro assays. However, the existing assays will need adjustments in order have a 
predictive value for the in vivo behavior of biomaterials. 
 
Keywords: in vitro assays, biomaterials, osteoconduction, osteoinduction. 
 
2.2 Introduction 
 
The continuous increase of life expectancy leads to an expanding demand for repair 
and replacement of damaged and degraded organs and tissues. Recent completion of 
a first version of the human genome sequence means a great breakthrough for the field 
of pharmaceutics. It is conceivable that new developments in pharmaceutical research 
will result in a large number of novel and improved medicines. A similar development is 
expected in the field of biomaterials used for bone repair and replacement. Spinal 
fusions and repairs of bone defects caused by traumas, tumors, infections, biochemical 
disorders and abnormal skeletal development, are some examples of the frequently 
performed surgeries in the clinic. For most of these surgeries, there is a great need for 
grafting materials.  
This expanding amount of newly developed biomaterials is accompanied by an 
increased need for the high-throughput screening systems which are reliable in 
predicting the performance of the material in the function it was developed for. For 
example, recently, a method was developed for rapid, microscale screening of 
polymer-cell interaction by using microarrays [155].  
In the research into new bone graft substitutes, in general two types of preclinical 
assays are used: in vitro assays using a cell- or an organ culture system (i.e. in vitro 
bone formation assays) and in vivo assays, using experimental animal models. In vitro 
assays have initially been developed to study the influence of growth factors and 
hormones on e.g attachment, proliferation, differentiation and mineralization of cells. 
Subsequently, investigators started to use these in vitro assays in the biomaterials 
research. Instead of studying the influence of e.g. growth factors on the differentiation 
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of cells, the behavior of cells in the presence of the testing material is studied. However, 
in general, it is ignored that the in vitro setting may significantly be changed by the 
presence of a material due to e.g. material-cell culture medium interaction. If such an 
interaction is not expected in vivo, the question raises what the predictive value of the in 
vitro assay is for the in vivo performance of the material.  
Besides the increasing need for reliable in vitro assays to test biomaterials prior to 
implanting them in animals and humans, investigators need tools which are helpful in 
unraveling mechanisms of complex in vivo phenomena. In vitro assays are attractive 
because of their simplicity, but, at the same time, their simplicity is an important 
limitation. It is of course impossible to fully simulate the in vivo situation in a culture dish 
and yet, in many publications, rather strong conclusions about the in vivo performance of 
biomaterials and about mechanisms of complex phenomena are drawn from the in vitro 
studies.  
In this paper, we try to give an idea of the predictive value of in vitro assays today by 
reviewing a number of studies in which different in vitro assays were used to test the 
performance of biomaterials for bone repair and replacement and comparing their 
results with the results of the in vivo studies. We should mention that the question 
whether in vivo assays in small and large animals are predictive for the performance of 
biomaterials clinically is at least as important as the question whether in vitro assays are 
predictive for their in vivo performance. However, few studies show clinical follow-up 
data which can be related to the results of animal studies. Therefore, this paper is 
limited to reviews of the studies in which first in vitro and consequently in vivo animal 
assays were performed. 
In the first part, we give some backgrounds on in vitro bone formation assays in 
general, and an overview of organs and cells which are commonly used in in vitro bone 
formation assays. We then give an overview of a number of in vitro and in vivo studies 
performed with similar materials for bone repair. Finally, we try to point out the 
shortcomings of the existing in vitro assays and give some recommendation for the 
improvement of the frequently used assays.  
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2.3 Backgrounds on in vitro bone formation assays 
 
In vitro bone formation assays have initially been developed as tools to study the 
effects of hormones and cytokines in a controlled environment [156]. Despite the 
inherent diversity in these systems, most of them share some common features. For 
example, the basic culture environment (medium composition, serum type and 
concentration, supplements, temperature and antibiotics) and methods of routine 
maintenance (feeding, subculturing, cloning) are very similar in all systems. Gronowicz 
and Raisz [156] have given an overview of the culture conditions which are generally 
applicable for different in vitro bone formation culture systems. The fact that they give 
a simplified reflection of the in vivo situation and allow for the research in a controlled 
environment are primary reasons for the use of in vitro assays. In addition, from a 
financial and ethical point of view, in vitro assays are preferred above the in vivo ones.  
The existing bone formation assays can be divided into two groups: organ culture 
systems and bone cell culture systems.  
As reviewed by Gronowicz and Raisz [156], tissues used for bone formation assays in 
bone organ culture systems vary in source and age including fetal, newborn and 
occasionally adult bone. Chicken, mouse and rat bones are most common, although 
human bone fragments have also been used. Bone from calvaria and limb is the most 
frequently cultured tissue. Fetal calvaria are characterized by intramembranous bone 
formation, while growth of long bones is mainly endochondral. However, as 
intramembranous and endochondral bone may have different responses to hormones, 
growth factors and environmental conditions, most in vitro organ culture systems have 
limitations and may not give a similar response as endochondral bone and adult bone 
cells.  
In addition to organ culture systems, the in vitro isolation and culture of bone-derived 
cell populations has substantially enhanced our ability to understand factors important 
for the proliferation and differentiation of cells of the osteogenic lineage. As recently 
reviewed by Kartsogiannis and Ng [157], commonly employed model systems include 
either primary cultures of osteoblastic cells derived from fetal calvaria and 
subperiosteal fetal long bones or established cell lines that can be divided into clonal 
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cell lines from cells isolated from bone tumors (osteosarcomas), non-transformed cell 
lines, experimentally immortalized cell lines and bone marrow cultures.  
 
 
2.4 Cells and cell sources of bone formation assays 
 
2.4.1 Primary cells 
 
Primary bone cell culture systems were mainly designed to study the functions and 
regulatory mechanisms of mature osteoblasts, i.e. the synthesis, secretion, organization 
and mineralization of bone extracellular matrix. Most osteoblast-like cell culture systems 
use cells in early primary or early passage cultures after isolation from bones of fetal 
or neonatal mice, rats, chickens and cattle. Tissues from such young animals are 
considered good sources of cells for culture as they proliferate readily in vitro and the 
rapid growth of bone during this phase of life ensures that the tissue contains a large 
number of active, phenotypically mature osteoblasts. Calvarial bones are particularly 
favorable since they are easy to dissect cleanly, show limited development of marrow 
and are not yet fully mineralized [158]. Besides functions of mature osteoblasts, another 
important aspect in bone formation research is developmental potential of 
osteoprogenitor cells and their relationships with other cell lineages such as 
chondrocytes, myoblasts and fibroblasts. It is important to investigate the factors that 
trigger the differentiation of osteoprogenitor cells along an osteogenic or alternative 
pathway and the reversibility of these pathways. Bone cell culture systems focusing on 
osteoprogenitor cells often use, in addition to bone, periosteum, bone marrow stroma 
and periodontal ligament as their cell source as reviewed by Majeska [158].  
 
 
2.4.2 Cell lines 
 
Extensive overviews of different cell lines which are commonly used in in vitro bone 
formation systems are given by Majeska [158] and by Kartsogiannis and Ng [157]. 
Below, a short summary is given. 
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The earliest cell lines to be characterized as osteoblastic and used for in vitro studies 
were derived from rat osteosarcomas. The family of clonal cell line ROS was derived 
from a spontaneous tumor in an ACI rat. The most commonly used group is ROS 17/2 
which exhibits adenylate cyclase activity in response to Parathyroid Hormone (PTH) as 
well as a high Alkaline Phosphatase (ALP) activity which is regulated by PTH and 
Vitamin D3 (1,25(OH)2D3). Subclone ROS 17/2.8 subsequently expresses Osteocalcin 
(OC) mRNA and calcifies in vivo when implanted in a diffusion chamber.  In addition, 
ROS17/2.8 cells respond to Transforming Growth Factor-β (TGF-β) with increase of 
ALP, Collagen Type I (Coll-I), Osteopontin (OP) and Osteonectin (ON) mRNA. Cell lines 
designated UMR106 were isolated from 32P-orthophosphate–induced tumors in rats. 
Several cell lines derived from human osteosarcoma are SaOS, TE-85 and MG-63 and 
OHS-4 cells. A recently characterized new osteosarcoma cell line CAL72 is more closely 
related to normal osteoblasts than other osteosarcoma cell lines. CAL72 expresses 
mRNA coding for Interleukin-6 (IL-6), Granulocyte-macrophage colony-stimulating factor 
(GM-CSF) and Granulocyte colony-stimulating factor G-CSF and thus appears to be 
closer to primary osteoblastic cells than e.g. SaOS and MG-63.  
In addition to cells derived from osteosarcomas, a number of osteoblast-like cell lines 
have been established from normal bone. Early clonal lines were derived from rodent 
tissues and included a series (designated RCJ) derived from normal rat calvarial cell 
preparations and a clonal cell line, designated MC3T3-E1, derived from mouse 
calvaria. This cell line has been shown to increase cyclic AMP in response to PTH and 
express high ALP activity which is regulated by PTH, 1,25(OH)2D3 and Prostaglandin-
E2 (PGE-2) and is capable of collagen synthesis. The cells represented by CRP 4/7, 
CRP 7/4, CRP 7/7, CRP 10/3 and CRP 10/30 also belong to the group of non-
transformed osteoblastic cell lines.  
The treatment of cells by a transfection with a recombinant retrovirus containing cDNA 
has been used to establish immortalized osteoblastic cells lines. These cell lines have the 
advantage of having a more fully characterized immortalization mechanism. RCT-1 and 
RCT-3 cells are examples of immortalized cell lines which express osteoblastic traits. 
Human osteoblast-like cells (hOB) are an example of cell lines established by 
transfecting normal human osteoblast-like cells, with a large and small T antigen against 
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SV40. They express mRNA for (I)-procollagen, OP, TGF-β, and IL-1 β, while treatment 
with 1,25(OH)2D3 results in increased expression of OC and ALP mRNA and protein. 
 
 
Figure 1: an overview of in vitro bone formation assays. 
 
 
Examples of cell lines that can be used to study osteogenic differentiation from 
progenitor cell populations are UMR-201 cells, established from neonatal rat calvaria 
and MBA-15 cells originating in bone marrow stroma. Another group of cells that can 
be used as a useful model to study the osteogenic differentiation and its regulation by 
hormones and growth factors are pluripotent mesenchymal cells. Pluripotent 
mesenchymal cells are capable of differentiating into different lineages: osteoblasts, 
chondroblasts, adipocytes, myoblasts and fibroblasts. One example of a widely used 
pluripotent cell line is “murine C2C12 mesenchymal precursor”. When C2C12 cells are 
cultured in the presence of TGFβ-1, terminal differentiation into myotubes is blocked. 
Similarly, when C2C12 cells are treated with Bone Morphogenetic Protein-2 (BMP2), 
myogenic differentiation is blocked, but osteoblast differentiation is stimulated. Another 
example of a pluropotent mesenchymal cell line is C3H10T1/2. For these cells it is 
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known that recombinant N-terminal sonic hedgehog (NShh) abolishes adipocytic 
differentiation both in presence and absence of BMP-2, while committing these cells into 
the osteogenic lineage.  
Another group of cells with a high potential to be a helpful tool in studying the 
principles of osteogenic differentiation and the factors influencing differentiation of cells 
towards osteoblasts are pluripotent embryonic stem cells (ESCs). ESCs have an unlimited 
potency to self renew and maintain their pluripotency in culture [159, 160]. Although the 
application of ESCs in bone development research is still at the early stage, there are 
reports showing successful differentiation of mouse ESCs into the osteogenic lineage in 
response to specific growth factors [161-164]. 
An overview of organs and cells used for in vitro bone formation assays is given in 
figure 1. 
 
 
2.5 In vitro models for assaying bone graft substitutes 
 
As mentioned before, the expanding development of (synthetic) biomaterials for 
support, replacement and regeneration of bone has created the need for in vitro 
systems in which the potential in vivo performance of these materials can be assayed. In 
vitro cell- and organ culture assays are in the first place used to investigate the “safety” 
of the material in terms of e.g. cytotoxicity and biocompatibility. In addition, in vitro 
bone formation assays are used in order to predict the performance of the material in 
vivo in its role of e.g. bone filler. In this case, the potential osteoconductivity of the 
material is tested. Finally, in vitro cell culture systems are used to study complex and not 
yet fully unraveled “biologically driven” phenomena such as osteoinduction. Below, we 
give a few examples of in vitro studies in which materials cytotoxicity, osteoconductivity 
and osteoinductivity were assayed. In addition, the results and authors’ conclusions 
drawn from these studies are compared to the results in vivo, where similar materials 
were tested. 
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2.5.1 Cytotoxicity 
 
Hyakuna et.al. investigated changes in calcium-, phosphate-, magnesium- and albumin 
content of cell culture medium after immersion of different biomaterials [165]. The 
results of this study showed that monocrystalline and polycrystalline alumina ceramics 
did not have any influence on the surrounding medium. Two types of apatite containing 
glass ceramics (A W-GC and A W CP-GC) showed a slight decrease of phosphorus and 
a slight increase of calcium ion concentration in the culture medium. Hydroxyapatite 
(HA) ceramics sintered at 600°C and 900°C with a very high specific surface area 
showed a high and rapid adsorption of calcium- and phosphate ions and albumin from 
the medium. Changes of calcium and phosphate concentrations of the medium were 
suggested to be the reason for the poor attachment of V79 Chinese hamster fibroblasts, 
and hence for a higher apparent cytotoxicity of the HA ceramics sintered at 600°C and 
900°C and the two glass ceramics as compared to the tissue culture plastic and alumina 
ceramics.   
Norman et.al. compared the attachment of MC3T3-E1 osteoblast-like cells on porous 
(sintered) and dense (unsintered) HA ceramic with the attachment on polystyrene culture 
discs [166]. Their observation was a significantly higher attachment on plastic as 
compared to the two ceramics. Furthermore, more cells attached on the porous in 
comparison to the dense ceramic, which was explained by 1) higher specific surface 
area of the porous ceramic, thus more available space for cells to attach and 2) lower 
reactivity of the surface of the porous ceramic in comparison to the unsintered ceramic, 
possibly a lower uptake of calcium- and phosphate ions from the culture medium and 
hence a lower cytotoxic effect on the cells.  
Suzuki et.al. prepared ceramics with Ca/P ratios varying from 1.50 to 1.67 by mixing 
different amounts of HA and tricalcium phosphate (TCP) ceramics and observed 
variations of zeta-potentials of different surfaces after immersion in the cell culture 
medium [167]. Decrease of calcium- and phosphate ions in the culture medium was 
always observed, but its intensity depended on the Ca/P ratio of the ceramics and so 
did the change of the pH of the medium. Changes of the ions concentrations and pH of 
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the medium were suggested to be of influence on the attachment of L-929 cells on the 
ceramic surfaces, and thus on the cytotoxicity of the material. 
Knabe and coworkers performed a similar study, in which they compared attachment 
and proliferation of rat bone marrow cells (RBMCs) on highly resorbable CaP ceramics 
[168] and on glassy materials with different rates of resorbability [169]. Interestingly, 
while in the previously described studies above authors observed a decrease of 
calcium- and phosphate ions from the medium and suggested this decrease to be the 
reason for a poor attachment and growth of the cells, Knabe and coauthors suggested 
that the inhibitory effect on cellular growth on some of their materials was associated 
with an increased concentration of phosphorus ions released into the medium by these 
materials and the formation of a phosphorus-rich layer on their surface. Daily 
refreshment of the medium increased the osteoblast attachment on some, but not on all 
tested ceramics.  
In later work of this group, in which highly resorbable CaP cements and CaP ceramics 
were compared, it was suggested that increased levels of phosphate- and potassium 
ions, decreased levels of calcium ions and hence elevated pH of the medium were 
reasons for poor attachment and proliferation of RBMCs.  
The above described examples of studies in which safety of materials in terms of 
cytotoxicity is tested all emphasized the presence of the biomaterial-cell culture medium 
interaction, which seems to be responsible for, or at least of influence on the behavior of 
cells. Although material-medium interactions are sometimes of great influence on the 
behavior of cells in vitro, in the in vivo environment they might be less important if 
observed at all, as, unlike in a culture dish, in the body there is a continuous supply and 
thus refreshment of nutrients and body fluids. For the cytotoxicity tests, this probably 
means that the in vitro settings give a more “negative” reflection of in vivo situation.  
 
 
2.5.2 Osteoconduction 
 
Osteoconduction, defined as “spreading of bone over the surface proceeded by 
ordered migration of differentiating osteogenic cells” [170], is supposed to be driven 
by physico-chemical properties of the material, having its origin in 
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dissolution/reprecipitation or precipitation of a calcium-phosphate layer on the surface 
of the material [171, 172]. An important aspect is thereby the direct bonding of bone 
to the materials without fibrous tissue deposition, so-called contact or bonding 
osteogenesis [170]. In a few studies, these properties of the materials were tested first 
in vitro and then in vivo. 
De Bruijn et.al. used an in vitro rat bone marrow cell culture system to study various 
types of calcium-phosphates [173]. Besides the elaboration of different interfaces, 
mineralization occurred at a later time on slow degrading materials such as 
fluoroapatite, than on fast degrading materials such as tricalcium phosphate. Authors 
therefore suggested that a more dynamic interface is formed on degrading materials 
that could be favorable for bone formation to occur. This hypothesis was further tested 
by implanting various plasma-sprayed calcium-phosphate coatings in rat femoral bone 
for relatively short period of time [174]. The results of this study indeed suggested that 
initially higher amount of bone was formed on fast degrading amorphous 
hydroxyapatite as opposed to the slow degrading highly crystalline hydroxyapatite. 
Similar to the study of de Bruijn et.al., in a study by ter Brugge et.al., the effect of the 
crystallinity of thin radio frequency (RF) magnetron sputtered calcium-phosphate 
coatings on the attachment, proliferation and mineralization of rat bone marrow cells 
was studied [175]. Authors observed proliferation, differentiation and mineralization of 
cells on uncoated titanium and crystalline calcium-phosphate coating, while no 
proliferation or differentiation was observed on the fast degrading amorphous calcium-
phosphate coating. It was observed that the thin, RF magnetron sputtered amorphous 
calcium-phosphate coating was completely dissolved in a relatively short period of time, 
which was suggested to be a reason for poor growth and mineralization of cells. 
Obviously, the in vitro effect of crystallinity on rat bone marrow cells differs between 
thick, plasma-sprayed and thin magnetron sputtered calcium-phosphate coatings.  
In a study by Hulshoff et.al., amorphous and crystalline plasma-sprayed calcium-
phosphate coatings, and amorphous and crystalline RF magnetron sputtered coatings 
were applied on titanium surfaces and compared in a rat bone marrow cell culture 
system [176]. Uncoated titanium was used as a control. In this study, no significant 
difference was found in attachment and proliferation of cells on various substrata. In 
addition, crystalline and amorphous magnetron sputtered coating and amorphous 
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plasma-sprayed coating showed the formation of the mineralized extracellular matrix 
after 18 days of culture, in contrast to the crystalline plasma-sprayed coating. When 
similar coatings on titanium substrata were compared in a rabbit femoral condyle 
model [177], at 6 and 9 weeks of implantation, no difference in bone contact was 
found between different types of coating. Regarding the amount of bone found at a 
certain distance from the implant, crystalline RF magnetron sputtered coating showed a 
better performance than other coatings. However, the observed difference was only 
significant after 6 weeks of implantation. This study showed that the in vitro observed 
difference in the formation of extracellular matrix between crystalline plasma-sprayed 
coating and other coating types could not be translated to the amount of bone contact 
in vivo. And further, a higher amount of bone at a certain distance from the implant 
which was observed in crystalline RF magnetron sputtered coating as compared to other 
coating types, could not be explained by any of the in vitro observations. 
In a study by Gaillard et.al. [178] PEO/PBT copolymers were provided with calcium 
ions by incubation in a CaCl2 solution (“calcium-containing PEO/PBT”). Subsequently, 
they were either incubated in an alkaline phosphate containing solution that resulted in 
precipitation of HA/β-TCP crystals on implant surface (“surface precalcification”) or in 
an acidic phosphate-containing solution resulting in the formation of calcium 
pyrophosphate crystals just underneath the implant surface (“matrix precalcification”). 
These materials, together with the untreated PEO/PBT copolymer were first tested in a 
rat bone marrow culture system. This study showed that control PEO/PBT material did 
not change calcium concentration of the culture medium. “Calcium-containing PEO/PBT” 
showed a fast release of calcium ions into the medium. While “matrix precalcified” 
PEO-PBT gradually released calcium ions into the medium, “surface precalcified” PEO-
PBT showed an uptake of calcium ions from the medium. During a 3-week rat bone 
marrow culture, the non-treated PEO/PBT copolymer showed a nodule formation, but no 
mineralization of the extracellular matrix was observed. The “calcium-containing” 
PEO/PBT showed mineralized foci formation already after 2 weeks of culture. On the 
surface of the two precalcified copolymers, instead of nodules, two or three continuous 
cell layers were formed and mineralization was observed after 2 weeks. Longer culture 
period resulted in more mineralization in close contact with the copolymer surface. 
Based on these results the authors concluded that the availability of calcium ions or 
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calcium phosphate crystals in PEO/PBT copolymers stimulates mineralization in bone 
marrow cell culture, which is an indication for improved bone-bonding characteristics in 
vivo. The four groups of materials, i.e. non-treated PEO/PBT, “calcium-containing” 
PEO/PBT, “surface precalcified” PEO/PBT and “matrix-precalcified” PEO/PBT were 
subsequently implanted in the femora of rats [179]. The results from this in vivo study 
revealed that “calcium-containing” PEO-PBT did not show an increase in calcification 
rate as compared to the non-treated PEO/PBT. Authors concluded that a too fast 
release of calcium ions was the reason for the inability of the “calcium-containing” 
PEO/PBT to stimulate calcification. The results further showed that the thickness of the 
calcified layer on the two “precalcified” copolymers did not increase during the 
implantation period as was observed in the in vitro study. Furthermore, the total amount 
of formed bone did not differ between the four implant types, but the percentage of 
bone contact was higher in “surface precalcified” implants as compared to the other 
three implant types. The authors suggested that the main reason for this observation lies 
in dissolution of calcium and phosphorus ions, leading to an increased concentration of 
the local ion concentrations and consequent precipitation of the biological apatite layer 
on the material surface.  
A recent report by Wang and coworkers described a comparison of proliferation and 
differentiation of SaOS-2 osteoblastic cell line on HA ceramics sintered at three 
different temperatures (1200°C, 1000°C and 800°C) [180]. Results of this study 
showed that cell proliferation rate on HA ceramic sintered at 1200°C was the highest. In 
addition, BSP, OC and ON protein levels after 12-day-culture were significantly higher 
on HA sintered at 1200°C as compared to HA ceramics sintered at 1000°C and 800°C 
respectively. Authors therefore concluded that HA ceramic sintered at 1200°C, which 
had a significantly lower specific surface area than the other two ceramics, was the best 
candidate to be used as a bone graft. They suggested that the ceramic sintered at 
higher temperature possibly had a less reactive surface and hence a lower cytotoxicity 
as compared to the other two tested ceramics. These results were in accordance with the 
results of the in vitro study of Hyakuna et.al. [165]. In a study by our group [181] 
however, biphasic calcium phosphate (BCP, consisting of HA and β-TCP) ceramics 
sintered at 1150°C and at 1300°C were implanted in a critical-sized iliac wing defect 
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of goats. Significantly more bone was found in the orthotopically implanted BCP 
sintered at 1150°C as compared to BCP sintered at 1300°C (figure 2) [181]. The two 
materials had similar compositions and macroporosities and they only differed in their 
microporosities. BCP1150 with its higher microporosity and hence higher specific surface 
area in comparison with BCP1300 was suggested to have a higher surface reactivity, 
which was consequently the reason for a higher bone regenerative potential. These in 
vivo results were thus in conflict with the in vitro data given by Hyakuna et.al. [165]  
and Wang et.al. [180], in which ceramics sintered at higher temperatures showed a 
more pronounced cell proliferation and osteogenic differentiation.  
 
Figure 2: digital photographs of BCP1300 (A) and BCP1150 (B) after implantation in goat iliac wing defect for 12 weeks. 
(1) = ceramic, (2) = bone, (3) = fibrous tissue. 
Only a small ridge of new bone has formed along the host bone bed in the BCP1300 disc (A),  
while bone has grown deeply inside the BCP1150 disc (B). → p214. 
 
 
The above described are only a few examples of the studies in which in vitro bone 
formation assays were used to predict the performance of biomaterials in vivo. As can 
be seen, in some studies, in vitro results completely fit the in vivo results, while in the 
others, differences observed in vitro could not be found in vivo or ware in full contrast 
with the in vivo data. In the reviewed studies, both in vitro and in vivo studies were 
performed with similar biomaterials. This is, however, not always the case. Sometimes, 
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only in vitro results are presented, and authors use these to draw conclusions on the 
performance of materials in vivo, which makes it impossible to elaborate on the 
predictive value of the in vitro assays. 
 
 
2.5.3 Osteoinduction 
 
Osteoinduction is an even less understood phenomenon as compared to osteoconduction. 
In the sixties, osteoinduction was defined as “the differentiation of the undifferentiated 
inducible osteoprogenitor cells that are not yet committed to the osteogenic lineage to 
for osteoprogenitor cells” [93]. In other words, osteoinductivity is the ability of a 
cytokine or a material to induce bone formation ectopically. Extensive research of Urist 
and others led to the conclusion that a discrete protein within the demineralized bone 
matrix (DBM) was the sole inducer of bone formation. This finding was published in 
1971 and this protein was named Bone Morphogenetic Protein (BMP) [94]. BMP was 
shown to be involved in the bone formation cascade of chemotaxis, mitosis, 
differentiation, callus formation and finally bone formation. Besides the BMP-driven 
osteoinduction, many investigators have shown that also some biomaterials that neither 
contain nor produce BMPs are also able to induce ectopic bone formation [124, 128, 
129, 135, 138, 182, 183]. Despite the extensive research, the underlying mechanism of 
osteoinduction is still largely unknown and reliable assays to study this phenomenon are 
needed. Below, a few in vitro studies on osteoinduction are described. 
Adkisson et.al. [184] developed a “rapid quantitative bioassay of osteoinduction” by 
using SaOS-2 osteosarcomas and studies cell proliferation rates under influence of 
DBM. However, correlation between cell proliferation and osteoinduction was not strong. 
Osteogenic factors, like BMP are not commonly associated with mitogenic response. 
Zhang et.al. [185] and Wolfinbarger and Zhang [186] used human periosteal cells and 
human dermal fibroblasts to relate cellular ALP activity to DBM osteoinductivity. In these 
studies, the authors failed to show a clear correlation between in vitro assays and in 
vivo bone formation.  
Carnes et.al. used an immature osteoprogenitor cell line, 2T9 to investigate the effect of 
DBM on the cell differentiation [187]. They failed to show any effect on differentiation 
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and concluded that there are no soluble factors being released from DBM into the 
culture medium.  
Han et.al. assayed ALP activity of the C2C12 cells in a culture in presence of DBM, and 
succeeded correlating it with the in vivo bone formation [188]. The last study mimics the 
in vivo situation more than other described studies, although the expression of ALP is not 
the most sensitive marker for the osteogenic differentiation. 
 
Figure 3: digital photograph of histological slides of BCP1300 (A) and BCP1150 (B) after 12-week  
intramuscular implantation in goat.  
(1) = ceramic, (2) = bone, (3) = fibrous tissue. 
In BCP1300, the ceramic is extensively filled with fibrous tissue, but no signs of bone formation are observed.  
In BCP1150 (B) bone has formed in the pores of the implant, aligning its surface. → p215. 
 
 
Regarding the mechanism of osteoinduction by biomaterials a very limited amount of 
studies is performed and published. In our group, an extensive number of studies has 
been performed in vivo. In addition, we have tried to perform a number of in vitro 
studies as well, however, their results were either inconclusive, or in contrast with the in 
vivo observations. Below, a few examples of the performed studies are given. 
In an earlier published study [183], HA ceramics sintered at 1150°C and 1250°C 
together with biphasic calcium phosphate (BCP, consisting of HA and β-TCP) ceramics 
sintered at 1100°C, 1150°C and 1200°C were implanted intramuscularly in goats and 
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we found that HA sintered at 1150°C induced bone formation intramuscularly, while no 
bone was induced by HA sintered at 1250°C. Furthermore, the amount of induced bone 
by the BCP ceramics increased with decreasing sintering temperatures.  
In another study [181], BCP ceramics sintered at 1150°C and at 1300°C were 
implanted intramuscularly in goats. Ectopic bone formation was only found in the BCP 
sintered at lower temperature (figure 3) [181]. The presence of microporosity in 
BCP1150 was suggested to be responsible for a higher osteoinductive potential in 
comparison with BCP1300 ceramic.  
 
 
Figure 4: RT-PCR data showing the temporal expression of osteogenic mRNA by C2C12 cells cultures with and without BMP-2 
(100ng/ml) (A) and MC3T3-E1 cells cultured without ascorbic acid (B) for 6 days on BCP1300 and BCP1150 discs (∅25 x 5 mm3). 
The expression of most osteogenic markers by C2C12 cells (A) is increased when cells are cultured in presence of BMP-2. In both 
presence and absence of BMP-2, the expression of most markers is highest when the C2C12 cells are cultured on tissue culture 
plastic. Cells show a higher expression of osteogenic markers when cultured on BCP1300 as compared to BCP1150.  
Similar to C2C12 cells, the expression of all investigated osteogenic markers by MC3T3-E1 cells (B) is the highest on TC plastic, 
followed by BCP1300 and then BCP1150. 
 
 
In order to compare BCP1150 and BCP1300 in vitro, we cultured MC3T3-E1 
osteblastic-like cells and C2C12 pluripotent mesenchymal cells (in presence and in 
absence of BMP-2) on BCP1150 and BCP1300 ceramics and consequently investigated 
the expression of various osteogenic markers (mRNA for ALP, OC, ON, OSF-2 and Osx) 
by using RT-PCR. For both cell types, a higher expression of most markers was observed 
on BCP1300 than on BCP1150 (figure 4). Furthermore, the expression of these markers 
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was the highest by cells cultured on TC plastic. Measurements of calcium- and phosphate 
contents of the medium after 3 hours of soaking showed a decrease of calcium 
concentration with 22% and a decrease of phosphate concentration with 18% in 
presence of BCP1300, while the decrease of calcium and phosphate concentrations in 
presence of BCP1150 was 62% and 60%, respectively. After 3 days of soaking, which 
is the normal time point at which culture medium is refreshed, calcium- and phosphate 
contents of the culture medium further decreased with 8% for both ceramics.   
 
 
Figure 5: Q-PCR data (n=3) showing relative expression of Osteocalcin mRNA by C2C12 cells cultured with and without BMP-2 
(100ng/ml) (A) and MC3T3-E1 cells cultured without ascorbic acid (B) for 6 days on BCP1300 and BCP1150 particles (1-2 μm). 
The Osteocalcin expression by C2C12 cells (A) is significantly increased when cells are cultured in presence of BMP-2 on both 
BCP1300 and BCP1150 ceramic. There are no significant differences in the Osteocalcin expression between cells cultured on 
BCP1300 and BCP1150 for neither cell type. However, the trend for both cell types is the same,  
namely a slight downregulation of Osteocalcin on BCP1150 as compared to BCP1300. 
 
 
No changes in calcium- and phosphate contents of the medium in the absence of 
ceramics were observed.  
In order to decrease the change of the contents of the medium, we repeated the 
experiment with MC3T3-E1 and C2C12 cell lines by using considerably smaller (±100 
times lower volume) amount of BCP1150 and BCP1300 scaffolds in the same volume of 
medium. This time, the amount of calcium decreased with 7% and the amount of 
phosphate with 11% in presence of BCP1300 scaffold after 72 hours of soaking. 
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Decrease of calcium concentration was 36% and that of phosphate 40% in presence of 
BCP1150. Although differences in the expression of OC (figure 5, Q-PCR data) for 
MC3T3-E1 and C2C12 cells between BCP1150 and BCP1300 were smaller this time, 
the trend of expression remained the same. Differentiation of cells towards the 
osteogenic lineage was higher on BCP1300 as compared to BCP1150, while in vivo 
significantly more bone was induced by BCP1150 in comparison to BCP1300.  
A similar study was performed with mouse embryonic stem cells (to be published 
separately), and interestingly, in this study, the expression of mRNA for OC and BSP 
was higher on BCP1150 as compared to BCP1300. Whether these results mean that the 
effect of the material is only visible in very early stages of differentiation, or simply 
that ESCs react differently to the changes of the medium caused by the presence of 
ceramics as compared to C2C12 and MC3T3-E1 cells, needs to be further investigated. 
 
 
2.6 Limitations of in vitro models for assaying bone graft substitutes 
 
All examples described above suggest that the use of the existing in vitro assays in 
biomaterials research might not always be valuable. Sometimes, the in vitro data are 
completely in accordance with the in vivo findings, especially when rather simple 
physico-chemically guided processes are studied. In other studies, in which more 
complex, biologically driven processes are studied, in vitro and in vivo results are in full 
contrast with each other. The question that needs to be answered is what the cause of 
these inconclusive results is. First of all it is important to note that in most cell culture and 
organ culture systems involving biomaterials there is, in addition to cell-biomaterial 
interaction, often a very important biomaterial-cell culture medium interaction which 
often markedly influences the outcomes of the study. In the in vivo environment these 
interactions might be less important if observed at all, as, unlike in a culture dish, in the 
body there is a continuous supply and thus refreshment of nutrients and body fluids.  
Although most examples given above are studies performed on CaP containing 
biomaterials, the changes in the medium can also be caused by non-CaP materials 
(certain polymeric sponges [114], alumina ceramics [134], porous titanium [136] 
scaffolds are able of forming a CaP layer when immersed in a CaP-rich environment). 
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Release of calcium, phosphate, magnesium, and other ions from highly resorbable 
materials, uptake of different ions from the culture medium by a high surface area of a 
material, changes of pH and Z-potentials on the surfaces, formation of phosphorus 
and/or calcium rich layers on the surfaces, adsorption of all, or selected proteins from 
the serum-containing cell culture media, are only few observations from this type of 
studies. Obviously, all these changes of the medium differ significantly between the 
tested materials and raise therefore the question if such in vitro systems are applicable 
for the comparative types of experiments. Different studies focus on comparing material 
A with material B by studying cell attachment, proliferation, differentiation and 
mineralization on their surfaces. However, if the interaction between material A and the 
culture medium is different from the interaction between material B and the medium, the 
cells will attach, grow and differentiate in different environments and can therefore not 
be compared with each others when similar biomaterial-body fluid interactions are not 
expected in vivo. In addition, changes which take place in the medium due to the 
presence of a biomaterial will influence different cell types in a different manner, which 
makes comparisons between different studies difficult, if not impossible.  
In addition to taking into account possible side effects of the presence of biomaterials in 
in vitro cell culture systems, the choice of cells is of great importance for the reliability of 
the results. For example, if one would like to compare two biomaterials and to be able 
to draw some conclusions regarding their potential performance as bone filler, would 
the attachment and proliferation of primary rat osteoblasts then be the right assay 
knowing that in vivo osteoblasts are not the cells which are initially in contact with 
biomaterial surface? The choice is probably even more difficult when one is trying to 
investigate a largely unknown phenomenon in vitro, such as osteoinduction by BMPs or 
even less understood osteoinduction by biomaterials. Obviously, in order to study the 
mechanism of osteoinduction by biomaterials, it is probably not sufficient to choose 
osteoblasts or osteoblast-like cells as osteoinduction is the process of differentiation of 
cells that are not yet committed to the osteogenic lineage to form osteoprogenitor cells. 
Therefore, murine pluripotent mesenchymal C2C12 cells could be better candidates than 
osteoblasts. However, it is well-known that ectopic bone formation by biomaterials is 
only very rarely found in mice [141-144], making cells of murine origin possibly a bad 
choice. In addition, it is hard to decide whether the culture of C2C12 cells on 
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osteoinductive biomaterials should be performed in presence or in absence of e.g. BMP-
2, as it is suggested, but not proven yet [138, 139], that BMPs play a role in the process 
of osteoinduction by biomaterials. Similar questions of the choice of cell origin and 
culture conditions should be answered if one would choose to use ESCs to study the 
phenomenon of osteoinduction by biomaterials in vitro.  
 
 
2.7 How to improve the existing in vitro assays? 
 
In conclusion, in our opinion, the in vitro assays which are nowadays used to study the 
potential performance of biomaterials in vivo, have a largely limited predictive value. It 
should be emphasized again the existing in vitro assays have originally been designed 
to test the influence of growth factors, cytokines and hormones on the behavior of cells 
and organs. In these in vitro assays, the presence of a material has never been taken 
into account. However, in the studies involving biomaterials, there is, in addition to the 
material-cell interaction, which is supposed to be studied, often a material-medium 
interaction, which can be of high importance for the results and should therefore not be 
ignored. Prior to starting an experiment, the following questions should be answered: 1) 
is there an interaction between the testing material and the medium?, 2) does this 
interaction have the consequence for the results of the study? and 3) is a similar 
interaction expected in vivo? If the biomaterial-cell culture medium seems to be an 
artifact of the used system, this effect of biomaterial-medium interaction should be 
removed. Knabe and coworkers suggested for example preïncubation of the material in 
the medium prior to the start of cell culture and daily medium replenishment [168]. 
Although possibly successful for some biomaterials, this solution might be expensive, in 
particular if the cell culture is performed in presence of e.g. growth factors. Another 
possible solution could be the use of bioreactors in in vitro systems, with continuous 
monitoring and adjustment of the changing contents of the medium. Only if cells grow in 
the same medium, their interactions with different biomaterials can be compared in a 
useful way, and only then some careful conclusion regarding their potential in vivo 
performance can be drawn.  
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As already mentioned, the choice of cells and assays can be of great importance on the 
outcomes of in vitro studies. This is important when e.g. osteoconductive potential of a 
biomaterial is studied. Instead of using mature osteoblasts, which are responsible for the 
appositional bone growth rather than for de novo bone formation in vivo, the use of 
inducible and determined osteoprogenitor cells, as present in the bone marrow, might 
be more useful. When studying the not yet unraveled complex biological phenomena 
such as osteoinduction, initially a pluripotent cell line should be used. The use of a 
homogeneous cell population can give an insight into processes governing 
osteoinduction. In the next step, adult mesenchymal stem cells from the recipient site 
(mostly muscle, or perivascular cells) should be used, as they are most probably 
involved in the process of osteoinduction.  
 
 
2.8 Conclusions 
 
Today’s in vitro assays in which potential synthetic bone graft substitutes are tested 
often give inconclusive results and their predictive value for the in vivo performance of 
the graft is limited. Most important limitations of the existing in vitro assays, which have 
initially been developed for a different purpose, are: 1) in in vitro systems there is often 
a biomaterial-cell culture medium interaction which can be of influence on the results of 
the in vitro study and is undesired as it is often not expected to occur in vivo in the same 
way and 2) cells used in in vitro systems are often not representative for the in vivo 
situation, in particular when complex biological phenomena, such as osteoinduction are 
investigated. 
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3.1 Abstract 
 
In this study, we investigated the influence of octacalcium phosphate (OCP) coating on 
osteoinductive properties of various biomaterials. Porous titanium alloy (Ti6Al4V), 
hydroxyapatite (HA), biphasic calcium phosphate (BCP) and polyethylene glyco 
terephtalate/polybuthylene terephtalate (PEGT-PBT) copolymer, all uncoated and 
coated with biomimetically produced OCP, were implanted in paraspinal muscles of 10 
goats for 6 and 12 weeks. Uncoated Ti6Al4V and HA did not show bone formation 
after intramuscular implantation. All OCP coated implants, except PEGT-PBT, induced 
bone in the soft tissue. Both uncoated and OCP coated BCP induced bone. However, 
bone incidence was higher in the coated BCP implants as compared to the uncoated 
ones. Biomimetic OCP coating might be a helpful tool for designing more advanced 
orthopaedic and dental implants.  
 
Keywords: biomimetic coatings, octacalcium phosphate (OCP), osteoinduction. 
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3.2 Introduction 
 
Osteoinduction can be defined as the process of bone formation in extraskeletal sites. 
Osteoinduction includes a process of differentiation of non-osteogenic cells into 
osteoblasts and bone morphogenesis.  
Various calcium phosphate (CaP) containing biomaterials, produced in the form of 
ceramics, cements and coatings, have been shown to induce ectopic bone formation in 
various animal models. In the last decade, a few reports showed osteoinduction by 
synthetic hydroxyapatite (HA) in dogs [116-120], coral derived HA ceramic in dogs, 
monkeys and baboons [117, 121, 122], synthetic α– and β-tricalcium phosphate (α-
TCP, β-TCP), biphasic calcium phosphate ceramics (BCP), α-pyrophosphate ceramics and 
β-pyrophosphate ceramics [125-129, 149]. Besides many reports of osteoinduction by 
CaP ceramics, Yuan et.al. [189] showed ectopic bone formation by a CaP cement in 
muscles of dogs. Recently, Yuan et.al., [140] and Barrere et.al. [132] reported 
osteoinduction by octacalcium phosphate (OCP) coating on porous tantalum (Ta) 
implants in dogs and goats, respectively. 
Composite of CaP coatings and metal implants is an example of combining different 
biomaterials in order to improve intrinsic properties of the final implant. Combination of 
sufficient mechanical properties of metals with bioactivity of CaPs makes CaP coated 
implants suitable for, e.g. total hip arthroplasty and other load bearing applications. 
The conventional technique of providing metal implants with a CaP coating is plasma-
spraying (PS). Although PS coated implants have shown some great clinical successes 
[42], the method of producing them shows many disadvantages. PS coating process 
takes place at very high temperatures, limiting this method to stable CaP phases. 
Furthermore, it is not possible to coat geometrically complex and porous implants by 
using the PS method, while introduction of porosity into orthopaedic implants is 
becoming more important, as mechanical interlocking might enhance bone-implant 
integration process. 
Recently, other techniques have been studied to improve the quality of coatings, such as 
electrophoretic deposition [43], sputter deposition [44] and sol-gel [45]. Nevertheless, 
the deposition of CaP coatings from Simulated Body Fluids (SBF) [190] offers the most 
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promising alternative to PS and other methods. The biomimetic coating method is 
inspired by the bone mineralization process of collagen fibers. As a result of the 
paraphysiological conditions of this technique, various CaP phases such as OCP [191] 
and carbonated apatite (CA) [192] can be deposited. The biomimetic coating process is 
performed in a solution, which allows for coating of geometrically irregular and porous 
implants. 
The aim of this in vivo study was to investigate the influence of biomimetic OCP coating 
on osteoinductive properties of various biomaterials. 
 
 
3.3 Materials and methods 
 
3.3.1 Implants 
 
In this study, we used four kinds of porous materials: Ti6Al4V, HA, BCP and PEGT-PBT. 
All materials, except PEGT-PBT were used with and without biomimetic OCP coating. 
Ti6Al4V implants were produced by a positive replica method as described earlier 
[193]. In short, 70 wt% of titanium alloy powder (Northwest Non-Ferrous Institute of 
China) consisting of spherical particles with a diameter lower than 44µm (325 mesh) 
was mixed with H2O (20 wt%). Polyethylene glycol (PEG) and methylcellulose were 
used as binders (8 wt%). Dolapix (CE 64, Germany) and ammonia solution (2 wt%) 
were added to improve the rheological property of the slurry. Porous titanium alloy 
bodies were made by impregnation of polymeric (PU) sponges (35-45 pores per inch) 
(Coligen Europe B.V., Breda, The Netherlands). When the slurry reached the designed 
viscosity range (3000-5000 cp), Polyurethane (PU) foams were dipped into the slurry 
and then extracted to dry. The dipping-drying process was repeated until the struts of 
the PU foam were coated with titanium alloy slurry. The superfluous slurry was removed 
by using a roller under pressure, to get an evenly distributed coating on the foam. After 
final drying, the samples were first heated to 500ºC to burn out foam, then, they were 
sintered in a vacuum furnace at 1250ºC with holding time of 2h. Cylinders (∅5 x 10 
mm3) were machined by using the electric sparkling method. The ultrastructure of porous 
titanium alloy was characterized by using an environmental scanning electron 
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microscope (ESEM; XL30, ESEM-FEG, Philips, The Netherlands) in the secondary electron 
mode. The porosity of the material was determined from the histological slides using an 
image analysis PC-based system equipped with KS400 version 3.0 software (Carl Zeiss 
Vision, Oberkochen, Germany). Average pore size was measured on the 2D cross-
section by using the automatic ruler of the ESEM. Pore interconnectivity was visually 
analyzed by the ESEM on the material cross-sections.  
Porous HA implants were produced by using the dual phase mixing method described 
earlier [129]. In this method, commercially available HA powder (Merck, Amsterdam, 
The Netherlands) was used. The processing route consisted of three steps. In the first 
step, HA slurry was prepared by mixing 2/3 wt% of calcined HA powder with 1/3 
wt% water containing deflocculant (Dolapix CE 64, Germany) and binder (carboxyl-
methyl cellulose, Pomosin BC, The Netherlands). In the second step, two immiscible 
phases were mixed: water-based HA slurry and polymethyl methacrylate (PMMA) resin 
with a volume ratio of 1:1. The PMMA resin consisted of PMMA powder, MMA monomer 
and an additional fugitive pore maker (<10 v/v%) such as naphthalene or wax 
particles. In the final step, the mixture was mould-shaped, polymerized, dried, pyrolised 
and sintered in air at 1250°C for 8 hours. Cylinders (∅5 x 10 mm3) were machined 
using a lathe. The structure of porous HA was characterized by an ESEM. Porosity, pore 
size and pore interconnectivity were analyzed by the same techniques as described for 
the Ti6Al4V implants. Composition and crystal structure of the material were determined 
by using Fourier transform infra red spectroscopy (FTIR; Spectrum100, Perkin Elmer 
Analytical Instruments, Norwalk, CT) and X-ray diffraction (XRD; Miniflex, Rigaku, 
Japan). 
Porous BCP implants were prepared by using the H2O2 foaming method as published 
earlier [129]. For the preparation of the ceramic, in-house made BCP powder was used. 
Porous green bodies were produced by mixing the BCP powder with 2% H2O2 solution 
(1.0 g powder / 1.2 ± 0.05 ml solution) and naphthalene (Fluka Chemie, The 
Netherlands) particles (710-1400 μm; 100 g powder / 30 g particles) at 60°C. The 
naphthalene was then evaporated at 80°C and the porous green bodies were dried. 
Subsequently, porous green bodies were sintered at 1200°C for 8 h and machined into 
cylinders (∅5 x 10 mm3) by using a lathe. The structure of porous BCP was 
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characterized by an ESEM. Porosity, pore size and pore interconnectivity were 
analyzed by the same techniques as described for the Ti6Al4V implants. Composition 
and crystal structure were determined by using FTIR and XRD. HA/β-TCP ratio in the 
BCP was determined by comparing the BCP XRD pattern to the calibration patterns 
prepared from the powders with the known HA/β-TCP weight ratios. 
PEGT-PBT copolymers were obtained from IsoTis SA (Bilthoven, The Netherlands) with a 
composition denoted as aPEGTbPBTc, where a represents PEG molecular weight, and b 
and c wt% of PEGT and PBT blocks, respectively. Final materials were prepared by 
using the compression molding and particle-leaching method described earlier [46]. In 
brief, PEGT-PBT granules with a size of 500-600 μm were homogeneously mixed with 
sodium chloride grains and sieved to obtain particles ranging in size form 400-600 μm. 
The amount of the salt was adjusted to a desired final volume percentage of 75%. The 
mixture was heated to 180°C for 3 min and subsequently compression molded for 1 min 
at 2.9 MPa in a hot press (THB 008, Fontijne Holland BV, The Netherlands) resulting in a 
block with dimensions of 120  x 100  x 10 mm3. The block was then immersed into 
demineralized water for 48 h to remove the sodium chloride, and dried under reduced 
pressure in vacuum oven. Final implants with a size of ∅5 x 10 mm3 were cored out of 
bigger blocks. The structure of porous PEGT-PBT was characterized by an ESEM. 
Porosity, pore size and pore interconnectivity were analyzed by the same techniques as 
described for other implants. 
 
 
3.3.2 Coating process 
 
Prior to the coating process, porous implants were ultrasonically cleaned in acetone, 
ethanol and water, subsequently. Next, they were soaked in SBF for 24h at 37°C to 
seed the metal surface with calcium phosphate nuclei. The used SBF solution was 5 times 
more concentrated than Kokubo’s SBF solution [190] (table 1) in order to increase the 
rate of the coating process. In order to produce crystalline OCP coating, the implants 
were then immersed in simulated calcifying solution (SCS) (table 1) for 48 hours at 37°C 
with one replenishment.  
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Table 1: inorganic composition (mM) of Kokubo’s SBF, supersaturated SBFx5 and SCS. 
Ion concentration (mM) 
 Na+ K+ Ca2+ Mg2+ Cl- HPO42- HCO3- SO42- 
SBF 142.0 5.0 2.5 1.5 148.8 1.0 4.2 0.5 
SBFx5 714.8 -- 12.5 7.5 723.8 5.0 21.0 -- 
SCS 140.4 -- 3.1 -- 142.9 1.86 -- -- 
 
The biomimetic method of producing the OCP coating has previously been described in 
detail [191]. The coating composition and crystallinity were investigated by using FTIR 
and XRD. Coating thickness was measured on 2-D implant cross-sections by the 
automatic ESEM ruler. 
 
 
3.3.3 In vivo experiments 
 
This study was approved by the Dutch Animal Care and Use Committee. Ten adult Dutch 
milk goats were housed at Central Animal Laboratory Institute (GDL), Utrecht, The 
Netherlands, at least four weeks prior to surgery. 
Before the surgical procedure, a dose of 0.1ml in 5ml of physiologic saline solution (± 
1ml/25kg body weight) of Domosedan (Pfizer Animal Health BV, Capelle a/d Ijssel, 
The Netherlands) was administered by intravenous injection. The surgical procedure 
itself was performed under general inhalation anesthesia of the animals. Thiopental 
(Nesdonal, ± 400mg/70kg of body weight, on indication, Rhone Merieux, Amstelveen, 
The Netherlands) was injected intravenously, and anesthesia was maintained with a gas 
mixture of nitrous oxide, oxygen and Halothane (ICI-Farma, Rotterdam, The 
Netherlands). 
After shaving the lumbar area and disinfection with iodine, the left muscle fascia was 
exposed and cut. Using blunt dissection, intramuscular pockets were created, and filled 
with one of the each above described implants: Ti6Al4V, OCP Ti6Al4V, HA, OCP HA, 
BCP, OCP BCP and OCP PEGT-PBT. Subsequently, the fascia was closed with a non-
resorbabale suture to facilitate implant localization at explantation. The skin was closed 
in two layers. After 6 weeks, the same procedure was repeated in the right back 
muscle. Table 2 gives an overview of the implanted materials. 
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Immediately after the surgery, pain relief was given by buprenofine (Temgesic; 
Schering-Plough, Kenilworth, NJ).  
12 weeks after the first implantation (i.e. implantation times 6 and 12 weeks), each 
animal was sacrificed by an overdose of pentobarbital (Euthesaat, Organon, Oss, The 
Netherlands) and potassium chloride. 
Intramuscular implants with surrounding tissue were explanted by sharp dissection and 
fixed in Karnovsky’s fixative. All implants were dehydrated in a graded ethanol series 
(70-100%) and transferred into MMA solution that polymerized at 37°C within 1 week. 
Longitudinal sections (10-15μm) were made by using the modified interlocked diamond 
saw (Leica Microtome, Nussloch, Germany). Sections were stained with 1% methylene 
blue and 0.3% basic fuchsin after etching with HCl/ethanol mixture. Qualitative analysis 
was performed on all retrieved implants by using a light microscope (E600 Nikon, 
Japan). 
 
 
Table 2: implantation scheme. 
Material Ti6Al4V OCP  
Ti6Al4V 
HA OCP  
HA 
BCP OCP  
BCP 
OCP 
PEGT-PBT 
6 weeks 10 10 10 10 10 10 10 
12 weeks 10 10 10 10 10 10 10 
 
 
3.4 Results 
 
3.4.1 Implant characterization 
 
As determined from the material cross-sections by using an image analysis system, the 
average porosity of the porous Ti6Al4V implants was 79 ± 5% and the pores varied in 
diameter between 400 and 1300 μm. Observations by the ESEM showed that the pores 
were well interconnected. Figure 1a illustrates the macrostructure of the uncoated 
porous Ti6Al4V. Higher magnification ESEM photograph (figure 1b) shows the rough 
metal surface, caused by the sintering of the alloy powder particles.  
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Figure 1: ESEM photographs of Ti6Al4V magnification 10x (A), and 500x (B), HA 10x (C) and 1000x (D), BCP 10x (E) and  
5000x (F), OCP PEGT-PBT 10x (G) and 500x (H). 
High magnification OCP PEGT-PBT photograph is representative for the structure of OCP coating on all implants. 
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Average macroporosity of the porous HA implants was 46 ± 8% with pores varying in 
size between 100 and 800 μm. Mercury porosimeter measurements showed that the 
average microporosity (<10μm) was around 1.3%.  ESEM observations revealed that 
the pores were well interconnected. ESEM photograph at low magnification (figure 1c) 
illustrates macroporous structure of HA, while the higher magnification photograph 
(figure 1d) shows its rough microstructure. XRD and FTIR analysis (results not shown) 
showed that the HA ceramic consisted of pure HA. 
BCP implants revealed a well-interconnected macroporous structure (figure 1e), with 
pores varying in size between 100 and 800 μm. Image analysis of the material cross-
sections gave an average macroporosity of 54 ± 4%.  Higher magnification ESEM 
analysis (figure 1f) showed that macropore walls contained micropores (pore size <10 
μm). As measured by mercury porosimeter, average microporosity was around 24%. 
XRD pattern and FTIR spectrum analyses (results not shown) of the produced material 
showed a biphasic chemistry consisting of 88% HA and 12% β-TCP. The material was 
highly crystalline. 
Final composition of PEGT-PBT implants was 1000PEGT70PBT30, meaning the PEG 
molecular weight of 1000 and the weight percentage of PEGT/PBT being 70 and 30, 
respectively. The average porosity of these implants was 75 ± 5% and their pore size 
varied between 500 and 600 μm. Figure 1g is a low magnification ESEM photograph 
of the OCP coated PEGT-PBT implant. High magnification photograph (figure 1h), that is 
representative for all OCP coated implants, shows the highly crystalline and rough 
structure of the final OCP coating. 
ESEM observations revealed that in all coated implants, the material surface was 
homogeneously covered with a CaP layer. However, the thickness of the coating was not 
the same throughout the implant. The average thickness varied between 20 μm at the 
interior of the implant and 60 μm at the implant periphery. Large OCP crystals were 
oriented perpendicularly to the surface of the implants, as illustrated by the high 
magnification ESEM photograph of the coated PEGT-PBT (figure 1h).  FTIR spectra and 
XRD patterns (not shown) were typical for a pure, highly crystalline OCP phase. 
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3.4.2 Bone induction 
 
At retrieval, all implants were surrounded by highly vascularized muscle tissue. Histology 
showed no evidence for toxicity of the implants nor was a deviating inflammatory 
reaction observed. 
Table 3 shows bone incidence in all implants after 6 and 12 weeks of intramuscular 
implantation. As can be seen, uncoated Ti6Al4V and uncoated HA implants did not show 
any ectopic bone formation after 6 and 12 weeks of implantation. Bone could be 
observed in the uncoated BCP implants. All OCP coated implants, except PEGT-PBT, 
sporadically induced bone after both 6 and 12 weeks of intramuscular implantation. 
The amount of induced bone was limited. 
 
 
Table 3: bone incidence after intramuscular implantation. 
Material 6 weeks 12 weeks 
Ti6Al4V 0/10 0/10 
OCP-Ti6Al4V 4/10 6/10 
HA 0/10 0/10 
OCP-HA 2/10 0/10 
BCP 3/10 6/10 
OCP-BCP 4/10 6/10 
OCP-PEGT/PBT 0/10 0/10 
 
Ti6Al4V, HA and OCP PEGT-PBT (figure 2a, c, and g respectively) were extensively 
filled with fibrous tissue, but no signs of bone formation were observed. The bone 
formed in OCP Ti6Al4V, OCP HA, BCP and OCP BCP (figure 2b, d, e and f, 
respectively) was always observed in the macropores inside the implants and never on 
the implant periphery or in surrounding soft tissue. The formed bone was normal in 
appearance, aligned with osteoblasts, and with mineralized bone matrix and osteocytes 
clearly visible. The OCP coating was often incorporated inside the newly formed bone. 
In the areas without bone, the OCP coating had extensively dissolved after 6 weeks, 
and could only occasionally be observed after 12 weeks of implantation. In the areas 
where the coating was still visible, signs of its resorption by multinucleated cells were 
observed.  
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Figure 2: LM photographs (magnification 10x) after 12 weeks of intramuscular implantation of Ti6Al4V (A), OCP Ti6Al4V (B), HA 
(C), OCP HA (D), BCP (E), OCP BCP (F) and OCP PEGT-PBT (G). 
Ti=titanium alloy, HA=hydroxyapatite, BCP=biphasic calcium phosphate, P=PEGT-PBT, FT=fibrous tissue and B=bone. → p216. 
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3.5 Discussion 
 
In this in vivo study, we investigated the effect of OCP coating on osteoinductive 
potential of various biomaterials. 
Because of the low bone incidence, and a low quantity of bone formed in this study, 
only a qualitatively analysis of ectopic bone formation was performed. 
All implants used in this study had a macroporous structure. The reason for this choice of 
structure was the fact that in all previous studies on osteoinduction by CaP biomaterials, 
ectopic bone formation was never observed on the non-porous implants or on the 
peripheries of the implants, suggesting the presence of porosity to be a prerequisite of 
osteoinduction.  
In this study, uncoated Ti6Al4V implants did not induce bone in any of the animals, while 
bone was induced after application of the CaP coating on their surface. This finding 
suggests that the presence of CaPs is another prerequisite for ectopic bone formation. 
Although Yuan et.al. [134] and Fujibayashi et.al. [135] have shown osteoinduction by 
alumina ceramic and chemically treated porous titanium, it is well know that both 
alumina ceramic and pretreated titanium are able to calcify when immersed in SBF in 
vitro. It has been suggested that the same process of calcification occurs in vivo, 
preceding the process of bone formation. Although CaP seems to be of importance in 
the process of osteoinduction, the presence of a CaP phase alone is not enough, as is 
suggested by the fact that no bone was found in uncoated the HA implants.  
Besides macroporosity and the presence of CaPs, microstructure of the material is 
believed to influence its osteoinductive properties as well. In the present study we 
compared different CaP phases (HA, BCP and OCP) as well as different macro- and 
microstructures. In the case of bulk ceramics, sintering process is often responsible for the 
formation of micropores inside the macropore walls. Increase of microporosity is 
responsible for the increase of the specific surface area of the ceramic. In the case of 
the OCP coating, we cannot speak of microporosity. However, also here, the specific 
surface area of the material is increased due to the presence of large crystals that 
perpendicularly grow on the implant surface. 
Obviously all three described material properties, i.e. chemical composition, macro- and 
microstructure are of great importance for osteoinductive potential of a material. 
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As shown in table 3, the presence of OCP coating increased osteoinductive potential of 
all tested biomaterials. Uncoated Ti6Al4V and HA, that did not show ectopic bone 
formation in this study, became osteoinductive after the application of the OCP coating 
on their surface. Similarly, bone incidence of BCP increased in the presence of OCP 
coating. The fact that uncoated BCP did and uncoated HA did not show any bone 
induction is probably due to the differences in their chemistry and structure as earlier 
reported by Yuan et.al. [129]. The reason for the poor osteoinductive performance of 
the coated polymer might be explained by the fact that, due to the chosen composition, 
this implant was soft und unable to retain its porous shape after implantation. 
Continuous movement of the muscle caused too much pressure on the PEGT-PBT implant, 
making the implant flat and its pores closed. 
Although our knowledge on the parameters which are of influence on osteoinductive 
behavior of biomaterials is increasing [127-129, 194], the exact mechanism of 
osteoinduction remains unknown. Concerning this mechanism, we hypothesize: 1) 
osteoinductive materials exert a direct effect on the growth and differentiation of 
relevant cells that attach to them, a 2) the surface of osteoinductive materials helps 
collecting relevant proteins, which in their turn exert an osteoinductive effect on the 
recruited cells. 
In both cases, the presence of porosity plays an important role. Nutrients can easily be 
supplied through the interconnected porous structure. On the other hand, microporous 
walls provide a protected area, without strong fluid movements, giving cells the space 
to differentiate towards the osteogenic lineage. The presence of CaP leads to a 
dissolution process, and therewith release of calcium and phosphate ions. This process 
results in a CaP supersaturation in the vicinity of the implant surface, eventually causing 
precipitation of bone like carbonated apatite layer, possibly accompanied with 
coprecipitation of relevant proteins from body fluids. Consequently, undifferentiated 
cells start differentiating into osteoblasts, finally forming new bone. 
An interesting observation from this study is a large difference in the amount of bone 
induced between individual animals, i.e. one goat was “more inductive” than another 
goat, for all implanted materials. The reason for this difference could be either genetic 
or pathological, but as long as the mechanism of osteoinduction itself is not clear, this 
phenomenon will be hard to explain. In addition to the intraspecies difference observed 
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in this study, it is well known that osteoinductive potential of a biomaterial varies 
between different species [116, 143].  
This study shows that we are able to produce an OCP coating on various kinds of 
porous implants by following a biomimetic route. OCP coating can improve the 
osteoinductive potential of various materials. It has previously been suggested that 
osteoinductive materials show more bone formation when implanted orthotopically as 
compared to the non-osteoinductive biomaterials [195], which suggests the importance 
of osteoinductivity in bone repair. The biomimetic coating method might be an elegant 
tool of producing more advanced orthopaedic and dental implants. 
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4.1 Abstract 
 
In order to unravel the mechanism of osteoinduction by biomaterials, in this study we 
investigated the influence of the specific surface area on osteoinductive properties of 
two types of calcium phosphate ceramics. Different surface areas of the ceramics were 
obtained by varying their sintering temperatures.  
Hydroxyapatite (HA) ceramic was sintered at 1150 and 1250 °C. Biphasic calcium 
phosphate (BCP) ceramic, consisting of hydroxyapatite and beta tricalcium phosphate 
(β-TCP), was sintered at 1100, 1150 and 1200 °C. 
Changes in sintering temperature did not influence the chemistry of the ceramics; HA 
remained pure after sintering at different temperatures and the weight ratio of HA and 
β-TCP in the BCP was independent of the temperature as well. Similarly, macroporosity 
of the ceramics was unaffected by the changes of the sintering temperature. However, 
microporosity (pore diameter <10μm) significantly decreased with increasing sintering 
temperature. In addition to the decrease of the microporosity, the crystal size increased 
with increasing sintering temperature. These two effects resulted in a significant 
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decrease of the specific surface area of the ceramics with increasing sintering 
temperatures. 
Samples of HA1150, HA1250, BCP1100, BCP1150 and BCP1250 were implanted in 
the back muscles of Dutch milk goats and harvested at 6 and 12 weeks post 
implantation. After explantation, histomorphometrical analysis was performed on all 
implants.   
All implanted materials except HA1250 induced bone. However, large variations in the 
amounts of induced bone were observed between different materials and between 
individual animals. 
Histomorphometrical results showed that the presence of micropores within macropore 
walls is necessary to make a material osteoinductive. We postulate that introduction of 
microporosity within macropores, and consequent increase of the specific surface area, 
affects the interface dynamics of the ceramic in such a way that relevant cells are 
triggered to differentiate into the osteogenic lineage.  
 
Keywords: hydroxyapatite (HA), biphasic calcium phosphate (BCP), sintering 
temperature, macrostructure, microstructure, specific surface area, osteoinduction. 
 
 
4.2 Introduction 
 
Osteoinduction can be defined as the “induction of undifferentiated inducible 
osteoprogenitor cells that are not yet committed to the ostogenic lineage to form 
osteoprogenitor cells” [93]. In order to prove the osteoinductive potential of a 
biomaterial, soft tissue implantation i.e. implantation in the absence of cells with direct 
bone forming capacity, can be used. First evidence of osteoinduction was given by Urist 
in 1965 [19], after implantation of demineralized bone matrix (DBM) in soft tissue of 
rabbits, rats, mice and guinea pigs. Later studies [101, 196, 197] suggested that DBM 
contained morphogenetic factors capable of inducing the differentiation of resident 
extraskeletal mesenchymal cells firstly into chondrocytes and then into osteoblasts, i.e. 
osteoinduction. At present, highly purified native bone morphogenetic proteins (BMPs) 
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and recombinant human BMPs are available and in many studies their osteoinductive 
potential has been shown [198-200].  
The general idea that BMPs are always necessary for triggering bone induction was 
challenged by Winter’s and Simpson’s discovery [114] of osteoinduction by a polymeric 
sponge.  In this study it was observed that prior to the process of bone formation, the 
calcification of a polymeric sponge had taken place, suggesting the importance of the in 
vivo calcification, and thereby calcium-phosphates (CaPs) in the process of 
osteoinduction. 
The importance of CaPs in osteoinduction has been supported by the reports of various 
groups in the last decade. Some examples are studies that showed bone induction in 
synthetic HA ceramic in dogs [116-120], in coral derived HA ceramic in dogs, monkeys 
and baboons [117, 121, 122], in α-TCP-, β-TCP-, BCP-, α-pyrophosphate- and β-
pyrophosphate ceramics [122, 124-129]. In addition to the CaP containing 
biomaterials, there have also been a few reports showing osteoinduction by alumina 
ceramic [134] and titanium [135] in dogs. Similar to Winter’s and Simpson’s observation 
[114], the in vivo calcification of these materials is believed to be the precursor of bone 
induction. 
Because the mechanism of osteoinduction by biomaterials is not completely understood, 
it is unknown whether it is the biomaterial, or possibly an interaction between the 
biomaterial and the relevant proteins present in body that is responsible for the process 
of bone induction. Since most implants do not induce bone, specific material properties 
are apparently needed for starting the process of bone induction. To start the 
differentiation of the undifferentiated inducible osteoprogenitor cells into bone forming 
cells, it has been suggested that not only the chemistry, but also geometry of the 
biomaterial in contact with these cells are critical factors [124, 128, 129, 134, 135]. In 
other words, the microenvironment around the cells is crucial. As earlier reported, 
changing the sintering temperature of a CaP ceramic has a consequence for its 
microstructure and crystal size, i.e. its specific surface area. This in turn not only 
influences mechanical strength [201] and initial bone-bonding of the ceramic [202], but 
also the microenvironment and thus possibly the ceramic osteoconductive properties 
[203]. An indicator of the influence of sintering temperature on ceramic osteoconductive 
properties is that the expressions of relevant markers, such as alkaline phosphatase and 
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osteocalcin, have been reported to be different for varying sintering temperatures 
[204]. 
The goal of the current in vivo study was to try to unravel the possible mechanism of 
osteoinduction by investigating the influence of the microenvironment around the 
undifferentiated inducible cells on the osteoinductive capacity of the CaP ceramics. The 
specific surface area was used to quantify the microenvironment. The tool used to vary 
the specific surface area was the sintering temperature of the ceramics. In order to 
avoid possible influence of the chemical composition, not one but two types of CaP 
ceramics, namely HA and BCP, were chosen. Osteoinduction was evaluated by 
implantation in back muscles of adult Dutch milk goats. 
 
 
4.3 Materials and methods 
 
4.3.1 Implants 
 
Porous HA implants were produced by using the dual phase mixing method described 
earlier [129]. In this method, commercially available HA powder (Merck, Amsterdam, 
The Netherlands) was used. The processing route consisted of three steps. In the first 
step, HA slurry was prepared by mixing 2/3 wt% of calcined HA powder with 1/3 
wt% water containing deflocculant (Dolapix CE 64, Germany) and binder (carboxyl-
methyl cellulose, Pomosin BC, The Netherlands). In the second step, two immiscible 
phases were mixed: water-based HA slurry and polymethyl methacrylate (PMMA) resin 
with a volume ratio of 1:1. The PMMA resin consisted of PMMA powder, MMA monomer 
and naphthalene (<10 v/v%) as an additional fugitive pore maker. In the final step, the 
mixture was mould-shaped, polymerized, dried and pyrolized. Finally, the materials 
were divided into two groups and sintered in air at 1150 and 1250 °C, respectively, 
for 8 hours. A lathe was then used to produce cylinders (∅5 x 10mm3).  
Ultrastructures of the porous HA ceramics were characterized by an environmental 
scanning electron microscope (ESEM; XL30, ESEM-FEG, Philips, The Netherlands) in the 
secondary electron mode. Macroporosities and average pore sizes of the ceramics 
were determined by using histological slides (10 cross-sections for 6-week- and 10 
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cross-sections for 12-week-implantation). First, the labels of the sections were covered.  
Then, high resolution (300dpi), low magnification (10x) digital micrographs were made 
of these sections. Using Adobe Photoshop 7.0, bone and material were pseudocoloured, 
red and green respectively. Image analyses were carried out with a computer-based 
system equipped with KS400 version 3.0 software (Carl Zeiss Vision, Oberkochen, 
Germany). Prior to measurements the system was geometrically calibrated with an 
image of a block of known dimensions. A program was developed in KS400 to quantify 
the pore diameter for individual pores and the total macroporosities of the ceramics. 
The macroporosity was determined as: [(total implant surface – scaffold surface) / total 
implant surface] * 100%. Microstructures of the ceramics were analyzed by using a 
mercury intrusion porosimeter (MP, AutoPore IV 9500, Micromeritics Instrument 
Cooperation, Norcross, Georgia). For a good comparison, the microporosity of each 
ceramic was expressed as total incremental pore volume (ml) per g of the material for 
the pores with a diameter lower than 10 μm. Specific surface areas of the ceramics 
were determined from the mercury porosimeter results, as the cumulative surface area 
(m2/g) when all the pores were filled with mercury. Pore interconnectivity was visually 
analyzed by an ESEM on the material cross-sections.  
Compositions and crystal structures of the ceramics were determined by using Fourier 
Transform Infra Red Spectroscopy (FTIR; Spectrum100, Perkin Elmer Analytical 
Instruments, Norwalk, CT) and X-Ray Diffraction (XRD; Miniflex, Rigaku, Japan). 
Porous BCP implants were prepared by using the H2O2 method as published earlier 
[129]. For the preparation of the ceramic, in-house made BCP powder was used. Porous 
green bodies were produced by mixing this powder with 2% H2O2 solution (1.0g 
powder / 1.2 ± 0.05ml solution) and naphthalene (Fluka Chemie, The Netherlands) 
particles (710 - 1400 μm; 100g powder/ 30g particles) at 60°C. The naphthalene was 
then evaporated at 80°C and the green porous bodies were dried. They were divided 
into three groups and sintered at 1100, 1150 and 1200 °C respectively for 8 hours. 
Finally, a lathe was used to produce cylinders with a size of ∅5 x 10mm3 for BCP1200 
and ∅7 x 7mm3 for BCP1100 and BCP1150. Due to the differences in the production 
techniques, BCP implants sintered at 1100 and 1150 °C had a different size from the 
BCP sintered at 1200°C and HA implants. Although the influence of the implant size 
Chapter 4 
 
 
 
82 
cannot be completely excluded, the results of this study suggest that we can reliably 
make the comparison between all implanted ceramics. Ultrastructures of the porous BCP 
ceramics were characterized by an ESEM. Porosities, pore sizes, pore interconnectivity 
and specific surface areas were analyzed by the same techniques as described for the 
HA implants. Ceramic chemical compositions and crystal structures were determined by 
using an FTIR and XRD. HA/β-TCP weight ratios in the BCP ceramics were calculated by 
comparing the BCP XRD patterns to the calibration patterns prepared from the powders 
with the known HA/β-TCP weight ratios. 
 
 
4.3.2 Animals and implantation 
 
This study was approved by the Dutch Animal Care and Use Committee. In total, ten 
adult Dutch milk goats were used. The animals were housed in Central Animal 
Laboratory Institute (GDL), Utrecht, The Netherlands, at least 4 weeks prior to surgeries. 
Before surgical procedures, a dose of 0.1mL in 5mL of physiologic saline solution (± 
1mL/25kg body weight) of Domosedan (Pfizer Animal Health BV, Capelle a/d Ijssel, 
The Netherlands) was administered by intravenous injection. Surgical procedures were 
performed under general inhalation anesthesia of the animals. Thiopental (Nesdonal, ± 
400mg/70kg of body weight, on indication, Rhone Merieux, Amstelveen, The 
Netherlands) was injected intravenously, and anesthesia was maintained with a gas 
mixture of nitrous oxide (66 v/v%), oxygen (33 v/v%) and Halothane (1 v/v%) (ICI-
Farma, Rotterdam, The Netherlands). 
Besides the implantations described in this study, the animals were used for a different 
study, to be published separately. Different groups of implants were assumed not to 
influence each other’s behavior, as they were implanted either at a different 
implantation site or at a sufficient distance from each other as approved by the Dutch 
Animal Care and Use Committee. 
After shaving the lumbar areas and disinfection with iodine, left muscle fascias were 
exposed and cut. Using blunt dissection, intramuscular pockets were created, and filled 
with one of each above-mentioned implants: HA1150, HA1250, BCP1100, BCP1150 
and BCP1200. Subsequently, fascias were closed with nonresorbable sutures to 
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facilitate implant localization at explantation. The skin was closed in two layers. After 6 
weeks, the same procedure was repeated in the right back muscle of each of the ten 
goats. Table 1 shows the total amounts of implanted materials for both time points. 
Immediately after surgeries, pain relief was given by buprenofine (Temgesic; Schering-
Plough, Kenilworth, NJ).  
Twelve weeks after the first implantations (i.e. implantation times 6 and 12 weeks), each 
animal was sacrificed by an overdose of pentobarbital (Euthesaat, Organon, Oss, The 
Netherlands) and potassium chloride. 
 
 
Table 1: overview of the total amounts of the implanted ceramics. 
Material 6 weeks 12 weeks 
HA1150 10 10 
HA1250 10 10 
BCP1100 10 10 
BCP1150 10 10 
BCP1250 10 10 
 
 
4.3.3 Retrieval of the implants, histology and histomorphometry 
 
The implants with surrounding tissue were explanted by sharp dissection and fixed in 
Karnovsky’s fixative. They were dehydrated in a graded ethanol series (70%-100%) 
and transferred into a methylmethacrylate (MMA) solution that polymerized at 37°C 
within one week. Longitudinal sections (10-15μm in thickness) were made by using the 
modified interlocked diamond saw (Leica Microtome, Nussloch, Germany). Sections were 
stained with 1% methylene blue and 0.3% basic fuchsin after etching with HCl/ethanol 
mixture.  
For histomorphometry, the same image analysis method was used as previously 
described for the measurement of material macroporosities. In the computer-based 
image analysis system, a program was developed to quantify different parameters 
concerning bone formation:  
• Percentage of bone occupying available pore area (%b.),  
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• Percentage of available scaffold outline (in 3D surface of the scaffold) in 
contact with bone: [%contact = (bone-scaffold contact length / scaffold outline 
length) * 100%] in the total area of the implant (%b.cont. in implant), and 
• Percentage of available scaffold outline in contact to bone in the peripheral 
area that was defined by drawing a line 40 pixels central from the outer 
contour (corresponds with a distance of 350 μm) (%b.cont. in outer zone). 
In addition to the measurements of the amounts of induced bone in the available pore 
areas, the bone contact measurements were performed as this parameter can give 
additional information on the bone growth direction in time [78, 205]. Measurements of 
the bone contact in both total area of the implant and in the peripheral area were 
performed in order to get more insight into preferable location for bone induction and 
consequently into the possible mechanism of this phenomenon. 
 
 
4.3.4 Statistical analysis 
 
Statistical calculations were done with the SPSS (Chicago, IL) 9.0 software. We found 
large variances between the individual animals. However, the trend within each animal 
was similar (material A induced more bone than material B in all goats). Because the 
distribution of the data was not normal, we chose non-parametric tests to perform the 
statistical analysis. Friedman rank test, followed by a post-hoc test [206] was chosen to 
make the comparisons between all ceramics at both time points.  
The Wilcoxon signed rank test [207] for paired comparisons was used to analyze the 
difference in bone formation per material between the two time points and the 
difference in bone contact per material between the total implant and the peripheral 
zone.  
In both tests, the significance level was set at p=0.05.  
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4.4 Results 
 
4.4.1 Material characterization 
 
HA ceramics, sintered at both 1150 and 1250 °C consisted of pure HA, as shown by the 
FTIR spectra and XRD patterns (figure 1a and 1b, respectively). No differences could 
be found in FTIR spectra and XRD patterns between the HA ceramics sintered at the 
either temperatures. Observations by the stereomicroscope and by the ESEM showed 
that both ceramics had similar macrostructures, consisting of well-interconnected 
macropores.  
 
 
Figure 1: FTIR spectra (A) and XRD patterns (B) of HA1150 and HA1250. 
 
 
Macropore diameters for both ceramics were similar ranging between 200 and 400 
μm, with an average of 249±38 μm (table 2). However, microstructures of the two 
ceramics differed: HA1250 had a rough microstructure, with only few micropores (pore 
diameter < 10 μm) (figure 2a), while macropore walls of HA1150 contained many 
micropores (figure 2b).  
Furthermore, the average crystal size of the HA1250 was higher as compared to 
HA1150. These observations were confirmed by the porosity measurements. 
Macroporosities of ceramics were 47±3% as determined from the material cross-
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sections (table 2). For the pores with the pore diameter lower than 10 μm, large 
differences in the total pore volume between the HA1150 and HA1250 were observed. 
As can be seen in figure 3, for both temperatures, most micropores had a diameter of 
around 0.5 μm. However, the total incremental volume of micropores, i.e. the 
microporosity is much higher for HA1150 as compared to HA1250.  
 
 
Figure 2: ESEM photographs (magnification 5000x) of HA1250 (A) and HA1150 (B).  
Decrease in the sintering temperature results in an increase of the amount of micropores  
and a decrease in the crystal size of a ceramic. 
 
 
Table 2: macroporosity and specific surface area overview. 
Material Macroporosity 
 (%) 
Diameter macropores 
 (μm) 
Specific Surface Area 
(m2/g) 
HA1150 47.5±1.2 243.9±38.7 1.32 
HA1250 46.5±4.9 248.4±51.0 0.07 
BCP1100 50.9±3.0 367.1±44.7 1.60 
BCP1150 54.3±8.0 380.2±60.6 1.02 
BCP1200 53.7±4.2 371.1±63.9 0.71 
 
The specific surface area of HA1150 was 1.32 m2/g and of HA1250 0.07 m2/g (table 
2). 
BCP ceramics sintered at 1100°C, 1150°C and 1200°C exhibited similar FTIR spectra 
and XRD patterns as is shown in the figures 4a and 4b respectively. As can be seen 
from the XRD pattern, there is a peak at 2θ = 31.2° typical of β-TCP, and absent on 
the XRD pattern of pure HA (figure 1b). Compositions of the three BCP ceramics were 
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the same, all consisting of 88% HA and 12% β-TCP. Similar to the two HA ceramics, 
BCP ceramics also consisted of highly interconnected macropores ranging in the size 
between 320μm and 470μm, with an average of 373±56 μm (table 2). LM and ESEM 
observations showed similar macrostructures for BCP1100, BCP1150 and BCP1200.  
 
 
Figure 3: total incremental pore volume of the implanted ceramics.  
Decrease in the sintering temperature results in an increase of the total micropore volume, i.e. microporosity of the ceramic. 
 
 
 
Figure 4: FTIR spectra (A) and XRD patterns (B) of BCP1100, BCP1150 and BCP1200. 
 
 
Microstructures of the BCP ceramics sintered at the three temperatures did differ. As can 
be seen from the high magnification ESEM photographs (figures 5a, 5b and 5c), 
lowering the sintering temperature increased the amount of micropores within 
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macropore walls and decreased ceramic’s crystal size. Measurements on cross-sections 
showed similar macroporosities for the three ceramics of 53±5% (table 2).  
 
 
 
Figure 5: ESEM photographs (magnification 5000x) of BCP1200 (A), BCP1150 (B) and BCP1100 (C). 
Decrease in the sintering temperature results in an increase of the amount of micropores  
and a decrease in the crystal size of a ceramic. 
 
 
As illustrated by figure 3, most micropores of the three BCPs had a diameter of around 
1μm. Figure 3 also shows that the increase in the sintering temperature resulted in a 
decreased total incremental micropore volume per gram of the material (microporosity), 
resulting, in turn, in a decreased specific surface area: BCP1100 = 1.60 m2/g, 
BCP1150 = 1.02 m2/g and BCP1200 = 0.71 m2/g (table 2). 
Material characterization results of this study can be summarized as follows: 
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• Macroporosities of all implanted ceramics were similar (~50%). Average 
macropore size of HAs was around 245 μm and that of BCPs around 370 μm 
in diameter. 
• Specific surface areas: BCP1100 (1.60 m2/g) > HA1150 (1.32 m2/g) > 
BCP1150 (1.02 m2/g) > BCP1200 (0.71 m2/g) > HA1250 (0.07 m2/g). 
• Chemical composition: 88wt% HA / 12wt% β-TCP in BCP versus 100wt% HA. 
 
 
4.4.2 Intramuscular implantation 
 
There were no surgical complications and all implants were retrieved. At retrieval, all 
implants were surrounded by well-vascularized muscle tissue.  Histology showed no 
evidence for toxicity of the implants, or signs of an inflammatory tissue response directly 
related to the implants. 
 
 
Table 3: bone incidence after 6 and 12 weeks of implantation. 
Material 6 weeks 12 weeks 
HA1150 5/10 7/10 
HA1250 0/10 0/10 
BCP1100 6/10 8/10 
BCP1150 7/10 6/10 
BCP1200 3/10 6/10 
 
Table 3 gives an overview of the bone incidence after 6 and 12 weeks of implantation. 
In some animals bone was not induced at all, while in the others (2 out of 10 after 6 
weeks, and 5 out of 10 after 12 weeks) bone induction was considerable (>2% bone 
contact) as compared to the results of the similar studies in the same model. Because of 
the large variations in the amounts of induced bone between individual animals (non-
normal data distribution), calculations of the average values and the standard errors of 
the mean for bone contact and bone area were not possible. To illustrate the large 
differences, we plotted the data found for %b.cont. in total implant for goats 1 and 3 
(figure 6).  
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HA1250 was the only ceramic that did not induce bone formation in any of the animals. 
Table 4 gives an overview of the significant differences (p<0.05) between the ceramics 
for each of the measured parameters and for both time points. 
Significant differences (p<0.05) between 6 and 12 weeks of implantation were only 
found for BCP1100 and HA1150, for all three measured parameters.  
 
 
Figure 6: histomorphometrical results: % bone contact with the implant surface in the total area of the implant  
in goats 1 and 3 after 6 weeks of implantation. 
Variations in the amount of formed bone are large between the individual animals,  
but the order of osteoinductive potential of the materials remains similar. 
 
 
Table 4: overview of the implanted ceramics between which a significant differences (p<0.05) was observed after 6 and 12 weeks 
of implantation for the three measured parameters according to the Friedman’s rank test. 
*p=0.05 
 6 weeks 12 weeks 
%b. BCP1100>HA1250 
BCP1150>HA1250 
BCP1100>HA1250 
BCP1150>HA1250 
BCP1100>BCP1200 
BCP1150>BCP1200 
HA1150>=HA1250* 
%b.cont. implant BCP1100>HA1250 
BCP1150>HA1250 
HA1150>=HA1250* 
BCP1100>HA1250 
BCP1150>HA1250 
BCP1100>BCP1200 
BCP1150>BCP1200 
%b.cont. peripheral zone BCP1100>HA1150 
BCP1150>HA1150 
BCP1100>HA1250 
BCP1150>HA1250 
BCP1100>HA1250 
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Significant differences (p<0.05) between %b.cont. in total implant and %b.cont. in 
peripheral zone were found for two ceramics: %b.cont. in total implant was significantly 
higher than %b.cont. in peripheral zone after both 6 and 12 weeks of implantation for 
HA1150 and only after 6 weeks of implantation for BCP1150. 
 
 
 
Figure 7: LM photographs of BCP1150 (magnification 4x) (A), BCP1150 (magnification 20x) (B), and HA1250 (magnification 4x) 
(C) after 12 weeks of implantation. 
B=bone, FT=fibrous tissue BCP=BCP1150 ceramic, HA=HA1250 ceramic 
The induced bone is formed in the pores of the implant, aligning its surface (A). The formed bone is normal in appearance, aligned 
with osteoblasts and with osteocytes and osteoid clearly visible (B).  
The non-inductive ceramic is filled with fibrous tissue, but no signs of bone formation are observed (C). → p217. 
 
 
No bone was observed on the outside of the implants. Bone formation was limited to 
inside the pores. Figure 7a illustrates new bone formation in BCP1150 after 12 weeks 
of implantation. The formed bone was normal in appearance as illustrated by figure 
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7b. Figure 7c is a histological slide of HA1250 after 12 weeks of implantation, the 
ceramic that did not induce bone in any of the animals.  
Bone induction results of this study can be summarized as follows: 
• Bone induction: (BCP1100, BCP1150) > (BCP1200, HA1150) > HA1250 (no 
induction at all). 
• Bone induction in individual animals: >2% bone contact in goats no. 1 and 3 
after 6 weeks and in goats no. 1, 2, 3, 4, and 6 after 12 weeks of 
implantation. Hardly any bone induction in goats no. 7, 8 and 10. 
 
 
4.5 Discussion 
 
Winter’s and Simpson’s observation of bone induction by a polymeric sponge [114] 
after soft tissue implantation in pigs could not be explained by the Urist’s BMP theory 
[94], as the implanted polymeric sponge initially neither contained nor produced BMPs. 
An interesting finding of the Winter’s and Simpson’s study was that the implanted 
polymer showed in vivo calcification prior to the process of bone formation, suggesting 
the significance of CaPs in the process of osteoinduction. In a large number of 
publications, osteoinduction by CaP biomaterials in the form of ceramics [116-119, 121, 
122, 124-126, 128, 149, 208], cements [124, 126, 131], coatings [132, 133, 182, 
209] and glass ceramics [137] has been shown. In addition to CaP containing 
biomaterials, osteoinduction has also been observed in alumina ceramic [134] and 
titanium [135].  
Although osteoinduction by biomaterials is obviously a real phenomenon, its mechanism 
is still largely unknown. This and previous work indicate some of the parameters 
necessary for making a biomaterial osteoinductive. In turn, these parameters suggest the 
mechanisms involved in the phenomenon of osteoinduction. 
The presence of macropores, or concavities [138] is shown to be a prerequisite for 
osteoinduction by biomaterials. The presence of a well-interconnected macroporous 
structure is important for a good supply of the body fluids with nutrients throughout the 
implant. Accompanied with this supply, the release of calcium- and phosphate ions, that 
is believed to be the origin of the bioactivity of CaP biomaterials [171, 172, 210], took 
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place, followed by the precipitation of a biological apatite layer [211]. The 
precipitation of this apatite layer took place when the concentration of calcium- and 
phosphate ions had reached the supersaturation level in the material vicinity. This might 
explain the fact that the bone induction always takes place in the pores in the center of 
implant and not on the implant periphery [205]. The diffusion of the released calcium- 
and phosphate ions might occur too fast at the implant periphery, and therefore not 
allow for the ion concentration increase required for the biological apatite formation. 
It is expected that a material with a higher dissolution rate will release calcium- and 
phosphate ions faster, followed by a faster formation of the biological apatite layer. 
One way to influence the in vivo dissolution rate of a material is by changing its specific 
surface area. This study showed, for the first time, that HA1250, which possessed very 
few micropores, and hence a low specific surface area, did not induce any bone, while 
HA1150, having the same chemical composition but a much higher specific surface area, 
did induce bone. Similarly, the amount of bone induced by BCP1200 was significantly 
lower than the amount of bone induced by both BCP1100 and BCP1150. However, no 
significant differences in the amounts of bone induced between BCP1100 and BCP1150 
were found, although they had different specific surface areas, which suggest the 
existence of an optimal specific surface area. Materials with a specific surface area 
below the optimum will degrade slower, and will finally induce less bone. Materials with 
a specific surface area above the optimum might degrade too fast, losing thereby the 
shape and stability that is necessary to facilitate bone formation. Finally, there is a 
minimum threshold in the amount of micropores and hence specific surface area below 
which bone will not be induced.  
Also the changes of the material chemical composition can influence its in vivo 
degradation. Both BCP1100 and BCP1150 performed significantly better than 
HA1250. Moreover BCP1150 induced more bone than HA1150. Although they were 
sintered at the same temperature, the specific surface area of the HA ceramic was 
slightly higher than that of BCP. From the conclusion on the effect of specific surface 
area drawn above one would expect more bone in HA1150 than in BCP1150. 
Therefore it is evident that there are other factors influencing osteoinductive capacity of 
a ceramic. In addition to the difference in the average macropore diameter of about 
100 microns between BCP1150 and HA1150, the most important difference between 
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the two materials was the presence of β-TCP in BCP. Although we cannot exclude the 
importance of the macropore size, based on the earlier research we hypothesize that 
the effect of the presence of the more soluble β-TCP in BCP, and subsequently faster 
dissolution of BCP is more relevant than the difference in macropore size between the 
two materials. 
In the biomaterials that initially do not contain CaPs, like alumina ceramic and titanium, 
the formation of the biological apatite layer will take longer than in biomaterials that 
do contain CaPs. In the non-CaP biomaterials, calcium- and phosphate ions from the 
body fluids will precipitate onto the microporous surface of the material. The 
microporous surface acts as the collection of nucleation sites for this precipitation.  
The formed bone-like biological CaP layer could be a physico-chemical trigger for the 
cells to differentiate into the osteogenic lineage similar to being in a bony environment. 
However, there is another important observation from this study: the large variation in 
osteoinductive potential of individual animals, in addition to the inter-species variation 
[117]. If the process of osteoinduction by biomaterials is only based on the above 
described dissolution-reprecipitation process of calcium- and phosphate ions, it would 
not be likely to observe such a large difference between individual animals. No reports 
describing large variations between individuals’ response to CaP biomaterials in an 
orthotopic context could be found. On the other hand, in addition to the difference in 
the response to BMPs between the higher animals and rodents [112], there are reports 
of differences in the response to BMPs between the individuals of the same species, 
probably due to genetic factors [113]. Similar differences were also observed in 
humans [56]. Thus, it seems plausible that endogenous BMPs, or other relevant proteins 
play a role in osteoinduction by biomaterials. This means that precipitation of the 
biological apatite layer in vivo could be accompanied by the coprecipitation of the 
relevant proteins (e.g. BMPs), which in turn trigger the recruited cells to differentiate into 
the osteogenic lineage. The amounts of coprecipitated proteins, that vary with the 
amounts of endogenous proteins, in conjunction with the variations in the body response 
to these proteins, could explain the observed intra-species differences. We have 
summarized our ideas in figure 8. In conclusion, from the results of this study we 
postulate that the undifferentiated inducible osteoprogenitor cells are triggered to start 
differentiating into the osteogenic lineage by the BMPs or other relevant proteins that 
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are coprecipitated in the newly formed biological apatite layer, and that consequently 
this biological apatite layer acts as the conductor of the bone formed by the induced 
cells. Further reading (figure 8): [212-215]. 
 
 
Figure 8: flow chart of the proposed mechanism of osteoinduction by biomaterials. 
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4.6 Conclusion 
 
This study shows that, in addition to macropores, a minimum amount of micropores within 
the macropore walls is necessary for a material to be osteoinductive. These micropores 
are probably required for acceleration of the dissolution-reprecipitation process of 
CaPs on the material interface. The large variation in the amounts of induced bone that 
is observed between the individual animals suggests that some endogenous proteins such 
as BMPs might also play a role in the mechanism of osteoinduction by biomaterials. 
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5.1 Abstract 
 
Osteoinduction by biomaterials has been shown to be a real phenomenon by many 
investigators in the last decade. The exact mechanism of this phenomenon is, however, 
still largely unknown.  
This in vivo study in goats was performed to get insight into processes governing the 
phenomenon of osteoinduction by biomaterials and had four main goals: 1) to further 
investigate influence of physico-chemical properties and structure on a biomaterial’s 
osteoinductive potential, 2) to investigate influence of implant size on the amount of 
induced bone, 3) to investigate implantation site dependence and 4) to investigate 
changes occurring on the surface of the material after implantation.  
Intramuscular implantations of four different biphasic calcium phosphate (BCP) ceramics, 
consisting of hydroxyapatite (HA) and β-tricalcium phosphate (β-TCP) and a 
carbonated apatite (CA) ceramic indicated that, for a maximal osteoinductive potential, 
there is an optimal specific surface area for each material type. 
It was further shown that a decrease of the implant size with a half significantly 
decreased the relative amount of induced bone.  
In addition, subcutaneous implantation did not give rise to bone formation in any of the 
animals, while bone was induced in most animals intramuscularly.  
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Analysis of the surfaces of the materials after subcutaneous implantation inside diffusion 
chambers indicated that the increased specific surface area leads to more surface 
reactivity, which is hypothesized to be essential for osteoinductivity of biomaterials. 
 
Keywords: osteoinduction, biomaterials, mechanism, biphasic calcium phosphate ceramic, 
carbonated apatite ceramic. 
 
 
5.2 Introduction 
 
First reports on bone and cartilage formation after implantation of devitalized tissues 
[89, 92, 216] and tissue extracts [87] ectopically (i.e. in the absence of bone cells) have 
already been published in the forties and fifties of the previous century. In the late 
sixties, Urist defined osteoinduction as “the mechanism of cellular differentiation towards 
bone of one tissue due to physico-chemical effect or contact with another tissue” [26]. A 
year later, Friedenstein defined osteoinduction as “the induction of undifferentiated 
inducible osteoprogenitor cells (IOPCs) that are not yet committed to the osteogenic 
lineage to form osteoprogenitor cells” [93]. Later work of Urist and Reddi [19, 101, 
196, 197] resulted in finding bone morphogenetic proteins (BMPs) which were proposed 
to irreversibly induce differentiation of perivascular mesenchymal-type cells into 
osteoprogenitor cells to finally form cartilage and bone [197]. Although osteoinduction 
by certain types of devitalized tissues and thus BMPs has been extensively investigated, 
the exact mechanism is not fully understood yet.  
The search for the explanation of the mechanism of osteoinduction was further 
complicated by Winter’s and Simpson’s early finding of ectopic bone formation after 
implantation of a polyhydroxylethylmethacrylate (poly-HEMA) sponge that neither 
contained nor produced BMPs [114]. In this study, authors observed that osteoinduction 
was preceded by the in vivo calcification of the polymeric sponge. Up to now, many 
groups reported osteoinduction by various synthetic biomaterials such as synthetic 
hydroxyapatite (HA) ceramic in dogs [116-120], coral derived HA ceramic in dogs, 
monkeys and baboons [117, 121, 122], α-tricalcium phosphate (α-TCP) , β-TCP-, BCP-, 
α-pyrophosphate- and β-pyrophosphate ceramics [122, 124-130, 181, 183, 209]. 
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Besides calcium-phosphate (CaP) bulk ceramics, ectopic bone formation was also found 
in CaP cements [124, 131] and in various porous implants coated with biomimetic 
octacalcium phosphate (OCP) [132, 182, 209]. In addition to the CaP containing 
biomaterials, there are a few reports showing osteoinduction by glass ceramic [137], 
alumina ceramic [134] and titanium in dogs [135, 136], all of which have the ability to 
calcify in a CaP rich environment. These reports all give further evidence that 
osteoinduction by biomaterials is a real phenomenon.  
Although both BMPs and biomaterials can lead to ectopic bone formation, it is unknown 
whether they (partially) follow the same pathway. In contrast to the, mainly 
endochondral, BMP- triggered osteoinduction [101], cartilage formation as a precursor 
of the final bone formation has never been observed in osteoinduction by biomaterials 
without added BMPs [121, 124, 129, 138, 183], and is thus intramembranous. Another 
difference between BMP- and biomaterials guided osteoinduction is their incidence in 
different animal models: bone is abundantly induced in soft tissue of rats and mice by 
using BMP-2 and BMP-7 (OP-1) [145-147], but hardly by synthetic biomaterials [116, 
141-144]. Ripamonti and coworkers suggested the influence of BMPs in osteoinduction 
by biomaterials, but did not prove this hypothesis by experimental data [138, 139].  
During the last decade, experiments by various investigators in large animal models 
have shown parameters which are of great importance in the process of osteoinduction 
by biomaterials. For instance, it has been shown that the presence of concavities or 
macropores is one of the prerequisites for osteoinduction [124, 138]. Furthermore, the 
presence of micropores, by which the specific surface area of the material is increased, 
seems to be essential too [124, 128, 129, 134, 135, 181, 183]. It has been proposed 
that the increased specific surface area leads to more surface reactivity in terms of 
dissolution and reprecipitation of a biological apatite layer, which possibly 
coprecipitates relevant endogenous proteins, which in turn initiate the differentiation of 
pluripotent cells into the osteogenic lineage [183].  
The present in vivo study was performed in order to get more insight into the processes 
governing the phenomenon of osteoinduction by biomaterials, by achieving following 
goals:  
• to further investigate the influence of physico-chemical properties and structure 
on a biomaterial’s osteoinductive potential. We compared five CaP ceramics, 
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four of which were biphasic, consisting of HA and β-TCP, with slightly varying 
chemical composition and large variations in microstructure, and a carbonated 
apatite (CA) ceramic, that is, based on its chemistry, closer to bone mineral than 
the BCP ceramics; 
• to investigate the influence of implant size on the amount of induced bone. The 
availability of the implant for cell and nutrient infiltration, as well as possible 
micromotion inside the implant could be influenced by the implant size;  
• to investigate the influence of implantation site on osteoinduction by 
biomaterials. Implantation site dependence, i.e. comparison of intramuscular 
and subcutaneous implantation, could shed light upon the importance of 
vascularization in the process of osteoinduction;  
• to investigate changes occurring on the surface of an osteoinductive and a non-
osteoinductive ceramic after implantation inside diffusion chambers. The idea 
behind this part of the study is to test the earlier given hypothesis that the high 
specific surface area of osteoinductive biomaterials, which causes a high 
surface reactivity, is essential for osteoinduction by biomaterials [183].  
 
 
5.3 Materials and methods 
 
5.3.1 Implants 
 
In this study, 5 ceramic types were investigated: biphasic calcium phosphate A (BCPA), 
BCPB, BCPC, BCPD and carbonated apatite (CA). The four BCP ceramics were used to 
investigate the influence of variations of physico-chemical properties, achieved by 
differences in preparation methods, on the osteoinductive potential of the ceramics. The 
osteoinductive properties of the rather novel CA bulk ceramic are interesting because, 
based on its chemical composition, CA ceramic resembles the bone mineral composition 
more than BCP ceramics do. 
BCPA and BCPB implants were prepared by using the H2O2 foaming method as 
published earlier [129]. For the preparation of the ceramic, in-house made BCP powder 
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was used. Porous green bodies were produced by mixing this powder with 2% H2O2 
solution (1.0 g powder / 1.2 ± 0.05 ml solution) and naphthalene particles (710 - 1400 
μm; 100 g powder/ 30 g particles) at 60°C. The naphthalene was then evaporated at 
80°C and the green porous bodies were dried. They were divided into two groups and 
sintered at 1150 °C (BCPA) and 1300 °C (BCPB) respectively for 8 hours.  
BCPC, BCPD and CA are novel ceramics, developed in the course of the EU “IntelliScaf” 
project (G5RD-CT-2002-00697).  
A lathe was used to produce cylinders with a size of ∅6.5 x 10 mm3 (all ceramic types) 
and ∅6.5 x 5 mm3 (BCPA and BCPB). All implants were cleaned in ultrasonic baths and 
sterilized by gamma irradiation. 
Composition and crystal structure of the ceramics were determined by using fourier 
transform infra red spectroscopy (FTIR) and X-ray diffraction (XRD). HA/β-TCP weight 
ratios in the BCP ceramics were determined by comparing the BCP XRD patterns to the 
calibration patterns prepared from the powders with the known HA/β-TCP weight 
ratios. 
Prior to implantation, ultrastructure of all ceramics was characterized by an 
environmental scanning electron microscope (ESEM) in the secondary electron mode. 
ESEM, coupled with an image analysis system was used to determine macroporosities 
(pore diameter >10 μm) of the ceramics. In addition, total-, macro- and microporosities 
(pore diameter < 10μm) as well as average pore sizes and pore size distributions were 
determined by using a mercury intrusion porosimeter (MP). Specific surface areas of the 
ceramics were determined from the MP results, as the cumulative surface area (m2/g) 
when all pores were filled with mercury.  
 
 
5.3.2 Animals and implantation 
 
This study was approved by the Dutch Animal Care and Use Committee. In total, ten 
adult Dutch milk goats (18-30 months) were used. The animals were housed in the 
Central Animal Laboratory Institute (GDL), Utrecht, The Netherlands, at least 4 weeks 
prior to surgery. 
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Surgical procedures were performed under general inhalation anesthesia of the animals 
preceded by an intravenous injection of Thiopental (Nesdonal, ± 400mg/70kg of body 
weight, on indication). 
For the comparison of osteoinductive potentials of the five used ceramic types, all 
materials were implanted intramuscularly in all animals. For intramuscular implantation, 
fascia incisions were created in the paraspinal muscles (L1-L3). Using blunt dissection, 
intramuscular pockets were created, and filled with one of the above described ceramic 
cylinders (∅6.5 x 10 mm3): BCPA, BCPB, BCPC, BCPD and CA. Subsequently, fascias 
were closed with nonresorbable sutures to facilitate implant localization at explantation. 
The skin was closed in two layers.  
For investigation of implantation site and implant size dependence on the amount of 
induced bone, we used BCPA and BCPB ceramics as a model. For the investigation of 
the implant size dependence, in addition to the above described intramuscularly 
implanted cylinders with the size ∅6.5 x 10 mm3, smaller cylinders (∅6.5 x 5 mm3) of 
both BCPA and BCPB were implanted.  
In order to investigate the implantation site dependence, BCPA and BCPB cylinders 
were, besides intramuscularly, also implanted subcutaneously. For subcutaneous 
implantations, separate blunt incisions were made in the skin of the back area, one 
cylinder with a size of ∅6.5 x 5 mm3 of each BCPA and BCPB ceramic was inserted, 
after which the skin was closed in two layers.  
Pain relief was given by Durogesic 25 (fentanyl transdermal system CII patches). 
8, 10 and 11 weeks after first surgery, in all animals, cylinders (∅6.5 x 10 mm3) of 
BCPA and BCPB ceramics inside diffusion chambers were implanted subcutaneously by 
following the same procedure as described above. Because of a relatively small impact 
on animals, during these surgeries, local anesthesia (subcutaneously injected Lidocaïne) 
was used. Diffusion chambers in which the ceramics were placed prior to implantation, 
consisted of a Plexiglas ring on both ends of which ∅ 0.45 μm Durapore® HV filters 
were pasted using the MF cement for diffusion chamber (Diffusion chamber kit, 
Millipore) as described previously [213]. Implantation of materials inside these semi 
permeable chambers allows the diffusion of macromolecules and ions into the chamber 
but blocks the invasion of host cells and tissues.   
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Table 1 gives an overview of total amounts of the implanted ceramics. 
In order to visualize the dynamics of bone growth, the goats received sequential 
fluorochrome labels at 4 weeks (Calceine green, 10 mg/kg, I.V.), 6 weeks 
(Oxytetracycline, 32 mg/kg I.M.) and 8 weeks (Xylenol orange, 80 mg/kg, I.V.) [78, 
80, 181].  
12 weeks after first implantations, each animal was sacrificed by an overdose of 
pentobarbital (Euthesaat) and potassium chloride. 
 
 
Table 1: overview of the total amounts of the implanted ceramics. 
DC = diffusion chamber. 
Implant IM  
(12 weeks) 
SC  
(12 weeks) 
SC  
(4 weeks) 
SC  
(2 weeks) 
SC  
(1 week) 
BCPA 10 
BCPB 10 
BCPC 10 
BCPD 10 
CA 10 
 
BCPAh 10 10 
BCPBh 10 10 
   
DC BCPA 20 20 20 
DC BCPB 
 
20 20 20 
 
 
5.3.3 Retrieval of the implants, histology, histomorphometry and material analysis 
 
The implants with surrounding tissue were explanted by sharp dissection and fixed in 
Karnovsky’s fixative. They were dehydrated in a graded ethanol series (70%-100%) 
and transferred into a methylmethacrylate (MMA) solution that polymerized at 37°C 
within one week. Longitudinal sections (10-15μm in thickness) were made by using the 
modified interlocked diamond saw. Sections were either stained with 1% methylene 
blue and 0.3% basic fuchsin after etching with HCl/ethanol mixture and then 
qualitatively investigated by using a light microscope (LM) or left unstained for 
epifluorescence microscopy with a LM equipped with a quadruple filter block (XF57, 
dichroic mirror 400, 485, 558 and 640 nm).  
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Histomorphometry was performed on histological sections. First, the labels of the sections 
were covered. Then, high resolution (300dpi), low magnification digital micrographs 
were made of these sections. Image analyses on the pseudocolored micrographs were 
carried out with a computer-based image analysis system. Prior to measurements, the 
system was geometrically calibrated with an image of a block of known dimensions. In 
the computer-based image analysis system, a program was developed to quantify two 
parameters concerning bone formation:  
• Percentage of bone occupying available pore area (area%b/pore); 
• Percentage of available scaffold outline (in 3D surface of the scaffold) in 
contact with bone: [%contact = (bone-scaffold contact length / scaffold outline 
length) * 100%] in the total area of the implant (%b.cont). 
The first parameter was chosen in order to allow for comparison with previous studies. 
The second parameter was chosen as in a study in which the performances of different 
materials are compared, it seems more appropriate to relate the new bone formation 
to available scaffold rather than to available pore space. Furthermore, contact 
percentage is more sensitive for early bone apposition which always occurs on the 
ceramic surface and has relatively low volume.   
After explantation, BCPA and BCPB ceramics, which were implanted subcutaneously 
inside diffusion chambers, were removed from the chambers and dried at 60 °C in air 
for 2 days. They were then powdered in a mortar, and the powder was homogenized. 
One part of the powder was used to perform FTIR and XRD analyses. Other part was 
used for Thermogravimetry Analysis (TGA). TGA analyses were performed on samples 
weighing 10-20 mg at a heating speed of 10 °C/min. Weight loss between 30 °C and 
200 °C, 200 °C and 450 °C and 450 °C and 900 °C were associated to water, 
organic compounds and CO3 respectively. From the weight loss, weight percentages of 
organic compounds and CO3 were calculated. 
 
 
5.3.4 Statistical analysis 
 
Statistical calculations were done with the SPSS 12.0 software.  
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In agreement with previous studies, intramuscularly implanted ceramics showed large 
variances between the individual animals [183, 209]. Hence, the distribution of the data 
was not normal and that is why the non-parametric Wilcoxon signed rank test [207] for 
paired comparisons was used to perform the statistical analyses.  
For the quantitative TGA data, the two-sided, paired Student’s t-test was used to 
analyze differences between BCPA and BCPB.  
For both tests the significance level was set at p=0.05. 
 
 
5.4 Results 
 
5.4.1 Material characterization 
 
FTIR spectra and XRD patterns of the four BCP and the CA ceramic are given in figure 
1a and 1b.  
All BCP ceramics had similar, biphasic composition, consisting of HA and β-TCP. 
However, their HA/β-TCP weight ratios differed: BCPA and BCPB ceramics consisted of 
80±3 wt% HA and 20±3 wt% β-TCP, while the contents of HA and β-TCP in BCPC and 
BCPD were 70±5 wt% and 30±5 wt% respectively, which is also illustrated by the 
differences in the height of the main β-TCP peak (at 2θ = 31.2°) in the BCP XRD 
patterns (figure 1b). The FTIR spectrum of the CA ceramic exhibits typical carbonated 
apatite structure with distinct bands assigned to CO32- group at 1497 cm-1, 1462 cm-1 
and 868 cm-1(figure 1a). CO32- content (B type >90%) in the CA ceramic was around 8 
wt%. All ceramics were highly crystalline.  
Different production techniques caused different macrostructures. Macropores of BCPA 
and BCPB had a somewhat longitudinal shape, with a length/width aspect ratio 
between 1.5 and 2. BCPC, BCPD and CA possessed macropores with a more regular 
circular shape, with a length/width ratio close to 1. Despite these differences, all 
ceramics had a macroporous structure with macropores varying in diameter between 50 
and 1000 μm. LM photographs of the ceramics macrostructures prior to implantation 
are shown in figure 2. 
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Microstructures of the ceramics differed significantly, as illustrated by figure 3. BCPB 
contained very few micropores and a larger average crystal size in comparison with 
other investigated ceramics. Macropores of the CA ceramic on the other hand, contained 
a large amount of micropores and small crystal size as compared to all other ceramics 
in this study. Crystal size of BCPA was smaller than that of BCPC, while the amount of 
micropores in BCPD was lower than the amount of micropores in BCPA and BCPC.   
 
 
Figure 1: FTIR spectra (A) and XRD patterns (B) of BCPA, BCPB, BCPC, BCPD and CA ceramic. 
Arrow = main β-TCP peak in BCP ceramics. 
 
 
Figure 4 exhibits the macro- and microporosities of the ceramics prior to implantation, 
expressed as differential mercury intrusion as a function of pore size. The diameter of 
most macropores of BCPA, BCPB and BCPD was around 400 μm, while macropores of 
CA had a slightly smaller average diameter. Average diameter of BCPC macropores 
was lower as compared to the other four ceramics.  
Both image analysis of ESEM photographs and mercury porosimetry measurements 
indicated that, prior to implantation, macroporosities of all ceramics were similar, 58±5 
%. Most micropores of all five ceramics had a diameter of around 1μm. In addition, CA 
ceramic possessed a high amount of micropores with a very small diameter of around 
0.1 μm. 
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Figure 2: LM photographs (magnification 4x) of BCPA (A), BCPB (B), BCPC (C), BCPD (D) and CA (E) ceramic. 
Bar = 1mm. 
 
 
Microporosities of BCPA, BCPB, BCPC, BCPD and CA were circa 17%, 4%, 24%, 10% 
and 20% respectively. Total porosities of BCPA, BCPB, BCPC, BCPD and CA were 75±5 
%, 70±5 %, 75±5%, 75±5% and 80±5% respectively, as measured by mercury 
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porosimetry. Data on macro- and microporosity and crystal size can be summarized in 
specific surface area (SSA) which allows for the comparison of these, slightly different, 
ceramics. SSAs of the five ceramics were: BCPA ca. 1.0 m2/g, BCPB ca. 0.2 m2/g, BCPC 
ca. 1.4 m2/g, BCPD ca. 0.8 m2/g and CA ca. 9.7 m2/g. 
Table 2 gives an overview of material characterization of the investigated ceramics. 
 
 
 
 
Figure 3: ESEM photographs (magnification 5000x) of BCPA (A), BCPB (B), BCPC (C), BCPD (D) and CA (E) ceramic. 
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Figure 4: summary of macro- and microporosities and pore size distribution of BCPA, BCPB, BCPC, BCPD and CA ceramic. 
 
 
Table 2: summary of chemical compositions, macroporosities, specific surface areas and bone incidence of the investigated ceramics. 
Implant Chemical 
composition 
Macro- 
porosity 
(vol.%) 
Micro- 
porosity 
(vol.%) 
S.S.A. 
(m2/g)
Bone 
incidence  
IM 
Bone 
incidence 
SC 
BCPA 
BCPAh 
HA/βTCP 
80wt%/20wt% 
58±5 17 1.0 9/10 
7/10 
N/A 
0/10 
BCPB 
BCPBh 
HA/βTCP 
80wt%/20wt% 
58±5 4 0.2 0/10 
0/10 
N/A 
0/10 
BCPC HA/βTCP 
70wt%/30wt% 
58±5 24 1.4 6/10 N/A 
BCPD HA/βTCP 
70wt%/30wt% 
58±5 10 0.8 0/10 N/A 
CA HA with 8wt% 
CO32- (type B) 
58±5 20 9.7 0/10 N/A 
 
Chapter 5 
 
 
 
110 
5.4.2 Intramuscular implantation 
 
5.4.2.1 Comparison of the materials 
 
There were no surgical complications and all implants were retrieved. At retrieval, all 
implants were surrounded by well-vascularized muscle tissue.  
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Figure 5: digital photograph of histological slides of intramuscularly implanted BCPA (A) (inset = LM photograph magnification 10x), 
BCPB (B), BCPC (C) (inset = LM photograph magnification 10x), BCPD (D), CA (E), BCPC (F),  
CA (G) and fluorochrome markers of BCPA (H) and BCPC (I). 
(1) = ceramic, (2) = bone, (3) = fibrous tissue, OTC = Oxytetracycline, XO = Xylenol orange. 
The induced bone in BCPA and BCPC (A and C respectively) is formed in the pores of the implants, aligning their surface. The bone 
is normal in appearance, aligned with osteoblasts and with osteocytes and osteoid clearly visible (insets of A and C). BCPB, BCPD 
and CA ceramics (B, D and E respectively) are extensively filled with fibrous tissue, but no signs of bone formation are observed. In 
some animals, BCPC ceramic was fragmented and mechanical degradation was observed. Note bone formation only in the non-
fragmented part of the implant (F). In some animals, chemical dissolution of CA ceramic was observed (G). Presence of both 
Oxytetracycline and Xylenol orange marker shows that the bone formation in both BCPA and BCPC (H and I respectively) had 
started before the sixth week of implantation. → p218/219. 
 
Histology showed no evidence for toxicity of the implants, or an unwanted inflammatory 
tissue response. 
Bone was formed intramuscularly in 9 out of 10 goats in BCPA implants and in 6 out of 
10 goats in BCPC implants, while no signs of bone formation were found in BCPB, BCPD 
and CA implants (table 2). Figures 5a-5e show photographs of the histological slides of 
the five implanted ceramics. In BCPA and BCPC ceramics, bone was formed in the pores 
of the implants, aligning the ceramic surface, and was never observed on implant 
peripheries. The newly formed bone was normal in appearance, aligned with 
osteoblasts and with osteocytes clearly visible. BCPB, BCPD and CA ceramics were fully 
infiltrated by fibrous tissue, however, no signs of bone formation were observed. 
An interesting observation from the histological slides was the material degradation 
behavior. As illustrated in figure 5f, in some animals, BCPC exhibited partial 
fragmentation and delamination of the particles. Interestingly, in these implants bone 
was only induced in the part of the implant that was not fragmented (left on the 
photograph). In addition, in some animals, we observed the loss of structure, probably 
due to chemical degradation of the CA ceramic (figure 5g).  
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Analyses of the fluorochrome markers confirmed that the bone growth generally started 
on the surface of the ceramics and continued towards the pore center. For both BCPA 
(figure 5h) and BCPC (figure 5i) in some animals, both 6-week Oxytetracycline and 8-
week Xylenol orange marker could be found, which suggested the start of new bone 
formation before the 6th week of implantation. In other animals, only the Xylenol orange 
marker was found, which suggests differences in the onset of bone formation between 
individual goats.  
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Figure 6: histomorphometrical results: boxplots (mean and interquartile values) of area%b/pore and %b.cont. of intramuscularly 
implanted BCPA and BCPC ceramics. 
For both, bone area-related parameter (area%b/pore) and bone contact parameter (%b.cont.) BCPA performed better than BCPC, 
but the difference was only significant (p=0.011) for %b.cont. 
 
 
The amount of induced bone largely differed between individual goats, for both BCPA 
and BCPC. For example, percentage of bone occupying available pore area 
(area%b/pore) in BCPA varied between 0.3% and 3.5%, with an average of 
1.4±1.5%. area%b/pore in BCPC varied between 0.7% and 4.1%, with an average of 
1.2±1.3%. Similar to this, area related parameter, percentage of available scaffold 
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outline in contact with bone (%b.cont.) varied largely between individual goats: 
%b.cont. in BCPA varied between 1.6% and 8.7% with an average of 3.9±3.5%; 
%b.cont. of BCPC varied between 1.9% and 5.6% with an average of 2.0±2.0%. 
Histomorphometrical data are summarized in a boxplot (figure 6). Although for both 
measured parameters BCPA showed a higher value than BCPC, significant difference 
between the two was only found for %b.cont (p=0.011).  Despite large differences in 
the amount of induced bone between individual goats, an intra-animal consistency was 
observed. This means that if a relatively large amount of bone was induced by BCPA in 
goat no.1, in this goat, BCPC induced a large amount of bone as well. And further, if 
BCPA induced very little bone in goat no.3, in this goat bone was not induced at all by 
BCPC. Thus, in all goats BCPA induced more bone than BCPC, however, there were 
“more” and “less” inductive goats, and the effect of inter-animal variations was visible 
for both BCPA and BCPC. 
 
 
5.4.2.2 Influence of implant size  
 
In order to investigate the influence of implant size on the amount of induced bone, we 
compared implants with the size ∅6.5 x 10 mm3 (BCPA and BCPB) with the implants 
with the same diameter, but with half of the length (BCPAh and BCPBh). As already 
mentioned, BCPA with the full length induced bone in 9 out of 10 animals (table 2). 
Bone incidence in BCPAh was 7 out of 10 (table 2). In both, large and small implants, 
the quality of the formed bone was similar. Qualitative analyses of the fluorochrome 
markers (photographs not shown) showed the presence of both 6-week Oxytetracycline 
and 8-week Xylenol orange label in some BCPA implants, while only the Xylenol orange 
label was observed in BCPAh implants, suggesting an earlier start of bone formation in 
the larger implants. 
Histomorphometrical data for both measured parameters, percentage of bone 
occupying available pore area (area%b/pore) and percentage of available scaffold 
outline in contact with bone (%b.cont.) showed a higher value for BCPA in comparison to 
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BCPAh, however, this difference was only significant (p=0.017) for area%b/pore 
(figure 7).  
Neither BCPB nor BCPBh induced bone in any of the animals.  
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Figure 7: histomorphometrical results: boxplots (mean and interquartile values) of area%b/pore and %b.  
between intramuscularly implanted BCPA and BCPAh ceramics. 
(ο) = outliers. 
For both, bone area-related parameter (area%b/pore) and bone contact parameter (%b.cont.) BCPA implant (∅6.5 x 10 mm3) 
showed more bone than a similar, but smaller (∅6.5 x 5 mm3) implant (BCPAh),  
however the difference was only significant (p=0.017) for area%b/pore. 
 
 
5.4.2.3 Implantation site dependence 
 
BCPAh and BCPBh implants were implanted both intramuscularly and subcutaneously. As 
mentioned before, bone incidence in intramuscularly implanted BCPAh was 7 out of 10 
(table 2), while no bone was observed in any of the subcutaneously implanted BCPAh 
ceramics. No bone formation was observed in either intramuscularly or subcutaneously 
implanted BCPBh ceramics. 
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5.4.3 Diffusion chamber study 
 
In order to investigate changes on the surfaces of the ceramics in vivo, we 
subcutaneously implanted BCPA and BCPB ceramics inside diffusion chambers which 
allowed the diffusion of macromolecules and ions into the chamber but blocked the 
invasion of host cells and tissues. Diffusion chambers containing BCPA ceramic and BCPB 
ceramic respectively were implanted for 1, 2 and 4 weeks. Qualitative observation of 
the two materials after implantation and removal from the chambers showed the 
macroscopical presence of a glassy layer on the implant surfaces. FTIR spectra of the 
ceramics after implantation (figure 8) exhibited some changes as compared to the 
spectra before implantation. Already one week after implantation of BCPA, new small 
carbonate bands (C-O in CO32-) appeared at 1448 cm-1 and 1475 cm-1, indicating the 
formation of the AB-carbonated apatitic phase. Additionally, new, more distinct bands 
appeared at 1458 cm-1 and 1546 cm-1, which correspond to N-H vibrations and a 
small band at 2960 cm-1 corresponding to C-H aliphatic vibrations. The appearance of 
these bands suggested the presence of organic compounds (proteins, peptides) on the 
surface of the BCPA ceramic. 2 and 4 weeks after implantation the above described 
bands looked even more pronounced in the BCPA FTIR spectrum.  
 
 
Figure 8: FTIR spectra of BCPA (A) and BCPB (B) implanted subcutaneously inside diffusion chambers for 1, 2 and 4 weeks. 
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Changes in the FTIR spectrum of BCPB after implantation were similar to those of BCPA 
ceramic. However, the newly appeared bands looked somewhat smaller on BCPB than 
on BCPA spectra. There were no noticeable differences between the XRD patterns of 
the two ceramics made before and after subcutaneous implantation in diffusion 
chambers (XRD patterns not shown). 
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Figure 9: TGA analysis: boxplots (mean and interquartile values) of %organic compounds (A) and carbonate (B) in subcutaneously 
implanted BCPA and BCPB ceramic inside diffusion chambers for 1, 2 and 4 weeks. 
(ο) = outliers. 
The amount of both organic compounds and carbonate was significantly higher in BCPA than in BCPB at all implantation time points. 
No significant difference between the time points was observed for neither of the measured compounds. 
 
 
TGA analyses of the two ceramics after implantation were performed in a temperature 
range 30°C – 900 °C. The weight loss observed between ±200 °C and ±540 °C was 
attributed to organic compounds, while the weight loss between ±540 °C and ±900 °C 
was associated with the presence of carbonate. TGA analysis of the BCPA and BCPB 
ceramics prior to implantation proved the absence of both organic compounds and 
carbonate in the initial ceramics. Quantitative data of the TGA analyses are 
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summarized in figure 9. At all three time points, i.e. 1, 2 and 4 weeks of implantation, a 
significantly higher (in all cases p<0.01) amount of organic compounds was found on 
BCPA ceramic surface as compared to the BCPB surface. The amount of carbonate on 
the surfaces of the ceramics was much smaller than the amount of organic compounds, 
but also in this case, the carbonate amount on the BCPA surface was significantly higher 
(p=0.015 for 1 week, p=0.009 for 2 weeks and p=0.019 for 4 weeks of implantation) 
than that on BCPB surface. No significant differences were observed in the amounts of 
organic compounds and carbonate between the three time points, for either of the 
investigated ceramics. 
 
 
5.5 Discussion 
 
Osteoinduction by CaP containing biomaterials in various forms, as well as by materials 
that initially do not contain CaPs has been shown in various reports in the last decade 
[116-122, 124-130, 134-136, 181, 183, 209] However, so far, little is known about 
the exact mechanism of the phenomenon underlying osteoinduction. The results of this 
study add to the knowledge of parameters which influence material osteoinductive 
properties.  
The first goal of this study was to further investigate the influence of physico-chemical 
and structural properties of a material on its osteoinductive potential. We compared 
five CaP ceramics, four of which were BCPs. Although produced from powders with a 
similar chemical composition, these four ceramics had quite different final properties. As 
previously described, BCPA and BCPB, with the same chemical composition and 
macrostructure, differed only in their microstructures due to differences in the 
temperatures they were sintered at [181]: BCPA had a highly porous microstructure, 
while hardly any micropores could be found in the macropore walls of BCPB. A 
consequence of the different microstructures was that the specific surface area of BCPA 
was about 5 times higher than that of BCPB. After implantation, BCPA induced bone in 
almost all animals. In contrast, no bone was found in any of the implanted BCPB 
ceramics. In agreement with previous studies, these findings suggest that below a certain 
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level of specific surface area, bone will not be induced. Therefore, a “high” specific 
surface area seems to be of essential importance for osteoinduction by biomaterials.  
BCPC and BCPD were produced from the same powder, but using different techniques. 
They had the same chemical composition, and similar macroporosities, but different 
microporosities. Although both microporous, the amount of micropores found in BCPC 
was higher as compared to BCPD. In addition, crystal size of BCPC was smaller than 
that of BCPD. Similar to the BCPA and BCPB ceramics, a consequence of more 
micropores and smaller crystal size was an around 2 times higher specific surface area 
of BCPC than that of BCPD. After implantation, BCPC induced bone in 7 out of 10 
animals, while no bone was observed in any of the BCPD implants. Similar to the 
comparison of BCPA and BCPB, also in this case, an increased specific surface area 
positively influenced osteoinductive potential of the ceramic.  
The comparison of the two osteoinductive ceramics in this study, namely BCPA and 
BCPC, is slightly more complicated. BCPC contained 10% more β-TCP than BCPA. In 
addition, the specific surface area of BCPC was around 1.5 times higher than that of 
BCPA. Both the higher amount of the more soluble component β-TCP and a higher 
specific surface area obviously increase the surface reactivity of a material, which 
should, as previously proposed [183], improve its osteoinductive properties. This was, 
however, not the case in the present study. Besides a lower bone incidence in BCPC, the 
amount of bone induced in BCPC was lower than the amount found in BCPA. Further 
differences between these two ceramics, which could possibly explain these unexpected 
results, are found in their macrostructures. Although both highly macroporous, most 
macropores of BCPA had a diameter of around 400 μm, while most macropores of 
BCPC had an average diameter smaller than 100 μm. As recently reviewed by 
Karageorgiou and Kaplan [217], based on early studies, the minimum requirement for 
pore size is considered to be ±100 μm due to cell size, migration requirements and 
nutrient transport [218]. However, pore sizes higher than 300 μm are recommended 
due to i.e. formation of capillaries. Although these recommendations were based on 
processes of bone formation which take place orthotopically, it is conceivable that they 
are also applicable for the process of osteoinduction.  It is thus possible, that although 
the higher surface reactivity of BCPC was preferable for osteoinduction according to 
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the earlier hypothesized mechanism [183], BCPA’s larger macropores were responsible 
for better nutrient and cell distribution and capillary formation throughout the implant. 
Nutrient and cell distribution and consequent capillary formation should precede the 
process of ectopic bone formation and if they are insufficient, this process may be 
delayed and its result decreased. Furthermore, BCPC ceramic, as is shown in the results 
paragraph, partially fragmented after implantation in some of the animals. This 
resulted in the formation of loose particles and debris, and in the loss of macroporous 
structure. Investigation of histological slides showed that in the fragmented parts of the 
implant, no bone could be found. This observation could be explained by the fact that in 
order to facilitate growth of the induced bone, a mechanically stable surface is needed. 
Micromotion caused by debris and loose particles may negatively influence the bone 
growth facilitation.  
The CA ceramic had a specific surface area which was significantly higher that that of 
any of the other ceramics used in this study. Furthermore, its chemical composition, which 
closely resembles that of bone mineral, was different from that of the four BCPs, which 
makes the comparison more challenging. Although we retrieved all implanted materials, 
histological slides showed a significant dissolution of the CA ceramic in some animals. 
This observation suggests that there is a limit in the increase of the specific surface area 
of the material that positively influences its osteoinductive properties. In the case of CA 
ceramic, chemical composition and a very high specific surface area might be the 
reasons for a too high surface reactivity, which leads to an extensive degradation of the 
material before the bone formation has started. Therefore, although the induction of 
differentiation towards osteoblasts might have taken place, bone formation could not 
be facilitated.  
In short, the results from the part of the study in which the influence of physico-chemical 
and structural properties on osteoinduction was investigated showed that on the one 
hand, bone is not induced below a certain low level of specific surface area and on the 
other hand, bone formation, although possibly initiated, does not take place above a 
certain high level of specific surface area due to a fast resorption. These findings 
suggest that for each material type there is an optimal specific surface area which 
leads to maximal osteoinduction, if any. In addition, results of this study emphasized 
previous observations that the right macrostructure (i.e. macropore size, 
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interconnectivity), which leads to an adequate nutrient and cell supply and 
vascularization, is of great importance in the process of osteoinduction by biomaterials. 
Finally, a mechanically stable surface is needed for facilitation of initiated bone 
formation. 
Results of the implant size investigation showed that bone incidence in BCPA implants 
with the size ∅ 6.5x10 mm3 was higher than in similar implants with half the length (∅ 
6.5x5 mm3). Histomorphometrical measurements further confirmed that the relative 
amount of bone in available pore area was relatively higher in bigger than in smaller 
implants. The observed implant size influence could be explained by the fact that, in 
comparison to smaller implants, larger implants have a larger periphery surface which 
allows for more migration of cells and nutrients inside the implant. Furthermore, there is 
possibly more micromotion in the smaller implants as compared to the larger ones, which 
could negatively influence the process of attachment, proliferation and differentiation of 
the cells in the centre of the implant. This implant-size dependence might be, in addition 
to the well known inter-species genetic and metabolic differences, one of the reasons 
that explains lack of osteoinduction by biomaterials in rodents, in which obviously only 
small implants can be inserted.  
Comparison of implantation sites showed that intramuscularly implanted BCPA induced 
bone, while no bone was found in any of the subcutaneously implanted BCPA ceramics, 
which is possibly due to a better vasularization intramuscularly.  These results contrast 
the findings of Gosain et.al. [124], in which authors compared intramuscular and 
subcutaneous osteoinduction in sheep after 1 year of implantation, and could not find 
any significant differences between the two sites. Although a similar type of comparison 
is made, our study in goats and Gosain et.al.’s study in sheep differed in osteoinductive 
materials used, implantation time, and most importantly, animal model. Our observation 
that subcutis was a less inductive implantation site than muscle was however in 
accordance with the finding of Yang et.al. [143]. Although this study lacked 
histomorphometrical data, the authors observed a delayed osteoinduction in 
subcutaneously implanted materials as compared to intramuscularly implanted materials 
in both pigs and dogs. The observations of the latter study suggest that there might be 
a difference in “osteoinductive potential” between subcutis and muscle, which is 
conceivable as it is generally accepted that intramuscularly, there is more 
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vascularization than subcutaneously. However, the difference between the two sites 
might only be visible during the early time of implantation. It is plausible that, after a 
certain implantation time the ectopically induced bone stops growing and starts 
resorbing as it lacks natural mechanical stimulation. The process of bone resorption 
occurs earlier intramuscularly than subcutaneously, as the bone formation intramuscularly 
takes place earlier as well. It is therefore possible that, after 1 year of implantation as 
in Gosain et.al’s study, difference in the amount of bone between subcutaneously and 
intramuscularly implanted materials is not visible anymore, while in our 3-month-study, 
this difference was clearly observed.  
As mentioned previously, osteoinduction by biomaterials shows large interspecies 
differences. Bone is hardly ever induced in rats and mice [116, 141-144], is rarely 
found in rabbits and very frequently in large mammals (i.e. goats, sheep, dogs) and 
non-human primates such as baboons [117, 124, 129, 130, 143, 219, 220]. However, 
there is also a difference in osteoinductive potentials between different large animals. 
The same material implanted intramuscularly in goats and dogs induced more bone in 
dogs [143]. Similarly, a material implanted in dogs and baboons induced more bone in 
baboons [117]. To our knowledge, direct comparisons between sheep and goats in the 
same study have not been made. Comparisons between our study in goats and the 
studies in sheep are hard to make, as, in addition to the difference in the materials used 
to study osteoinduction, the implantation time of Gosain et.al.’s study was 1 year and Le 
Nihouanned et.al.’s [130] study 6 months while implantation time of our study was 3 
months. Besides, in the study by Le Nihouanned et.al., the volume of implanted ceramic 
was around 6 times higher than the volume of the present study, and this, as showed 
above, might be of importance for the amount of induced bone. When comparing 
studies on osteoinduction by biomaterials, it is therefore important to take into account 
that, in addition to the animal model and material used, implantation time, implantation 
site and the amount of implanted material may be of great importance for the amount 
of induced bone.  
Implantation of osteoinductive and non-osteoinductive ceramic inside diffusion chambers 
was meant to investigate changes on the material surface, without interference with cells 
and tissues. Implantation periods of 1, 2 and 4 weeks were chosen because, in this 
model, ectopic bone formation starts before the sixth week of implantation, as is shown 
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by the fluorochrome markers. The results of FTIR and TGA analyses on the materials 
explanted and removed from the diffusion chambers support the hypothesis that in the 
process of osteoinduction, surface reactivity plays a role. It is proposed that on the 
surface of the material, a dissolution-reprecipitation process takes place, which is 
accompanied by coprecipitation of relevant endogenous factors such as cytokines or 
proteins [183]. On a material with a higher specific surface area, this process of 
induction is faster and more prominent. The results from the present study indeed show 
that, during the implantation, more carbonate and more organic compounds were found 
on the surface of the osteoinductive BCPA ceramic as compared to the non-
osteoinductive BCPB ceramic. Whether this process is essential for the osteoinductivity of 
a material needs to be further proven. However, these results give a direct relationship 
between specific surface area and the material interaction with its in vivo environment. 
The next step in the finding the mechanism of osteoinduction would be to investigate 
which organic compounds are present on the material surface, and what their role is in 
the induction of ectopic bone formation. 
 
 
5.6 Conclusion 
 
The results of the present study showed that for each material type there is an optimal 
specific surface area at which the osteoinductive potential of the material is highest. This 
study further showed that the decrease of the implant size significantly decreases the 
relative amount of induced bone. In addition, in the model used in this study, the same 
material induced bone intramuscularly but not subcutaneously, which suggests the 
importance of vascularization in the process of osteoinduction by biomaterials.  
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6.1 Abstract 
 
The in vivo behavior of a porous Ti6Al4V material that was produced by a positive 
replica technique, with and without an octacalcium phosphate (OCP) coating, has been 
studied both in the back muscle and femur of goats. Macro- and microporous biphasic 
calcium phosphate (BCP) ceramic, known to be both osteoconductive and able to induce 
ectopic bone formation, was used for comparison purpose.  
The three groups of materials (Ti6Al4V, OCP Ti6Al4V and BCP) were implanted 
transcortically and intramuscularly for 6 and 12 weeks in 10 adult Dutch milk goats in 
order to study their osteointegration and osteoinductive potential.  
In femoral defects, both OCP Ti6Al4V and BCP were performing better than the 
uncoated Ti6Al4V, at both time points. BCP showed a higher bone amount than OCP 
Ti6Al4V after 6 weeks of implantation, while after 12 weeks, this difference was no 
longer significant.  
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Ectopic bone formation was found in both OCP Ti6Al4V and BCP implants after 6 and 
12 weeks. The quantity of ectopically formed bone was limited as was the amount of 
animals in which the bone was observed. Ectopic bone formation was not found in 
uncoated titanium alloy implants, suggesting that the presence of calcium phosphate 
(CaP) is important for bone induction. 
This study showed that CaPs in form of coating on metal implants or in form of bulk 
ceramic have a significantly positive effect on the bone healing process.  
 
Keywords: porous Ti6Al4V, biomimetic coatings, octacalcium phosphate (OCP), biphasic 
calcium phosphate (BCP), osteointegration, osteoinduction. 
 
 
6.2 Introduction 
 
Calcium phosphate (CaP) containing biomaterials, in particular hydroxyapatite (HA), 
beta tricalcium phosphate (β-TCP), and the mixtures of two, are known for having a 
good biological performance [17, 221-224], but they often lack satisfactory 
mechanical properties.  
Metals, on the other hand, possess great mechanical properties, making them suitable 
for load-bearing applications [37]. However, high stiffness of the metals often leads to 
stress-shielding from residual bone, which may result in detrimental resorptive bone 
remodeling [38], and consequently to a poor fixation of the implant. Recent 
developments in metallic implant designs therefore focus on adapting the mechanical 
properties of metals to those of biological systems. Certain metals, such as stainless 
steel, titanium and its alloys are already widely used in orthopaedics and dentistry 
because of their good biocompatibility [35, 36], but their ability to bond to bone and 
to guide bone growth are distinctly smaller as compared to the above mentioned 
ceramics.  
Recent designs of orthopeadic implants therefore often include combinations of metallic 
and CaP materials. One example is the application of CaP coating on metal implants 
that combines the mechanical strength of the metal with the ceramics favorable 
biological properties. In addition to the interfacial bonding to bone introduced by CaP 
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coatings on dense metal implants, applying a porous structure can even further advance 
bony integration, whereby mechanical interlocking may also enhance the integration 
process.  
Porous titanium and its alloys have been used in dental and orthopaedic applications 
since the end of 1960s [225-227]. Many available methods of producing porous 
titanium and titanium alloy scaffolds include sintering together of the particles [228, 
229] or plasma spraying of the powder on a dense substrate followed by the cutting of 
the porous layer [135]. The shortcoming of these production methods is that they often 
result in a low porosity (< 50%), low average pore size (< 300 µm) and poorly 
interconnected pores. All these factors might have a negative effect on the biologic 
performance of these materials. Another method includes compacting single titanium 
fiber into a die to certain porosity, followed by vacuum sintering, resulting in the 
formation of a so-called titanium fiber mesh [135]. Besides excellent biocompatibility 
[230], sintered titanium fiber meshes have been shown to act as a good carrier for 
growth factors [231, 232] and as tissue engineering scaffold [233, 234]. However, in 
absence of the growth factors and/or osteogenic cells, their osteoconductive 
performance is limited. In addition to titanium and its alloys, promising reports on the 
use of porous metals based on tantalum (Ta) for orthopaedic applications have been 
given [235-237].  
Our group has recently developed a porous Ti alloy material by using a positive 
replica technique. This technique allows us to produce a controllable high porosity 
structure, with open and interconnected pores [193].  
As mentioned earlier, apart from the mechanical interlocking provided by implant 
porosity, applying a bioactive coating on the metal surface could further enhance its 
biological performance. The conventional technique to provide metallic implants with a 
CaP coating is plasma-spraying (PS). Earlier investigations have shown that these 
coatings can successfully enhance clinical success to a <2% failure rate after 10 years 
[42]. Despite this clinical performance, the PS method is limited by some intrinsic 
drawbacks. For instance, the coating is being produced at very high temperatures, 
limiting this method to stable CaP phases.  Furthermore, by using this line-of-sight 
method, it is impossible to coat geometrically complex and porous implants.  
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One of the alternative methods uses the so-called biomimetic route, in which the bone 
mineralization process is mimicked by immersing implants in simulated body fluids (SBF) 
[190]. As a result of the paraphysiological conditions of this technique, various CaP 
phases such as octacalcium-phosphate (OCP) [191] or bone-mineral like carbonated 
apatite (CA) [192] can be deposited. A previous study in femoral condyle of goats by 
Barrère et.al. [132] showed a direct contact between the newly formed bone and the 
OCP coated porous Ta surface. Between the newly formed bone and uncoated Ta 
however, a layer of fibrous tissue was often observed. Intramuscular implantation of the 
OCP coated porous Ta implants also showed the ability of such an implant to induce 
bone in non-osseous site, i.e. osteoinductive behavior [132, 133, 140]. 
The objective of this goat study was to investigate the biological performance of a 
porous titanium alloy (Ti6Al4V) material, produced by a positive replica method, with 
and without biomimetic OCP coating, in terms of osteointegration and osteoinduction.  
 
 
6.3 Materials and methods 
 
6.3.1 Implants 
 
Porous titanium alloy (Ti6Al4V) implants were produced by a positive replica method as 
described earlier [193]. In short, 70 wt% of titanium alloy powder (Northwest Non-
Ferrous Institute of China) consisting of spherical particles with a diameter lower than 44 
µm (325 mesh) was mixed with H2O (20 wt%). Polyethylene glycol (PEG) and 
Methylcellulose were used as binders (8 wt%). Dolapix and ammonia solution (2 wt%) 
were added to improve the rheological property of slurry. Porous titanium alloy bodies 
were made by impregnation of polymeric (PU) sponges (35-45 pores/in) (Coligen 
Europe B.V., Breda, The Netherlands). When the slurry reached the designed viscosity 
range (3000-5000 cp), Polyurethane (PU) foams were dipped into the slurry and then 
extracted to dry. The dipping-drying process was repeated until the struts of the PU 
foam were coated with titanium alloy slurry. The superfluous slurry was removed by 
using a roller under pressure, to get an evenly distributed coating on the foam. After 
final drying, the samples were heated in argon to 500ºC to burn out the foam. This 
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process resulted in a small change of color of the metal, which suggests the formation of 
a thicker titanium oxide (TiO2) layer. Finally, the metal bodies were sintered in a 
vacuum furnace (10-5 mbar) at 1250ºC with holding time of 2h. The Energy Dispersive 
X-Ray (EDX) analysis (result not presented) showed a higher oxygen peak in comparison 
to the green body, confirming the formation of a thicker TiO2 layer. Cylinders (∅5 x 10 
mm3) were machined by using a wire electric discharge machine, with demineralized 
water as medium. The ultrastructure of porous titanium alloy was characterized by using 
an environmental scanning electron microscope (ESEM; XL30, ESEM-FEG, Philips, The 
Netherlands) in the secondary electron mode. The porosity of the material was 
determined by both volume/weight method (n=3) and by image analysis technique on 
the histological slides (10 cross-sections for 6-week- and 10 cross-sections for 12-week 
implantation). In the volume/weight method the following calculation is made: 100% - 
[(weight of the porous implant/ the weight a dense implant with the same size)*100%]. 
For the second method, high resolution (300dpi), low magnification (10x) digital 
micrographs were made of blinded sections. Using Adobe Photoshop 7.0, bone and 
material were pseudocoloured, red and green respectively. Image analysis was carried 
out with a PC-based system equipped with KS400 version 3.0 software (Carl Zeiss 
Vision, Oberkochen, Germany). Prior to measurement the system was geometrically 
calibrated with an image of a block of known dimensions. A program was developed in 
KS400 to quantitate the pore size for each pore and the material porosity. The porosity 
was determined as: [total implant surface – (scaffold surface + bone surface) / total 
implant surface] * 100%. Pore interconnectivity was visually analyzed on the material 
cross-sections by using an ESEM. The compression strength of the material was 10.3 ± 
3.1 MPa, as measured and reported earlier [193]. 
Porous Biphasic Calcium Phosphate (BCP) implants were prepared by using the so-
called H2O2 method as published earlier [129]. For the preparation of the ceramic, in-
house made BCP powder was used. Porous green bodies were produced by mixing this 
powder with 2% H2O2 solution (1.0 g powder / 1.2 ± 0.05 ml solution) and 
naphthalene (Fluka Chemie, The Netherlands) particles (710 - 1400 μm; 100 g 
powder/ 30 g particles) at 60°C. The naphthalene was then evaporated at 80°C and 
the green porous bodies were dried. Finally, the bodies were sintered at 1200°C for 8 
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h. These bodies were machined into cylinders (∅5 x 10mm3) using a lathe. The structure 
of porous BCP was characterized by using an ESEM. Porosity, pore size and pore 
interconnectivity were analyzed by the same techniques as described for the Ti alloy 
implants. Material composition and its crystal structure were determined by using Fourier 
Transform Infra Red Spectroscopy (FTIR; Spectrum100, Perkin Elmer Analytical 
Instruments, Norwalk, CT) and X-Ray Diffraction (XRD; Miniflex, Rigaku, Japan). HA/β-
TCP weight ratio in the BCP was calculated by comparing the BCP XRD pattern to the 
calibration patterns prepared from the powders with the known HA/β-TCP weight 
ratios. The specific surface area of the material was measured by using the Brunauer, 
Emett and Teller method (BET, cfDIN66131) (Institut des materiaux de Nantes L.C.S., 
Nantes, France). The compression strength of the used BCP was 3.4 ± 0.8 MPa 
[unpublished results]. 
 
 
6.3.2 Coating process 
 
Prior to the coating process, porous Ti alloy cylinders were ultrasonically cleaned in 
acetone, ethanol and water, subsequently. Next, they were soaked in Simulated Body 
Fluid (SBF) for 24h at 37°C to seed the metal surface with calcium phosphate nuclei. The 
used SBF solution was 5 times more concentrated than Kokubo’s SBF solution [190] 
(table 1) in order to speed up the coating process. The supersaturation of the SBF 
solution was achieved by addition of slightly acidic gas CO2. The starting pH of the 
solution was 5.8. At the end of the process, the pH reached a value of 8.3.  
In order to produce crystalline OCP coatings, the implants were then immersed at 37°C 
in Simulated Calcifying Solution (SCS) (table 1) for 48 h with one replenishment. SCS 
was buffered at pH 7.4 by using the TRIS/HCl. The biomimetic methods of producing 
the two CaP layers have previously been described in detail [191, 192]. The coating 
composition and crystallinity were investigated by using FTIR and XRD. Coating thickness 
was measured on 2D implant cross-sections by the automatic ESEM ruler. The specific 
surface area of the coating was determined by using the BET method. 
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Table 1: inorganic composition (mM) of Kokubo’s SBF, supersaturated SBFx5 and SCS. 
Ion concentration (mM) 
 Na+ K+ Ca2+ Mg2+ Cl- HPO42- HCO3- SO42- 
SBF 142.0 5.0 2.5 1.5 148.8 1.0 4.2 0.5 
SBFx5 714.8 -- 12.5 7.5 723.8 5.0 21.0 -- 
SCS 140.4 -- 3.1 -- 142.9 1.86 -- -- 
 
 
6.3.3 Animals  
 
This study was approved by the Dutch Animal Care and Use Committee. Ten adult Dutch 
milk goats were used in total and housed at Central Animal Laboratory Institute (GDL), 
Utrecht, The Netherlands, at least 4 weeks prior to surgery. 
Before the surgical procedure, a dose of 0.1 ml in 5ml of physiologic saline solution (± 
1 ml/25 kg body weight) of Domosedan (Pfizer Animal Health BV, Capelle a/d Ijssel, 
The Netherlands) was administered by intravenous injection. The surgical procedure 
itself was performed under general inhalation anesthesia of the animals. Thiopental 
(Nesdonal, ± 400 mg/70 kg of body weight, on indication, Rhone Merieux, Amstelveen, 
The Netherlands) was injected intravenously, and anesthesia was maintained with a gas 
mixture of nitrous oxide, oxygen and Halothane (ICI-Farma, Rotterdam, The 
Netherlands). 
Besides the implantations described in this study, the animals were used for a different 
study, to be published separately. Based on the previous in vivo studies by our group, 
we hypothesize that different groups of implants could not influence each other’s 
behavior, as they were implanted either at a different implantation site or at a 
sufficient distance from each other.  
 
 
6.3.4 Orthotopic implantation 
 
The implants were inserted in the left diaphyseal femur of the goats, which was 
exposed by a lateral skin incision and blunt dissection. The holes were drilled in the 
lateral cortex using a pneumatically powered orthopaedic drill (drilling speed 150 
Chapter 6 
 
 
 
130 
rpm), under permanent cooling with saline. Each defect was created according to a 
four-step procedure, to a final diameter of 5.0 mm.  
The implants (uncoated Ti6Al4V, OCP Ti6Al4V and BCP) were allocated according to 
randomized scheme. Using gentle tapping, the implants were press-fit inserted in their 
designated positions. The incision was routinely closed with sutures. After 6 weeks, the 
same procedure was repeated in the right diaphyseal femur of all goats. Table 2 gives 
an overview of the implanted materials. 
 
 
Table 2: implantation scheme. 
             Femoral diaphysis Back muscle Time 
(weeks) Ti6Al4V OCP Ti6Al4V BCP Ti6Al4V OCP Ti6Al4V BCP 
6  10 10 10 10 10 10 
12  10 10 10 10 10 10 
 
 
6.3.5 Intramuscular implantation 
 
After shaving the lumbar area and disinfection with iodine, the left muscle fascia was 
exposed and cut. Using blunt dissection, intramuscular pockets were created, and filled 
with the above-mentioned implants. Subsequently, the fascia was closed with a 
nonresorbable suture to facilitate implant localization at explantation. The skin was 
closed in two layers. After 6 weeks, the same procedure was repeated in the right back 
muscle. Table 2 shows the amounts of implanted materials. 
Immediately after the surgery, pain relief was given by buprenofine (Temgesic; 
Schering-Plough, Kenilworth, NJ).  
12 weeks after the first implantation (i.e. implantation times 6 and 12 weeks), each 
animal was sacrificed by an overdose of pentobarbital (Euthesaat, Organon, Oss, The 
Netherlands) and potassium chloride. 
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6.3.6 Retrieval of the implants, histology and histomorphometry 
 
The implants from the retrieved femora were isolated “en block” using a diamond saw, 
and fixed at 4°C in Karnovsky’s fixative (4% paraformaldehyde, 5% glutaraldehyde). 
Intramuscular implants with surrounding tissue were explanted by sharp dissection and 
fixed in Karnovsky’s fixative as well. All implants were dehydrated in a graded ethanol 
series (70%-100%) and transferred into a methylmethacrylate (MMA) solution that 
polymerized at 37°C within one week. Longitudinal sections (10-15μm) were made by 
using the modified interlocked diamond saw (Leica Microtome, Nussloch, Germany). 
Sections were stained with 1% methylene blue and 0.3% basic fuchsin after etching with 
HCl/ethanol mixture. The midsections of the implants retrieved from femora were used 
for histomorphometry. In case of intramuscular implants, only qualitative analysis using a 
light microscope (E600 Nikon, Japan) was performed. 
For histomorphometry of femora implants, high resolution (300dpi), low magnification 
(10x) digital micrographs were made of blinded sections. Using Adobe Photoshop 7.0, 
bone and material were pseudocoloured, red and green respectively. Image analysis 
was carried out with a PC-based system equipped with KS400 version 3.0 software 
(Carl Zeiss Vision, Oberkochen, Germany). Prior to measurement the system was 
geometrically calibrated with an image of a block of known dimensions. A program was 
developed in KS400 to quantitate different parameters concerning bone formation:  
• %b.cont. in cortex: percentage of available scaffold outline (which is the 
surface of the scaffold) in contact to bone: [%contact = (bone-scaffold contact 
length / scaffold outline length) * 100%] within the cortical area (area C in 
figure 1);  
• %b.cont. in implant: percentage of available scaffold outline in contact to 
bone: [%contact = (bone-scaffold contact length / scaffold outline length) * 
100%] in the total implant area (area B in figure 1);  
• %b.cont. in outer zone: percentage of available scaffold outline in contact to 
bone: [%contact = (bone-scaffold contact length / scaffold outline length) * 
100%] in an outer zone of cortical area that is defined as the area of the 
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implant within the cortical area with a thickness of 350 μm measured from the 
edges of the implant (area E in figure 1);  
• %b.cont. in inner zone: percentage of available scaffold outline in contact to 
bone: [%contact = (bone-scaffold contact length / scaffold outline length) * 
100%] in the inner zone, that is defined as the area of implant in the total 
cortical area and excludes the outer zone E (area D in figure 1);  
• %b.cont. bone marrow: percentage of available scaffold outline in contact to 
bone: [%contact = (bone-scaffold contact length / scaffold outline length) * 
100%] in the bone marrow area (area F in figure 1);  
• %b. in cortex: the percentage of bone in available pore area within cortical 
area (area C in figure 1);  
• %b. in implant: the percentage of bone in available pore area in the total 
implant area (area B in figure 1).  
 
 
Figure 1: zones of histomorphometrical analysis: (A) host cortical bone, (B) total implant area; (C) cortical area, (D) inner zone of the 
cortical area, (E) outer zone of the cortical area and (F) bone marrow area. 
 
 
We measured de novo bone formation in different areas of the formed defect in order 
to distinguish new bone formation in the cortical area, where the defect should be 
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healed from the part of the implant that was situated in the bone marrow. Furthermore, 
we distinguished the outer zone of the cortical area with a thickness of 350 μm, from 
the inner zone (the rest of the implant) to get more insight into the osteoconductive 
properties of the materials. 
 
 
6.3.7 Statistics 
 
Statistical calculations were done with the SPSS (Chicago, IL) 9.0 software. We found 
large variances between the individual animals and the data received were not 
normally distributed. That is why we chose the non-parametric tests to perform the 
statistical analysis. Friedman rank test, followed by a post-hoc test [206] was chosen to 
make the comparisons between the materials at both time points. Friedman test 
computes a Friedman two-way analysis of variance on selected variables. This test is a 
nonparametric extension of the paired t test, where, instead of two measures, each 
subject has n measures (n > 2). In other terms, it is a nonparametric analog of repeated 
measures analyses of variance with one group. The Friedman test is often used for 
analyzing ranks of three or more objects by multiple judges or like in the case of this 
study, various materials implanted in all animals.  
We used the Wilcoxon signed rank test [207] to analyze the difference in bone 
formation per material between the two time points. The Wilcoxon test compares the 
rank values of the selected variables, pair by pair, and displays the count of positive 
and negative differences. For ties, the average rank is assigned. It then computes the 
sum of ranks associated with positive differences and the sum of ranks associated with 
negative differences. The test statistic is the lesser of the two sums of ranks.  
In both cases, the significance level was set at p=0.05. As can be seen from the 
descriptions above, the two used statistical tests are both based on ranks, instead of 
average or median values. However, the results of histomorphometry in this paper are 
presented in graphs with the average values with standard error of the mean (SEM), in 
order to make the results more recognizable and comparable with previous studies. And 
although the asterisks indicating the significant differences are illustrated on these 
graphs, they are based on the above-mentioned rank tests. 
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6.4 Results 
 
6.4.1 Implant characterization  
 
6.4.1.1 Uncoated Ti6Al4V 
 
As determined from the material cross-sections, and by the volume/weight method, the 
porosity of the Ti alloy implants was 79±5% and the pore size between 400 and 1300 
μm. Observations by the ESEM showed that the pores of the implant were well 
interconnected. Figure 2a shows the structure of the non-coated porous Ti alloy. Higher 
magnification photograph (figure 2b) shows the rough metal surface, caused by the 
sintering of the alloy particles. 
 
 
Figure 2: ESEM photographs of porous Ti6Al4V implant magnification 15x (A) and 500x (B). 
 
 
6.4.1.2 OCP coated Ti6Al4V 
 
As observed by the ESEM, in the coated implants, the surface of the Ti alloy was 
homogeneously covered with a CaP layer. Figure 3a is a low magnification photograph 
of the coated Ti6Al4V implant. However, the thickness of the coating was not the same 
throughout the implant. It varied between 20 μm at the interior of the implant and 60 
μm at the implant periphery. Large OCP crystals were oriented perpendicularly to the 
Biological performance of uncoated and octacalcium phosphate coated Ti6Al4V 
 
 
 
135 
surface of the metal. Figure 3b illustrates the crystalline structure of the coating.  FTIR 
spectrum and XRD pattern (figures 4a and 4b, respectively) were typical of the pure, 
highly crystalline OCP phase. The specific surface area of the coating was 7.2±0.1 
m2/g. 
 
 
Figure 3:  ESEM photographs of OCP coated porous Ti6Al4V implant magnification 15x (A) and 500x (B). 
 
 
Figure 4: FTIR spectrum (A) and XRD pattern (B) of the OCP coating. 
 
 
6.4.1.3 BCP 
 
As observed by the ESEM, BCP implants consisted of a well-interconnected macroporous 
structure, with a pore size varying between 100 and 800 μm. Histomorphometry on 
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cross-section and determination by the volume/weight method gave an average 
macroporosity of 54±4%.  Higher magnification ESEM analysis showed that macropore 
walls contained micropores (pore size<10μm). Figure 5a illustrates the macroporous 
structure of the BCP, while higher magnification photograph (figure 5b) shows its 
micropores. FTIR and XRD analysis of the produced material (figures 6a and 6b 
respectively) showed a biphasic chemistry consisting of ±88 wt% HA and ±12 wt% β-
TCP. The material was highly crystalline. The specific surface area of the ceramic was 
1.2±0.1 m2/g. 
 
 
Figure 5: ESEM photographs of BCP implant magnification 15x (A) and 5000x (B). 
 
 
Figure 6: FTIR spectrum (A) and XRD pattern (B) of BCP ceramic. 
Arrow indicates the main β-TCP peak in BCP. 
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6.4.2 Transcortical implantation 
 
There were no surgical complications and all implants were retrieved. No macroscopic 
or microscopic signs of infection were found. 
 
 
6.4.2.1 Comparison of the materials 
 
As can be seen from the results shown in the figures 7a and 7b of the measurements in 
the total implant area, both OCP Ti6Al4V and BCP gave a significantly higher amount 
of bone as compared to the uncoated Ti6Al4V after 6 weeks of implantation, looking at 
both, %b.cont. in implant and  %b. in implant. Furthermore, BCP performed significantly 
better than OCP Ti6Al4V after 6 weeks. After 12 weeks of implantation, the difference 
between Ti6Al4V and OCP Ti6Al4V and Ti6Al4V and BCP was still significant, while this 
was no longer the case for the difference between OCP Ti6Al4V and BCP.   
 
 
Figure 7: histomorphometrical results of the %b.cont. (A) and %b. (B) in total implant area. 
For both parameters after 6 weeks significant difference (p<0.001 for %b.cont. and p=0.001 for %b.) can be found between OCP 
Ti6Al4V and Ti6Al4V, between BCP and Ti6Al4V and between BCP and OCP Ti6Al4V.  
After 12 weeks, significant differences exist between OCP Ti6Al4V and Ti6Al4V and between BCP and Ti6Al4V for both 
parameters (p=0.002 for %b.cont. and p=0.008 for %b.).  
According to the Wilcoxon test, significant difference between 6 and 12 weeks was found for the uncoated Ti6Al4V for both 
%b.cont. (p=0.022) and %b. (0.009) and for OCP Ti6Al4V only for parameter %b. (p=0.005). 
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Figure 8: histomorphometrical results of the %b.cont. (A) and %b. (B) in the cortical area. 
For parameter %b.cont, after both 6 (p<0.001) and 12 (p=0.020) weeks significant difference is found between OCP Ti6Al4V and 
Ti6Al4V and between BCP and Ti6Al4V. For the parameter %b., after 6 weeks significant difference (p=0.002) is found between 
OCP Ti6Al4V and Ti6Al4V, between BCP and Ti6Al4V and between BCP and OCP Ti6Al4V.  
After 12 weeks, no significant differences (p=0.273) is found between different implants.  
The Wilcoxon signed rank test showed significant difference between 6 and 12 weeks for the uncoated Ti6Al4V for both %b.cont. 
(p=0.007) and %b. (p=0.005). Similarly, for OCP Ti6Al4V there was a significant difference between 6 and 12 weeks in both 
%b.cont. (p=0.017) and %b. (p=0.008). 
 
 
Figure 8a represents %b.cont. in cortex. After 6 weeks of implantation we can see that 
the differences between Ti6Al4V and OCP Ti6Al4V and Ti6Al4V and BCP are 
significant. However, there is no significant difference between OCP Ti6Al4V and BCP 
that was observed in the graph of the total implant area. Concerning the % b. in the 
available pore space of the cortical area (figure 8b), both OCP Ti6Al4V and BCP are 
significantly higher than the uncoated Ti6Al4V, and BCP is significantly higher than OCP 
Ti6Al4V after 6 weeks of implantation. After 12 weeks, however, there are no 
differences between the three kinds of implants. Figures 9 a, c and e illustrate an 
example of the bone ingrowth in the cortical area after 6 weeks of implantation in 
uncoated Ti6Al4V, OCP Ti6Al4V and BCP, respectively.   
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Figure 9: LM photographs of histological slides of uncoated Ti6Al4V after 6 weeks (magnification 2x) (A) and 12 weeks 
(magnification 10x) (B); OCP coated Ti6Al4V after 6 weeks (magnification 2x) (C) and 12 weeks (magnification 10x) (D) and BCP 
after 6 weeks (magnification 2x) (E) and 12 weeks (magnification 10x) (F) of transcortical implantation. 
Ti=Ti6Al4V, B=bone, FT=fibrous tissue, BCP=ceramic. 
More bone has grown in the OCP Ti6Al4V and BCP (A and C) implants in comparison to the uncoated Ti6Al4V implant (E). Similarly, 
there is more direct bone contact between the newly formed bone in OCP Ti6Al4V and BCP implants (B and D) in comparison with 
the uncoated Ti6Al4V implants (F). → p220. 
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In the case of uncoated Ti6Al4V (figure 9a) bone ingrowth starts from the host bone 
bed towards the implant. In the OCP Ti6Al4V implant (figure 9c), new bone had grown 
deeply into the center of the implant. Similarly, newly formed bone had bridged the 
formed defect within the BCP implant (figure 9e). From the analysis of the histology 
slides of the implants after 12 weeks of implantation by the light microscope, we 
observed a lower amount of bone as well as less direct bone contact in the uncoated Ti 
alloy implants in comparison to both OCP Ti6Al4V and BCP. Figure 9b is a high 
magnification of the uncoated Ti alloy after 12 weeks of implantation showing a poor 
direct contact between metal and bone. Figures 9d and 9f, illustrating OCP Ti6Al4V 
and BCP after 12 weeks of implantation respectively, show a direct contact between 
the bone and the material. 
 
 
Figure 10: histomorphometrical results of the %b.cont. in bone marrow area. 
After 6 weeks significant difference (p<0.001) is found between OCP Ti6Al4V and Ti6Al4V, between BCP and Ti6Al4V and 
between BCP and OCP Ti6Al4V. After 12 weeks (p=0.001), significant differences exist between OCP Ti6Al4V and Ti6Al4V and 
between BCP and Ti6Al4V. The Wilcoxon signed rank test did not show significant differences between 6 and 12 weeks  
for any of the implant groups. 
 
 
When looking at the results illustrated by the figure 10, we can see significant 
differences in %b.cont. between Ti6Al4V and OCP Ti6Al4V and between Ti6Al4V and 
BCP at both time points.  
Measurements of %b.cont. in inner and outer zone of the cortical area (not illustrated) 
showed a significantly higher %b.cont. in the outer zone than in the inner zone after 6 
weeks of implantation for each kind of implant. After 12 weeks, however, this 
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difference could only be found for BCP. Differences between the individual materials in 
both zones were similar to the differences found in the total cortical area (see figure 
8a), meaning that for both time points in both zones, OCP Ti6Al4V and BCP showed a 
significantly higher amount of bone contact than the uncoated Ti6Al4V, while there was 
no difference between BCP and OCP Ti6Al4V. 
 
 
 
Figure 11: LM photographs of histological slides magnification 10x of uncoated Ti6Al4V (A), OCP coated Ti6Al4V (B) and BCP (C) 
after 12 weeks of intramuscular implantation. 
Ti=Ti6Al4V, B=bone, FT=fibrous tissue, BCP=ceramic. → p221. 
 
 
6.4.2.2 Time dependence 
 
The Wilcoxon test was used to statistically compare individual materials at the two time 
points. The test showed significant difference between 6 and 12 weeks of implantation 
for the uncoated Ti6Al4V in the parameters: %b.cont. in cortex, %b. cortex, %b.cont. in 
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implant, %b. in implant and %b.cont. in inner zone. Significant difference in the OCP 
Ti6Al4V was found in the parameters: %b.cont. in cortex, %b. in cortex, %b. in implant 
and %b.cont. in inner zone.  No difference between 6 and 12 weeks of implantation in 
the BCP implants could be found for any of the measured parameters. 
 
 
6.4.3 Intramuscular implantation 
 
At retrieval, all implants were surrounded by well-vascularized muscle tissue.  Histology 
showed no evidence for toxicity of the implants nor were the signs of an inflammatory 
tissue response specifically related to the implants observed. 
As observed by light microscopy, uncoated Ti alloy implants did not induce bone in the 
soft tissue. The implants were, however, extensively filled with fibrous tissue, which is 
illustrated by figure 11a.  
Both OCP coated Ti alloy and BCP (figure 11b and 11c), on the other hand, did show 
extraskeletal bone formation. Although bone was consistently observed, it occurred in 
small volumes only. Table 3 gives an overview of the bone incidence in time. In the case 
of both OCP Ti6Al4V and BCP, more goats showed bone formation after 12 weeks 
than after 6 weeks. Furthermore, although the bone areas were not measured, the LM 
analyses of the histological slides suggested an increased amount of formed bone after 
12 weeks of implantation when compared to 6 weeks of implantation. The bone was 
never observed on the implant periphery, and was always found inside the pores. The 
formed bone was normal in appearance, aligned with osteoblasts, and with mineralized 
bone matrix and osteocytes clearly visible. In the case of OCP coated Ti alloy implants, 
the coating was often incorporated into the newly formed bone.  
Observations of the histological slides of the coated Ti6Al4V implants by LM showed 
that the OCP coating had extensively dissolved after 6 weeks, and could only 
occasionally be observed after 12 weeks of implantation, in particular on the periphery 
of the implant, where the initial coating was the thickest. OCP coating has a typical 
crystalline structure that can easily be distinguished from bone on histological slides. The 
exact dissolution of the coating was however, not measured. Similar in vivo dissolution 
behavior of the OCP coating has previously been described [132]. Figures 12a and 
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12b are examples of dissolved OCP coating after 6 and 12 weeks of implantation 
respectively. In the areas where the coating was still visible, signs of its resorption by 
multinucleated cells could be observed, as shown in figure 12c. In vitro resorption of 
OCP coating has previously been shown by Leeuwenburgh et.al. [47]. 
 
 
 
Figure 12: LM photographs of histological slides magnification 5x of the OCP Ti6Al4V after 6 weeks (A) and 12 weeks (B) of 
implantation, and magnification 20x after 6 weeks of implantation. 
Ti=Ti6Al4V, B=bone, FT=fibrous tissue, C=OCP coating; BCP=ceramic. 
In (A) there is still some coating present on the periphery of the implant after 6 weeks of implantation, in (B) after 12 weeks of 
implantation the coating is further degraded, in (C) multinucleated cells (see arrow) are resorbing  
the coating left after 6 weeks of implantation. → p222. 
 
 
6.5 Discussion  
 
In this goat study, we investigated the in vivo behavior of a porous Ti6Al4V material, 
produced by a positive replica method, uncoated and coated with a biomimetic OCP 
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coating, in ectopic and orthotopic locations. We chose BCP ceramic as a reference, 
because previous animal studies have shown that this material has a large 
osteoinductive potential [124, 129, 143, 220] and could possibly be good bone filler in 
the clinic [238]. 
We introduced a porous structure into all used implants in order to improve mechanical 
interlocking, and therewith also the bone integration process. However, because of 
different production techniques, the porosity and the average pore size varied between 
the metal and the ceramic implants. 
As we did not find any signs of toxicity or deviating inflammation related to the 
implants, we can conclude that our novel material has an acceptable biocompatibility as 
bone filler. However, the ability of metal itself to guide new bone formation and to 
form a tight bond with the newly formed bone, i.e. its osteoconductivity [34] is limited. 
By modification of its surface chemistry and topography, through the application of a 
CaP coating, we tried to enhance its bioactivity.  
Although BCP ceramic, with its high osteoinductive potential and good performance as a 
bone filler was a good positive control in this study, it is important to note that it had a 
lower porosity and average pore size than Ti6Al4V and OCP Ti6Al4V. The chemistry of 
the BCP, that is a mixture of HA and β-TCP, and the biomimetically produced OCP 
differed as well. Furthermore, due to the sintering process, BCP ceramic macropore 
walls consisted of micropores, increasing therewith the surface roughness. Such a 
microporosity was not present in the OCP coating. Nevertheless, OCP coating surface 
was rough as well, due to the large crystals that were perpendicularly oriented to the 
metal surface. 
The above-mentioned material characteristics: chemical composition, macroporosity, 
crystallinity and surface roughness are all of great importance for the bone integration 
process. The release of calcium and phosphate ions is believed to be at the origin of the 
bioactivity of CaPs [171, 172, 210]. This dissolution is followed by the precipitation of 
a biological CaP layer [211]. In addition, organic compounds are incorporated into this 
newly formed layer, and cells like osteoprogenitor cells, osteoblasts and osteoclasts 
colonize the biomaterial [239, 240].  
Transcortical implantation results of this study confirmed a well-known fact that the 
application of a CaP layer on a metal surface significantly increases its bioactivity. 
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Biomimetically produced OCP coating applied on our porous Ti6Al4V metal enhances its 
osteoconductive properties, while keeping its mechanical strength. Differences in the 
amount of newly formed bone between the coated and the uncoated Ti alloy implants 
were significant in the cortical area of the defect as well as in the bone marrow, 
suggesting a high osteoconductive potential of the OCP coating. We found a significant 
difference between Ti6Al4V and OCP Ti6Al4V after 12 weeks of implantation in the 
contact between the newly formed bone and the implant surface, but this difference 
could not be found in the amount of formed bone in the available pore area. In order 
to get a full overview of both osteoconductive properties of a material and defect 
healing process by the material, both histomorphometric methods should be used.  
BCP as bulk ceramic caused a faster bone growth, when looking at both bone contact 
and bone area, in comparison to the OCP as coating on the metal implant. The BET 
measurements showed that OCP had a specific surface area that was about 5 times 
higher than that of BCP. Furthermore, the solubility isotherms of various CaPs show that 
OCP powder is slightly more soluble than β-TCP powder, and significantly more soluble 
than HA powder [212]. Both characteristics suggest a higher dissolution rate of OCP in 
comparison to the BCP that should be followed by a faster carbonated apatite 
formation of the material surface and consequently by a faster bone formation. 
However, as mentioned earlier, the OCP Ti6Al4V implants had a much higher porosity 
and pore size as compared with BCP. The lower porosity and average pore size of BCP 
might have been more suitable for bone ingrowth, possibly because of a better balance 
between a sufficient nutrient and blood supply into the implant on one hand and a 
protected area that is necessary to reach the supersaturation of Ca2+ and PO43- ions, in 
order to initiate the formation of carbonated apatite layer on the other, in comparison 
to the OCP coated Ti6Al4V implant. This is a possible explanation of the observations 
from this study. However, due to the many differences in material chemistry and 
morphology between OCP and BCP, further investigations are needed to fully 
understand their effect on the bone ingrowth. 
The difference in the bone amount formed in BCP and OCP Ti6Al4V disappeared after 
12 weeks of implantation, which suggests that, on longer term, both CaP materials have 
the same effect on the bone integration process. This could be explained by the fact 
that, on longer term, surface of both materials is covered by a bone like carbonated 
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apatite layer, and that the effect of dissolution behavior of the initial materials became 
less relevant. In the case of OCP, the coating is fully replaced by the newly formed 
bone within approximately 12 weeks, and bone continues to grow until the defect is 
filled. The bulk ceramic, on the other hand, will undergo the same process, but in this 
case material degradation will continue as well, although very slowly. Comparison of 
the amount of formed bone between 6 and 12 weeks showed a difference for Ti6Al4V 
and OCP Ti6Al4V but not for BCP. This once again supports our observation that the 
bone formation in BCP scaffolds is taking place faster than in the other two materials. 
From the results of the intramuscular implantation, we can conclude that uncoated Ti 
alloy was not osteoinductive in this study, while both OCP Ti6Al4V and BCP did show 
some extraskeletal bone formation. The amount of formed bone, and the number of 
animals in which the bone was induced, was similar for the both biomaterials. Although 
the bone was consistently found, its amount was limited. 
It is interesting to note that very large differences were observed between the amount 
of bone that was induced in individual animals, i.e. one goat was “more inductive” than 
another goat, for all implanted materials. The reason for these differences could be 
searched in genetic as well as in pathological backgrounds, but as long as the 
mechanism of osteoinduction itself is not clear, this phenomenon will be hard to explain. 
Because of such a limited amount of induced bone, any statistical analysis was 
impossible to perform. The only conclusion is therefore that both BCP and OCP Ti6Al4V 
have an osteoinductive potential, and that a non-inductive material such as Ti alloy can 
become inductive by combining it with a CaP coating. The findings from this study would 
therefore suggest that the presence of CaP is a critical factor in the process of 
osteoinduction. And although Yuan et.al. [134] and Fujibayashi et.al. [135] showed the 
possibility of bone induction by alumina ceramic and chemically treated porous titanium 
respectively, most of the biomaterials that were shown to induce bone consist of CaP. 
Although we know that many different material characteristics (chemistry, composition, 
macro and microstructure) may be important for its osteoinductive behavior [127-129, 
194], the exact mechanism of osteoinduction remains unknown. Concerning this 
mechanism, we hypothesize: 1) Osteoinductive materials exert a direct effect on the 
growth and differentiation of relevant cells that attach to them, and 2) The surface of 
osteoinductive materials helps collecting relevant proteins, which in their turn exert an 
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osteoinductive effect on the recruited cells.  To test these hypotheses, and to investigate 
which cells are important in the process of osteoinduction, additional research needs to 
be performed.  
In our study, CaP containing materials are performing better than the bare metal both 
ectopically and orthotopically, but from our observation, we cannot draw the conclusion 
that osteoinductivity improves the ingrowth in orthotopic sites, because of the fact that 
Ti6Al4V is not only non-inductive, but its conductive properties are limited as well. 
Nevertheless, it has been reported that osteoinductive materials are performing better 
orthotopically than the non-inductive materials [195]. This suggests that increased bone 
ingrowth in OCP Ti6Al4V is not only due to increased osteoconductivity but also due to 
osteoinductivity of the OCP coating.  
 
 
6.6 Conclusion 
 
In our study we introduced a porous Ti6Al4V material, produced by a novel technique, 
with sufficient mechanical properties and biocompatibility. Furthermore, we have shown 
that the application of OCP coating on the metal implants can improve its performance 
in bone healing process. BCP ceramic showed better osteoconductive properties than 
both, uncoated and OCP coated Ti alloy. Finally, both OCP Ti6Al4V and BCP showed 
an osteoinductive potential in the muscles of goats. 
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7.1 Abstract 
 
Several publications have shown the phenomenon of osteoinduction by biomaterials to 
be real. However, it has been questioned whether the ability of a biomaterial to initiate 
bone formation in ectopic implant sites improves the performance of such osteoinductive 
biomaterial in clinically relevant orthotopic sites. Until now, no studies have been 
published in which osteoinductive potential of a biomaterial is directly related to its 
performance orthotopically. 
In this study, we compared an osteoinductive and a non-osteoinductive biphasic calcium-
phosphate (BCP) ceramic ectopically and in a clinically relevant critical-sized orthotopic 
defect in goats. 
The two materials compared in this study, BCP1150 and BCP1300, had similar chemical 
composition, crystallinity and macrostructure, but their microstructure differed 
significantly. BCP1150, sintered at a lower temperature, had a large amount of 
micropores, small average crystal size and hence a high specific surface area. In 
contrast, BCP1300 with few micropores, had a significantly lower specific surface area 
as compared to BCP1150. 
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12-week-intramuscular implantation in goats (n=10) showed that bone was induced in 
all BCP1150 implants, while no signs of bone formation were found in any of the 
BCP1300 implants.  
After 12 weeks of implantation in a bilateral critical-sized iliac wing defect in the same 
goats, the osteoinductive BCP1150 showed significantly more bone than the non-
osteoinductive BCP1300. In addition, the analysis of fluorochrome markers, which were 
administered to the animals 4, 6 and 8 weeks after implantation in order to visualize 
the bone growth dynamics, showed an earlier start of bone formation in BCP1150 as 
compared to BCP1300.  
Significantly better performance of osteoinductive ceramic in a critical-sized orthotopic 
defect in a large animal model in comparison to the non-osteoinductive ceramic suggests 
osteoinduction to be clinically relevant. Further improvement of a material’s 
osteoinductive properties is thus a significant step forward in the search for alternatives 
for autologous bone graft.  
 
Keywords: osteoinduction, biphasic calcium-phosphate ceramic, critical-sized defect, 
bone repair. 
 
 
7.2 Introduction 
 
The role of biomaterials in osteoinduction, i.e. “the induction of undifferentiated 
inducible osteoprogenitor cells (IOPCs) that are not yet committed to the osteogenic 
lineage to form osteoprogenitor cells” [93] has been investigated by various groups 
during the last decade. Osteoinduction has been shown by a number of calcium-
phosphate (CaP) containing bulk ceramics such as hydroxyapatite- (HA) [116-122, 
183], α-tricalcium phosphate- (α-TCP), β-TCP-, BCP, α-pyrophosphate- and β- 
pyrophosphate [116, 122, 124, 125, 127-129, 140, 182, 183, 209, 241], in soft 
tissues of various animal models. Furthermore, ectopic bone formation has been 
observed by octacalcium phosphate (OCP) coated porous biomaterials [132, 182, 
209], CaP cements [124, 131] and glass ceramics [137]. In addition to the CaP-
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containing biomaterials, there have also been a few reports showing osteoinduction by 
porous alumina ceramic [134] and titanium [135, 136].  
The presence of concavities on implant surfaces or macropores is shown to be a 
prerequisite for osteoinduction by biomaterials [138]. In addition, a certain, not yet 
well- defined microstructure seems to be an essential element in the mechanism of 
osteoinduction [124, 128, 129, 134, 135, 183]. Despite the extensive research into 
osteoinductive properties of various biomaterials, the mechanism of osteoinduction 
remains largely unknown.  
An important clinical question that needs to be answered is whether an osteoinductive 
material that is able to induce bone formation ectopically is also able to accelerate the 
growth and increase the amount of the newly formed bone orthoptopically. In that case, 
osteoinductive biomaterials might perform better than most of the currently used 
synthetic bone graft substitutes and could be better alternatives for the “golden 
standard” i.e. the autologous bone graft without the well-known complications of the 
harvesting procedure [24, 242], extended surgical procedure and limited availability. 
Therefore, in the present study we compared bone formation by an osteoinductive 
[183] and a non-osteoinductive BCP ceramic in an established orthotopic critical-sized 
defect model that allows paired comparisons [29], as well as ectopically with the aim of 
answering the question whether osteoinduction is a clinically relevant property for bone 
repair.  
 
 
7.3 Materials and methods 
 
7.3.1 Implants 
 
Porous BCP implants were prepared by using the H2O2 foaming method as published 
earlier [129]. For the preparation of the ceramic, in-house made BCP powder was used. 
Porous green bodies were produced by mixing this powder with 2% H2O2 solution (1.0 
g powder / 1.2 ± 0.05ml solution) and naphthalene (Fluka Chemie, Zwijndrecht, The 
Netherlands) particles (710 - 1400 μm; 100 g powder/ 30 g particles) at 60°C. The 
naphthalene was then evaporated at 80°C and the green porous bodies were dried. 
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They were divided into two groups and sintered at 1150 °C and 1300 °C respectively 
for 8 hours.  
Compositions and crystal structures of the ceramics were determined by using Fourier 
transform infra red spectroscopy (FTIR; Spectrum100, Perkin Elmer Analytical 
Instruments, Norwalk, CT) and X-ray diffraction (XRD; Miniflex, Rigaku, Japan). HA/β-
TCP weight ratios of the BCP ceramics were determined by comparing the BCP XRD 
patterns to the calibration patterns prepared from the powders with the known HA/β-
TCP weight ratios.  
A lathe was used to produce ceramic discs with a size of ∅17 x 6 mm3. All implants 
were cleaned in ultrasonic baths and sterilized by gamma irradiation (Isotron 
Nederland BV, Ede, The Netherlands). 
Prior to implantation, ultrastructures of the porous BCP ceramics were characterized by 
an environmental scanning electron microscope (ESEM; XL30, ESEM-FEG, Philips, 
Eindhoven, The Netherlands) in the secondary electron mode. Total-, macro- (pore 
diameter >10 μm) and microporosities (pore diameter < 10μm) as well as average 
pore sizes and pore size distributions were determined on ESEM photographs by an 
image analysis system and by using a mercury intrusion porosimeter (MP; Auto Pore IV 
9500, Micromeritics European Analysis Service, Mönchengladbach, Germany). For a 
good comparison, the microporosity of each ceramic was expressed as total incremental 
pore volume (ml) per gram of the material for the pores with a diameter lower than 10 
μm. Specific surface areas of the ceramics were determined from the MP results, as the 
cumulative surface area (m2/g) when all pores were filled with mercury.  
After implantation, macroporosities of the ceramics were measured again, by using 
histological sections [183, 209]. First, the labels of the sections were covered. Then, high 
resolution (300dpi), low magnification digital micrographs were made of these sections. 
Image analyses on the pseudocolored micrographs were carried out with a computer-
based system equipped with KS400 version 3.0 software (Carl Zeiss Vision, 
Oberkochen, Germany). Prior to measurements, the system was geometrically 
calibrated with an image of a disc of known dimensions. A program was developed in 
KS400 to quantify macroporosities of the ceramics. The macroporosity was determined 
as: [(total implant surface – scaffold surface) / total implant surface] * 100%.  
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7.3.2 Animals and implantation 
 
This study was approved by the Dutch Animal Care and Use Committee. In total, ten 
adult Dutch milk goats (18-30 months) were used. The animals were housed in the 
Central Animal Laboratory Institute (GDL), Utrecht, The Netherlands, at least 4 weeks 
prior to surgeries. 
Surgical procedures were performed under general inhalation anesthesia of the animals 
preceded by an intravenous injection of Thiopental (Nesdonal, ± 400mg/70kg of body 
weight, on indication, Rhone Merieux, Amstelveen, The Netherlands). After shaving and 
disinfection of the dorsal thoracolumbar area, a central skin incision at T8-L5 was made 
to expose the muscle fascia. Both iliac wings were identified and cleared of muscle 
tissue. Using constant saline cooling, central guide holes were drilled before ∅17 mm 
trephine holes were made [29]. BCP1150 and BCP1300 implants were press-fit 
inserted into the defects according to a randomized scheme. The muscles were then 
tightly sutured to the remaining fascia on the wings. 
For intramuscular implantation, separate fascia incisions were created in the paraspinal 
muscles (L1-L3). Using blunt dissection, intramuscular pockets were created, and filled 
with one BCP1150 and one BCP1300 ceramic disc. Subsequently, fascias were closed 
with nonresorbable sutures to facilitate implant localization at explantation. The skin 
was closed in two layers.  
Pain relief was given by Durogesic 25 (fentanyl transdermal system CII patches; 
Janssen-Cilag EMEA, Beerse, Belgium). 
In order to visualize the dynamics of bone growth, the goats received sequential 
fluorochrome labels at 4 weeks (Calceine green, 10 mg/kg, I.V., Sigma Aldrich, 
Zwijndrecht, The Netherlands), 6 weeks (Oxytetracycline, 32 mg/kg I.M., Engemycine, 
Mycofarm, Amersfoort, The Netherlands) and 8 weeks (Xylenol orange, 80 mg/kg, I.V. 
Sigma Aldrich, Zwijndrecht , The Netherlands) [78, 80].  
12 weeks after the implantations, each animal was sacrificed by an overdose of 
pentobarbital (Euthesaat, Organon, Oss, The Netherlands) and potassium chloride. 
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7.3.3 Retrieval of the implants, histology and histomorphometry 
 
The iliac wing implants with surrounding bone were removed by using an oscillating saw. 
The intramuscular implants with surrounding tissue were explanted by dissection. All 
explanted implants were fixed in Karnovsky’s fixative, dehydrated in a graded ethanol 
series (70%-100%) and transferred into a methylmethacrylate (MMA) solution that 
polymerized at 37°C within one week.  
In order to obtain histological sections, orthotopic implants were ground in the plane 
parallel to the iliac wing, until the outer circular margin of the implant on the anterior 
side of the iliac wing appeared. Then, 3 mm below the ground surface three central 
sections with a thickness of 10-15μm were made by using the modified interlocked 
diamond saw (Leica Microtome, Nussloch, Germany). Sections were stained either with 
1% methylene blue and 0.3% basic fuchsin after etching with HCl/ethanol mixture for 
routine histology and histomorphometry or left unstained for epifluorescence microscopy 
with a light microscope (LM; E600 Nikon, Japan) equipped with a quadruple filter block 
(XF57, dichroic mirror 400, 485, 558 and 640 nm, Omega Filters, Didam, The 
Netherlands). Intramuscular implants underwent the same procedure of sectioning (three 
central sections 3 mm below the surface of the disc) and staining as did the orthotopic 
implants.  
For histomorphometry, the same image analysis method was used as previously 
described for the post-implantation measurement of material macroporosities. In the 
computer-based image analysis system, a program was developed to quantify 
different parameters concerning bone formation:   
• Percentage of bone occupying available pore area (area%b/pore); 
• Percentage of available scaffold outline in contact with bone: [%contact = 
(bone-scaffold contact length / scaffold outline length) * 100%] in the total 
area of the implant (%b.cont). 
The first parameter was chosen in order to allow for comparison with previous studies. 
The reason for the choice of the second parameter, %b.cont., was that in a study in 
which the performances of two materials are compared, it seems more appropriate to 
relate the new bone formation to available scaffold rather than to available pore 
Relevance of osteoinductive biomaterials in a critical-sized orthotopic defect 
 
 
 
155 
space. Furthermore, contact percentage is more sensitive for early bone apposition 
which generally occurs on the ceramic surface and has a relatively low volume.   
In order to get insight into healing of the defect, in the iliac wing implants, the 
histomorphometry was not only performed in the total implant area, but also in the 
central area of the implant with the diameter of 8.5 mm (half of the total implant 
diameter). 
 
 
7.3.4 Statistical analysis 
 
Statistical calculations were done with the SPSS (Chicago, IL) 12.0 software.  
For orthotopic implants, the two-sided, paired Student’s t-test was used to analyze 
differences between BCP1150 and BCP1300.  
In agreement with previous studies [183, 209], intramuscularly implanted ceramics 
showed large variances in the amount of induced bone between the individual animals. 
Hence, the distribution of the data was not normal and that is why the non-parametric 
Wilcoxon signed rank test for paired comparisons [207] was used to perform the 
statistical analyses.  
For both tests the significance level was set at p=0.05. 
 
 
7.4 Results 
 
7.4.1 Material characterization 
 
FTIR spectra (figure 1a) and XRD patterns (figure 1b) of both BCP1150 and BCP1300 
ceramics were similar and characteristic of a biphasic CaP composition. Both ceramics 
were fully crystalline and consisted of 80±3 % HA and 20±3 % β-TCP. As observed by 
LM and ESEM, both ceramics consisted of highly interconnected macropores, with an 
average pore size of around 400 μm (figures 2a and 2b). Both image analysis of ESEM 
photographs and mercury porosimetry measurements indicated that prior to 
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implantation total porosity of BCP1150 was 76±2 % and that of BCP1300 68±2 %. 
Macroporosity of the two materials was similar, 55±5 %. 
 
 
Figure 1: FTIR spectra (A) and XRD patterns (B) of BCP1150 and BCP1300. 
Arrow indicates the main β-TCP peak. 
 
 
Figure 2: LM photographs (magnification 4x) of BCP1150 (A) BCP1300 (B). 
Bar = 1mm. 
 
 
Unlike other material characteristics, the microstructures of the two ceramics were 
different. As shown by the high magnification ESEM photographs of BCP1150 and 
BCP1300 (figures 3a and 3b respectively), changes of the sintering temperature 
changed the materials microstructures. The macropore walls of BCP1150 contained 
more micropores than BCP1300. In addition, crystals of BCP1150 were smaller than 
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those of BCP1300. These observations were confirmed by the mercury porosimetry 
results that are shown in figure 4. As can be seen in figure 4, most micropores of 
BCP1300 had a diameter of around 0.7 μm, whereas the diameter of the BCP1150 
micropores was around 1μm. Figure 4 further demonstrates that the total incremental 
volume of micropores, i.e. the microporosity, was much higher for BCP1150 as 
compared to BCP1300. Microporosity of BCP1150 was ca. 17 % and that of BCP1300 
ca. 3 %. Macro- and microstructure characterizations of the two ceramics can be 
summarized by their specific surface areas. The specific surface areas of BCP1150 and 
BCP1300 were about 1 m2/g and 0.2 m2/g, respectively. 
 
 
Figure 3: ESEM photographs (magnification 3000x) of BCP1150 (A) and BCP1300 (B). 
Decrease in the sintering temperature results in an increase of the amount of micropores and a decrease  
in the crystal size of a ceramic. 
 
 
Figure 4: total incremental micropore volume for BCP1150 and BCP1300. 
Decrease in the sintering temperature results in an increase of the total micropore volume, i.e. microporosity of a ceramic. 
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7.4.2 Ectopic implantation 
 
There were no surgical complications and all implants were retrieved. All explanted 
ceramics were surrounded by well-vascularized muscle tissue and no macroscopic or 
microscopic signs of inflammation were found. 
 
 
 
Figure 5: digital photograph (A), LM photograph (magnification 10x) of a histological slide (B) and fluorochrome markers (C) of 
intramuscularly implanted BCP1150. 
(1) = ceramic, (2) = bone, (3) = fibrous tissue, OTC = Oxytetracycline, XO = Xylenol orange. 
The induced bone is formed in the pores of the implant, aligning its surface (A). The bone is normal in appearance, aligned with 
osteoblasts and with osteocytes and osteoid clearly visible (B). The presence of both Oxytetracycline and Xylenol orange marker 
shows that the bone formation had started before the sixth week of implantation (C). → p223. 
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Macroporosities of the two ceramics measured after implantation, were similar to those 
before implantation (58±5%), indicating that no substantial resorption of either of the 
materials had taken place during the 12-week-implantation period. 
Bone formation was observed in all implanted BCP1150 discs. Histology showed small 
foci of bone aligning the ceramic surface as is illustrated in figure 5a. Bone had formed 
throughout the implants, but was however never observed on the implant exteriors. The 
formed bone was normal in appearance, aligned by an osteoblast layer and with 
osteocytes well visible (figure 5b). Fluorescence microscopy confirmed observations from 
previous studies that bone formation started on the implant surface and continued 
towards the pore center. In some BCP1150 implants, both Oxytetracycline and Xylenol 
orange marker were observed, suggesting that bone formation had started before the 
sixth week of implantation (figure 5c). In other BCP1150 implants, only Xylenol orange 
marker was visible, emphasizing again the observed intra-species differences. 
 
 
Figure 6: digital photograph (A) and LM photograph (magnification 10x) (B) of a histolological slide  
of the intramuscularly implanted BCP1300. 
(1) = ceramic, (3) = fibrous tissue. 
The ceramic is extensively filled with fibrous tissue, but no signs of bone formation are observed. → p224. 
 
 
Although bone was observed in all BCP1150 implants, in agreement with previous 
studies [183, 209], the amount of formed bone varied significantly between the 
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individual animals. For example, percentage of bone area occupying available pore 
area (area%b/pore) varied between ca. 0.05% and ca. 6% with an average of 
1.5±2.0%. Similarly, percentage of available scaffold outline in contact with bone 
(%b.cont) varied between ca. 0.5% and ca. 10% giving an average of 2.9±3.8%.  
All BCP1300 implants were extensively filled with fibrous tissue as is shown by figures 
6a and 6b. However, no bone formation was observed in any of the implants. As 
expected, the Wilcoxon signed rank test showed that for both measured parameters, 
BCP1150 performed significantly better (p=0.018) than BCP1300. 
 
 
7.4.3 Orthotopic implantation 
 
There were no surgical complications and all implants were retrieved. At retrieval, iliac 
wing implants of all animals were overgrown by tissue and could neither visually nor 
manually be detected (no motion). Histology showed no evidence for toxicity of the 
implants, or signs of an inflammatory tissue response. All implants were totally 
integrated in the surrounding cancellous bone, without interposition of fibrous tissue. 
 
 
Figure 7: digital photographs of BCP1150 (A) and BCP1300 (B) after explantation from the iliac wing defect. 
(1) = ceramic, (2) = bone, (3) = fibrous tissue. 
Bone has grown deeply inside the BCP1150 disc (A) while only a small ridge of new bone has formed along the host bone bed  
in the BCP1300 disc (B). → p225. 
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Similar to the intramuscular implants, no significant resorption of either of the materials 
had taken place during the 12-week-implantation period orthotopically.  
As shown in figure 7a, a considerable amount of bone had formed in the pores of 
BCP1150 implants. In all animals, new bone had grown deeply inside the BCP1150 
discs and most defects were almost completely filled with bone. In BCP1300 implants, 
however, a relatively small amount of bone had formed (figure 7b). The new bone 
formation had taken place in the areas of the implant close to the host bone bed, while 
no bone could be observed in the center of any of the BCP1300 discs. 
 
 
 
Figure 8: LM photographs (magnification 10x) of the fluorochrome markers on the periphery of BCP1150 (A) and BCP1300 (B) and 
in the center of BCP1150 (C) and BCP1300 (D) discs explanted from the iliac wing defects. 
CG = Calcein green, OTC = Oxytetracycline, XO = Xylenol orange. 
On the peripheries of both BCP1150 (A) and BCP1300 (B) all markers can be seen, which shows that in both ceramics bone 
formation near the host bone bed had started before the fourth week of implantation.  
The presence of the Oxytetracycline and Xylenol orange marker in the center of BCP1150 disc (C) shows that the bone formation 
far away from the host bone bed had started before the sixth week of implantation. Absence of any of the markers in the center of 
BCP1300 (D) illustrates the absence of new bone within the first eight weeks of implantation. → p226. 
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Analyses of the presence of the fluorochrome markers indicated that in both ceramics, 
the bone apposition generally started at the ceramic surface and continued away from 
the surface, towards the pore center. In the peripheral areas of both implant types, the 
presence of the Calcein green label indicated that the bone growth had started before 
the fourth week of implantation (figures 8a and 8c). In BCP1150, however, more 
Calcein green label could be observed, suggesting more early bone formation on 
BCP1150 than on BCP1300 ceramic surface. In the central part of BCP1150 implants, 
Xylenol orange marker could be observed indicating the start of bone formation before 
the eighth week of implantation. In addition to the Xylenol orange marker in some of the 
implants, Oxytetracycline marker was observed, indicating an even earlier bone 
formation in the central area of BCP1150 (figure 8b). In the central areas of most 
BCP1300 implants, the absence of any of the used markers confirmed the absence of 
bone formation within the first 8 weeks of implantation as is shown in figure 8d. 
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Figure 9: histomorphometrical results: boxplots (mean and interquartile values) of area%b/pore and %b.cont. in the total (A) and 
central (B) area of the orthotopically implanted BCP1150 and BCP1300 discs. 
(ο) = outliers, (∗) = extreme outliers. 
In the total implant area (A) BCP1150 performed better than BCP1300 for both measured parameters. The difference was 
however only significant (p<0.01) for %b.cont. In the central implant area BCP1150 was significantly better (p<0.01) than 
BCP1300 for both area%b/pore and %b.cont. 
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Figure 9 illustrates histomorphometrical results of the percentage bone area occupying 
available pore area (area%b/pore) and percentage of available scaffold outline in 
contact with bone (%b.cont) in the total (figure 9a) and in the central (figure 9b) area 
of the iliac wing implants. BCP1150 showed more bone than BCP1300 (15.2±4.2% vs 
13.5±5.1%), although this difference was not significant for the area%b/pore 
(p=0.494). The bone apposition (%b.cont) however, was significantly higher in 
BCP1150 as compared to BCP1300 (p<0.01) (13.9±3.1% vs 8.1±3.6% respectively). 
These observations were amplified when only the middle of the implant was analyzed 
(11.0±7.2% vs. 1.4±2.8% (p<0.01) for area%b/pore and 9.6±5.8% vs. 1.1±1.9% 
(p<0.01) for %b.cont.) in BCP1150 and BCP1300, respectively. 
 
 
7.5 Discussion 
 
In the current study, for the first time, bone formations in an osteoinductive and a non-
osteoinductive porous CaP ceramic were compared in a clinically relevant critical-sized 
defect in goats.  
The two ceramics used in this study had identical composition, crystallinity and 
macrostructure, but differed significantly in their microstructure. BCP1150 had a high 
microporosity and a small average crystal size, which consequently resulted in a high 
specific surface area. In contrast to BCP1150, the BCP1300 ceramic possessed a low 
microporosity, large average crystal size and hence a relatively low specific surface 
area. The differences in microstructures between the two ceramics were achieved solely 
by different temperatures at which they were sintered, as described previously [183]. 
The ectopic implantation of the two ceramics showed only bone formation in BCP1150 
ceramic in all animals. This is in agreement with observations from previous studies in 
which it is suggested that the microstructure may be crucial and responsible for the 
osteoinductive potential of biomaterials [135, 136, 183, 209]. Although the exact 
mechanism of this process is still not unraveled, the fact is that in the used model 
BCP1150 somehow stimulated undifferentiated cells to generate bone at its surface. 
BCP1300 completely lacked this ability. 
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When implanted in the critical-sized iliac wing defects, the biological performances of 
the two ceramics differed as well. After twelve weeks of implantation, bone had grown 
deeply inside the BCP1150 discs, and in most animals the defect was even fully 
bridged by new bone. In contrast to BCP1150, in the BCP1300 discs new bone had only 
formed a small ridge along the host bone bed. Differences in the healing between the 
two ceramics were highly significant as demonstrated by the histomorphometrical results 
in the central area of the implants.  
Besides differences in bone yield, we observed more Calcein green (4-week-label) on 
the periphery of the BCP1150 in comparison to the BCP1300 ceramic, which indicated 
that the new bone formation started earlier in the osteoinductive material. Furthermore, 
the presence of the 6-week Oxytetracycline marker in the center of the BCP1150 
implants showed the start of the new bone formation deep inside the implant before the 
sixth week of implantation. Differences in bone formation onset observed between the 
two ceramics might be an explanation for the fact that the measured percentage of 
bone area in the available pores was not significant in the total implant area. Namely, 
after 12 week-implantation period bone formed in BCP1150 is likely to be in a 
different phase of remodeling from that formed in BCP1300. In particular on the edges 
of the implant along the host bone bed, where the earliest bone formation had taken 
place, bone may transfer to the structure of the surrounding cancellous bone. The 
parameter percentage of contact between the newly formed bone and the scaffold is 
less sensitive for the remodeling processes and highly sensitive for early bone 
apposition and might therefore be more appropriate for comparing the performance of 
different materials at one time point. 
The findings of an earlier start and a higher amount of bone formation in the 
orthotopically implanted osteoinductive CaP ceramic in comparison to the non-
osteoinductive ceramic, suggests the osteoinductive potential to be relevant for the 
performance of a material as a bone filler. However, it does not necessarily mean that 
osteoinduction itself is the cause for a better performance as it cannot be excluded that 
more micropores and consequent higher specific surface area lead to better 
osteoconduction. In other words, the presence of osteoinduction and increased 
osteoconduction might be two independent consequences of introducing microporosity in 
porous BCP.  
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Davies and Hosseini defined osteoconduction as “the recruitment and migration of 
osteogenic cells into the wound site” [243]. According to the authors, bone formation 
during either healing or the anabolic phase of bone remodeling comprises the two 
distinct phenomena: 1) de novo bone formation, preceded by osteoconduction, formed 
by the migrating osteogenic cells along the solid surface of the implant and 2) 
appositional bone growth by polarized cells and differentiated osteoblasts formed in 
the direction perpendicular to the solid surface of the implant. The former process is by 
far more important in the bone healing than the latter one.  
During the process of osteoconduction, recruited osteogenic cells differentiate into 
osteoblasts and stop migrating as soon as they have reached the target surface (old 
bone or implant). The newly differentiated osteoblasts start producing bone matrix, 
while osteoconduction continues along the implant surface by new osteogenic cells. Thus, 
osteoconduction followed by de novo bone formation, takes place from the host bone 
bed towards the center of the (porous) implant. Osteoinductive BCP1150 ceramic might 
have the ability to attract more osteogenic cells than the non-osteoinductive ceramic, 
which could explain an earlier start of bone formation on the periphery of BCP1150.  
However, neither de novo bone formation nor appositional bone growth can explain the 
early bone formation in the center of the BCP1150 implants in the critical sized iliac 
wing defect. It is therefore conceivable that osteoinduction plays an important role. 
However, if we assume that the process of osteoinduction is the same both ectopically 
and orthotopically, difference between percentage of bone contact in the central areas 
of BCP1150 and BCP1300 implanted orthotopically should have a maximum of about 
2.9% (=average %b.cont. found in BCP1150 implants intramuscularly). The larger 
difference observed may be explained by the fact that there is a higher amount of 
IOPCs at orthotopic than at ectopic sites. This is conceivable, because, in addition to 
IOPCs from the surrounding muscle, it is known that bone marrow also contains IOPCs 
[244, 245].  
The above described findings suggest that new bone formation in an orthotopic defect 
is reproducibly enhanced by the osteoinductive material, which is responsible for the 
“production” of new bone cells (effect of osteoinduction) and/or recruitment of a higher 
amount of osteogenic cells as compared to non-osteoinductive ceramic (enhancement of 
osteoconduction).  
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In summary, the results of this study show that the improvement of the intrinsic bone 
inductive properties of biomaterials can significantly improve their performance in the 
role of bone filler. Improving osteoinductive properties of biomaterials might be a way 
to make them a suitable substitute for autograft, with a similar performance to that of 
growth factors and tissue-engineered hybrids, but without disadvantages associated 
with their use. 
 
 
7.6 Conclusion 
 
Although the exact mechanism of the effect of osteoinductivity on the performance of a 
biomaterial as bone filler is still largely unknown, this study has shown a significantly 
better performance of an osteoinductive CaP ceramic in comparison to a similar, but 
non-osteoinductive ceramic in a critical-sized orthotopic defect in a large animal model.  
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8.1 Discussion 
 
In this chapter, a brief overview of the findings that have been discussed in detail in the 
chapters 2-7 are given. 
In Chapter 2, we reviewed a number of existing in vitro models to assay bone formation 
in general and in relation to osteoinduction in particular. We discussed the limitations of 
the use of the existing in vitro systems to study the potential in vivo performance of 
biomaterials in terms of osteoconduction and osteoinduction. When biomaterials are 
introduced in an in vitro system, there is a risk of an interaction between the biomaterial 
and the cell culture medium in addition to the biomaterial-cells interaction that is being 
studied. Resorbabale materials can release compounds into the medium. Similarly, 
contents of the medium, such as calcium- and phosphate ions can precipitate on the 
material with a high specific surface area. The biomaterial-cell culture medium 
interaction might be an artifact of the in vitro system, if a similar interaction between the 
material and body fluids is not expected in vivo. The use of bioreactors, by which 
changes of the medium composition are screened and adjusted in time, might be a way 
to avoid the artifact caused by the biomaterial-cell culture medium interaction. Without 
required adjustments, the existing in vitro systems are inadequate for the biomaterials 
research. 
When trying to study complex and largely unknown biological phenomena in vitro, such 
as osteoconduction and osteoinduction by biomaterials, attention should be focused on 
the appropriate cell and assay choice. It is important to keep in mind that the 
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established in vitro systems are simplified models of the in vivo environment, and that, 
although in vitro studies can give some valuable information, only very careful 
conclusions can be drawn from their results. Preclinical in vivo studies remain therefore 
necessary in order unravel complex biological phenomena. 
In Chapters 3-7 of this thesis, attempts were made to get more insight into the 
mechanism underlying osteoinduction by biomaterials and into the relevance of 
osteoinductive biomaterials in bone repair. The achievements of the research described 
in this thesis will be attended by answering the specific questions given in the 
Introduction Chapter 1: 
• What is the influence of chemical composition, microstructure and surface 
morphology on material osteoinductive properties? 
• Is there an influence of implant size and implantation site on the amount of 
induced bone? 
• What occurs on the surface of an osteoinductive material during ectopic 
implantation? 
• What is the performance of osteoinductive biomaterials at orthotopic 
implantation sites? 
 
 
8.1.1 Influence of physico-chemical parameters and microstructure 
 
In Chapter 3 of the thesis, we applied biomimetic octacalcium phosphate (OCP) coating 
on porous titanium alloy (Ti6Al4V), hydroxyapatite (HA) ceramic, biphasic calcium 
phosphate (BCP) ceramic consisting of hydroxyapatite (HA) and β-tricalcium phosphate 
(β-TCP) and polyethylene glycol terephtalate/polybuthylene terephtalate (PEGT-PBT) 
copolymer. Uncoated materials were used as control.  
After intramuscular implantation for 6 and 12 weeks in goats, bone was induced by all 
OCP-coated porous materials, apart from the OCP-coated PEGT-PBT copolymer. From 
the uncoated materials, only BCP ceramic showed ectopic bone formation, although 
bone incidence was higher when BCP ceramic was coated with OCP. 
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The results of this study showed that there was a difference in osteoinductive properties 
between different biomaterials. The tested materials differed not only in their chemical 
composition, but also in their macro- and microstructures. It was therefore difficult to 
conclude which of these factors influenced materials’ osteoinductive properties. 
It was further shown that biomimetic OCP coating could be applied on different porous 
materials, independent on their chemistry, and that therewith the osteoinductive 
properties of these materials can be improved. Ti6Al4V and HA, which did not induce 
bone when uncoated, showed ectopic bone formation in presence of the OCP coating. 
Bone incidence in BCP ceramic, which was osteoinductive without OCP coating, increased 
in the presence of the coating. 
The fact that OCP-coated PEGT-PBT copolymer did not induce ectopic bone formation 
was probably due to poor mechanical properties of the chosen polymer composition, 
which caused a loss of porous structure and delamination of the OCP coating after 
implantation. The presence of macropores has previously been shown to be a 
prerequisite of osteoinduction by biomaterials [116, 117, 124, 125, 135, 220]. 
In conclusion, this study confirmed that chemistry does influence osteoinductivity of 
biomaterials [128, 129, 208], as previously suggested by different authors. In addition, 
it was confirmed that the presence of macroporosity [116, 117, 124, 125, 135, 220] is 
a prerequisite for osteoinduction. Finally, biomimetic OCP coating was shown to be 
osteoinductive when applied on porous surfaces of different materials, in analogy to the 
previously published results  for porous tantalum [132]. 
In Chapter 4, we investigated the influence of microstructure on osteoinductive 
properties of two types of porous ceramic, HA and BCP, after intramuscular 
implantations in goats for 6 and 12 weeks. Different microstructures were achieved by 
changing the sintering temperatures of the ceramics. HA ceramic was sintered at 1150 
°C and 1250 °C, while biphasic calcium phosphate BCP ceramic was sintered at 1100 
°C, 1150 °C and 1200 °C. 
Decrease of the sintering temperatures significantly increased microporosity and 
therewith also the specific surface area of the ceramics. Increase of the specific surface 
area consequently had a positive influence on the osteoinductive properties of the 
ceramics. While bone was not induced by HA sintered at 1250 °C, HA sintered at 1150 
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°C induced bone in 50% of the animals after 6 and in 70% of the animals after 12 
weeks of implantation. All BCP ceramics induced bone, however, both bone incidence 
and the amount of induced bone were higher in BCP sintered at 1100°C and 1150°C 
as compared to the BCP ceramic sintered at 1200°C. Comparison of HA ceramic 
sintered at 1150°C with BCP ceramic sintered at 1150°C showed more bone in the 
latter.  
In conclusion, the results of this study indicated that the presence of micropores, in 
addition to the presence of macropores, is a prerequisite for osteoinduction by 
biomaterials, and that this phenomenon is independent on the material chemistry. 
Furthermore, there seems to be a limit in the increase of microporosity solely by 
decreasing sintering temperature. Namely, difference in microporosity between BCP 
sintered at 1200°C and BCP sintered at 1150°C was much larger than difference 
between BCP sintered at 1150°C and BCP sintered at 1100°C. Finally, the finding that 
BCP ceramic sintered at 1150°C induced more bone than HA sintered at the same 
temperature indicated the importance of chemistry, and, in this particular case, the 
presence of the more soluble β-TCP phase in the ceramic. 
In Chapter 5, we compared osteoinductive properties of four, slightly different porous 
BCP ceramics, consisting of HA and β-TCP and a porous carbonated apatite (CA) 
ceramic, after a 12-week intramuscular implantation in goats.  
Results of the study confirmed observations from previous studies that the material 
needs a relatively high specific surface area, which is achieved by the increase of 
microporosity, in order to be able to induce ectopic bone formation. However, this study 
showed that if the surface area is too high, or material is too resorbable due to its 
chemical composition, the implants might degrade and lose their porous shape. In that 
case, ectopic bone formation does not occur, as a relatively stable surface is needed to 
facilitate new bone growth. These findings suggest that, for each type of material, there 
is an optimal specific surface area at which the osteoinductive potential is highest. 
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8.1.2 Implant size and implantation site dependence 
 
In Chapter 5, BCP ceramics sintered at 1150°C and 1300°C were intramuscularly 
implanted in two implant sizes for 12 weeks in goats. BCP1150 ceramic cylinders with 
the size of ∅6.5 x 10 mm3 induced bone in 90% of animals, while the cylinders with 
half the volume (∅6.5 x 10 mm3) induced bone in 70% of animals. In addition, the 
amount of induced bone was higher, and the start of bone formation took place earlier 
in larger in comparison to smaller implants. As expected, BCP1300 ceramics did not 
induce bone in neither large nor small implants, as it lacked micropores, and had a 
relatively small specific surface area. 
In Chapter 5, BCP ceramic implants sintered at 1150°C and 1300°C with a size of 
∅6.5 x 5 mm3 were implanted both intramuscularly and subcutaneously in goats for 12 
weeks. While intramuscularly implanted BCP1150 induced bone in 70% of animals, 
bone was not induced after subcutaneous implantation of BCP1150. As expected, 
BCP1300 did not induced bone at either implantation sites. 
In conclusion, this study showed that there is an influence of the implant size on the 
materials’ osteoinductive potential, namely, the larger the implant, the more bone is 
induced. This might explain the fact that ectopic bone formation by biomaterials is 
rarely found in rodents and other small animals [67, 116, 142-144], in which, obviously, 
only implants of a small size can be inserted. We observed differences in the amount of 
induced bone between intramuscular and subcutaneous locations, which contrasts a 
previous study in sheep [124], and might therefore be species dependent. 
 
 
8.1.3 In vivo changes on the surface of osteoinductive materials 
 
In order to investigate changes occurring on the surface of osteoinductive implants after 
implantation, in Chapter 5 we implanted the osteoinductive BCP1150 ceramic and the 
non-osteoinductive BCP1300 ceramic inside diffusion chambers subcutaneously in goats 
for 1, 2 and 4 weeks. Consequently, thermogravimetry analysis on the explanted 
materials was performed. 
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The results of this study showed that, after explantation, more carbonate and organic 
compounds were present on the surface of osteoinductive ceramic as compared to the 
non-osteoinductive ceramic. These results suggested that, during implantation, on the 
surface of the osteoinductive ceramic more dissolution took place, followed by the 
reprecipitation of the carbonated-apatite layer and possible coprecipitation of the 
organic compounds such as endogenous proteins, than on the surface of the non-
osteoinductive ceramic. This finding might be explained by the difference in the specific 
surface area between osteoinductive and non-osteoinductive ceramic. 
 
 
8.1.4 Performance of osteoinductive biomaterials at orthotopic implantation sites 
 
In Chapter 6, we implanted porous titanium alloy (TI6Al4V), uncoated and coated with 
biomimetic OCP coating and porous BCP ceramic (all implants were cylinders with the 
size ∅5x10 mm3), intramuscularly and in the diaphyseal femur of goats for 6 and 12 
weeks. 
As expected from the data described in Chapter 3, intramuscularly implanted uncoated 
porous Ti6Al4V did not induce bone in any of the animals. Bone was observed in 
intramuscularly implanted OCP-coated Ti6Al4V (in 40% of goats after 6 and in 60% 
after 12 weeks of implantation) and BCP ceramic (30% of goats after 6 and 60% 
after 12 weeks of implantation).  
Orthotopically, after both 6 and 12 weeks of implantation, more bone was formed in 
OCP-coated Ti6Al4V and BCP implants as compared to the uncoated Ti6Al4V. BCP 
ceramic showed significantly more bone than OCP-coated Ti6Al4V after 6 weeks, 
however, this difference was no longer significant after 12 weeks of implantation. 
In conclusion, this study showed that the presence of calcium-phosphates in the form of 
coating on metal implants or in the form of bulk ceramic had a significantly positive 
effect on the bone healing process as compared to the uncoated metal. Whether this 
positive effect is due to the fact that both OCP-coated Ti6Al4V and BCP were 
osteoinductive is hard to conclude from this study, as the uncoated Ti6Al4V was not only 
non-osteoinductive, but its osteoconductive properties were limited as well.  
General discussion 
 
 
 
173 
In Chapter 7, osteoinductive BCP ceramic sintered at 1150°C and the non-
osteoinductive BCP ceramic sintered at 1300°C were implanted in paraspinal muscles 
and in a critical-sized iliac wing defect [29] in goats for 12 weeks. 
As expected from the results of the study described in Chapter 5, intramuscularly 
implanted BCP1150 induced bone in all animals, while no ectopic bone formation was 
found in any of the implanted BCP1300 ceramic discs. 
After 12 weeks of implantation in the critical-sized iliac wing defect, in BCP1300 
implants only a small ridge of new bone had formed along the host bone bed. In 
contrast, in BCP1150 implants, bone had grown deeply inside the implants, and in most 
animals, the defect was fully bridged by new bone. In addition to a higher amount of 
bone formed in BCP1150 than in BCP1300 implants, analyses of fluorochrome markers, 
which were administered in order to visualize the bone growth dynamics, showed that 
new bone formation had started earlier in BCP1150 implants. In addition, fluorochrome 
markers illustrated that in BCP1150 implants, bone did not only grow from the host 
bone bed towards the center of the implant, as the new bone growth took place 
simultaneously in the center of the implant and on its periphery. 
Results of this study showed a significantly positive effect of the osteoinductive ceramic 
in a clinically-relevant critical-sized defect as compared to the non-osteoinductive 
ceramic with the same chemical composition. 
 
 
8.2 General observations 
 
There are two general observations from this research that need to be addressed. First 
of all, so far, all our trials to develop an in vitro study that might help unraveling the 
mechanism of osteoinduction or at least understanding certain aspects of this 
phenomenon were unsuccessful. Cultures of cells belonging to osteoblastic cell lines, 
pluripotent cell lines and primary cells, followed by assays for cell attachment, 
proliferation and differentiation all gave inconclusive results, which were often in 
contrast to the findings from the in vivo studies. 
The second general observation concerns in vivo studies. We observed very large 
variations in the amount of induced bone between individual goats within a group. In all 
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performed studies, there were goats with “high” and “low” osteoinductive potential. In 
other words, the amount of bone induced by the same material in goat 1 and goat 2 
could differ significantly. That the reason for these difference probably does not lie in 
materials themselves, or in any kind of coincidence, was shown by the trends within each 
animal, the analyses of which were possible due to paired implantations. It was namely 
observed, that, if smaller amount of bone was induced by material A in the goat with a 
“low” osteoinductive potential, the amount of bone induced by material B, C, etc. was 
relatively small in the same goat as well. Thus, there were inter-animal variations, but 
intra-animal consistencies. Much smaller variations were observed at orthotopic 
implantation sites, and these could not be related to the differences observed at ectopic 
sites.  
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9.1 General conclusions 
 
In Chapter 1, General introduction, it was indicated that the two main goals of this thesis 
were: (Ι) gathering relevant information on parameters which are important in the 
process of osteoinduction by biomaterials in order to unravel this, so far largely 
unknown, phenomenon and (ΙΙ) investigating the performance of osteoinductive 
biomaterials orthotopically in order to get more insight into their potential use in the 
clinic. 
 
 
9.1.1 Mechanism of osteoinduction 
 
With regard to the first goal, our research has shown that: 
• various calcium-phosphate biomaterials are able of inducing ectopic bone 
formation depending on their chemical composition, making osteoinduction by 
biomaterials a general phenomenon;  
• in addition to, previously demonstrated, macroporosity, our research has shown 
that presence of microporosity is an essential element in osteoinduction by 
biomaterials;  
• there seems to be an optimum in specific surface area for each type of 
biomaterial, different for each chemical composition;  
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• besides the well known species dependence, we have demonstrated that 
implantation site as well as the implant size influence the osteoinductive 
potential of biomaterials;  
• the high specific surface area of osteoinductive biomaterials is responsible for 
a high interaction with the in vivo surrounding resulting in a high level of 
dissolution and reprecipitation of more biological carbonated apatite layer, 
accompanied by coprecipitation of possibly relevant endogenous proteins. This 
typical surface reactivity is lower on non-osteoinductive biomaterials. 
In General introduction of the thesis, we hypothesized a mechanism of osteoinduction. 
The presence of macropores, or well-defined three-dimensional concavities has 
previously been shown to be a prerequisite for osteoinduction by biomaterials [132, 
135, 138, 140]. A well-interconnected macroporous structure is of importance for an 
adequate supply of the body fluids with nutrients throughout the implant. Accompanied 
with this supply, the release of calcium- and phosphate ions, believed to be the origin of 
the bioactivity of calcium-phosphate biomaterials [138, 171, 172, 210], takes place, 
followed by the precipitation of a biological carbonated apatite layer [211]. The 
precipitation of this apatite layer occurs when the concentration of calcium- and 
phosphate ions has reached the supersaturation level in the material vicinity. This might 
explain the experimental fact that the bone induction always takes place in the 
supersaturated pores in the center of implant and not at or near the, less saturated, 
implant periphery [205].  
It is expected that a material with a higher dissolution rate releases calcium- and 
phosphate ions faster, and thus allows a faster formation of the biological layer 
[Chapter 5]. One way to influence the in vivo dissolution rate of a material is by 
changing its specific surface area. Increase of the specific surface area increases its 
surface reactivity [Chapters 5 and 6]. However, there seems to be an optimal specific 
surface area for each type of biomaterial. Materials with a specific surface area below 
the optimum have a consequent low surface reactivity and will therefore induce bone 
later or will not be inductive at all [Chapters 3, 4, 5 and 7]. Materials with a specific 
surface area above the optimum or materials with poor mechanical properties might 
degrade, loosing thereby the shape and stability that is necessary to facilitate bone 
formation [Chapter 5].  
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Also the material chemical composition can influence its in vivo degradation. For 
example, presence β-TCP in BCP has a positive influence on the ceramics osteoinductive 
properties [Chapter 4]. In the biomaterials that initially do not contain CaPs, like 
alumina ceramic and titanium, the formation of the biological apatite layer needs more 
time. In this case, calcium- and phosphate ions from the body fluids precipitate onto the 
microporous surface of the material macropores which acts as a collection of nucleation 
sites for the precipitation.  
Changes that occur after implantation on the surface of the osteoinductive biomaterial 
inside or around its micropores are obviously responsible for its ability to trigger 
undifferentiated cells to start forming osteoblasts. The formed bone-like biological 
carbonated apatite layer could be a physico-chemical trigger for the cells to 
differentiate into the osteogenic lineage similar to being in an orthotopic environment.  
On the other hand, coprecipitated “relevant endogenous proteins” are also possible 
candidates for the role of inducer of osteogenic differentiation. The fact that the ectopic 
bone formation by biomaterials in very rarely found in rodents and other “small 
animals” [116, 141-144] and that osteoinduction by biomaterials is always 
intramembranous [121, 129] suggest that osteoinduction by biomaterials does not 
involve BMPs.  
However, our research has shown that implant size is of large importance on 
osteoinduction by biomaterials [Chapter 5], which could be a reason for the lack of 
bone formation by biomaterials in rodents. Obviously, only small implants can be 
introduced in small animals. In addition, implantations in rodents are mostly 
subcutaneous, and our research has shown that for osteoinduction by biomaterials, 
subcutis is a less inductive site implantation site than muscle [Chapter 5]. Furthermore, in 
our research we observed large differences in osteoinductive potential between 
individual animals [Chapters 4 and 5], and these types of differences are also observed 
in response to BMPs [56, 112, 113]. Finally, whether bone induction by BMPs is 
endochondral or intramembranous depends on the carrier as well [104, 246, 247]. It is 
thus possible that, in combination with osteoinductive biomaterials, BMP always gives 
rise to intramembranous bone formation. It is therefore conceivable that BMPs play a 
role in osteoinduction by biomaterials, but as long as we did not find conclusive 
evidence, other possibilities should be left open.  
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9.1.2 Clinical relevance of osteoinductive biomaterials 
 
Regarding the second goal of our research, we have shown that osteoinductive 
biomaterials perform better orthotopically than the non-osteoinductive ones in small 
[Chapter 6] and large, critical-sized defects [Chapter 7]. 
In particular Chapter 7, in which a clinically relevant defect was chosen, showed an 
importantly better performance of osteoinductive in comparison to the non-
osteoinductive ceramic with similar chemical composition. Analyses of fluorochrome 
markers gave valuable information on bone growth dynamics, and indicated that bone 
formation started rather early in the center of osteoinductive ceramic, which could not 
be explained by the phenomenon of osteoconduction. Although we did not completely 
unravel the exact mechanism of the effect of osteoinductive potential orthotopically, the 
results of this study suggest that osteoinductive biomaterials have the potency of 
becoming a good alternative for autologous bone grafts. 
 
 
9.2 Recommendations for future research 
 
Although our research has given some new insights into the mechanism of osteoinduction 
by biomaterials as well as into its clinical relevance, a lot of work is still needed in order 
to be able to design a perfect synthetic alternative for autologous bone graft. 
It is important to investigate in detail the exact events that take place on the surface of 
osteoinductive and non-osteoinductive biomaterials in vivo. A similar study could be 
performed as described in Chapter 5 of this thesis, in which materials are implanted 
intramuscularly or subcutaneously inside diffusion chambers for different periods of 
time. This implantation should be followed by the analysis of the organic compounds 
which are then present on the surface. For this type of study, the goat might not be the 
best model because of the lack of antibodies. Therefore, additional attention should be 
paid on interspecies differences. Understanding of reasons for lack of osteoinduction in 
rodents and other “small” animals can lead to the solution of the problem. The use of 
(transgenic) mice and rats would make the fundamental research into mechanism of 
osteoinduction much easier. 
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It is further important to investigate how relevant the formation of biological apatite 
layer and coprecipitation of organic compounds is for the material osteoinductive 
potential. In order to investigate this relevance, implantation of osteoinductive and non-
osteoinductive materials inside diffusion chamber for short period of time in e.g. goats, 
could be followed by the reïmplantation of these materials in soft tissues of rodents, 
where they are, so far, unable to induce bone.  
More effort should be put in developing reliable in vitro systems to study certain aspects 
of osteoinduction. The use of fully pluripotent embryonic stem cells in combination with 
osteoinductive biomaterials, in a well controlled cell culture medium might give valuable 
information of molecular pathways involved in the process of osteoinduction by 
biomaterials. 
Finally, further understanding of the effect of osteoinductivity at an orthotopic 
implantation site is the most important goal for the future research. Clinically relevant 
orthotopic implantations will give the answers to most important questions concerning the 
use of osteoinductive biomaterials for bone replacement and support of bone 
regeneration. 
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Summary 
    
The improvement in the quality of life and consequent increase of life expectancy are 
accompanied by the expanding demand for the repair of damaged and degraded 
organs and tissues. Bone tissue regeneration remains an important challenge in the field 
of orthopaedic- and maxillofacial surgery. Spinal fusions and repairs of bone defects 
caused by traumas, tumors, infections, biochemical disorders and abnormal skeletal 
development, are some examples of the frequently performed surgeries in the clinic. For 
most of these surgeries, there is a great need for grafting materials. In general, 
grafting materials can be divided into the categories of natural bone grafts (autograft, 
allograft, xenograft), synthetic bone graft substitutes (metals, ceramics, polymers and 
composites) and tissue-engineered hybrids (cell-based, bioactive molecules-based). 
Because of the drawbacks of natural bone grafts and tissue-engineering techniques, 
such as additional invasive surgical procedure which may lead to donor site morbidity, 
chronic post-operative pain, hypersensitivity and infection, there is a great need for 
further development of synthetic bone graft substitutes that are largely available, do 
not cause antigenic response and can easily be tailored depending on the intended 
application. Future research should focus on improving biological performance of 
synthetic bone graft substitutes, which is today still inferior to that of autografts. Fully 
synthetic “intelligent” biomaterials should be able to perform at least as good as 
autologous bone graft. A group of potentially “intelligent” biomaterials are 
osteoinductive biomaterials. 
Osteoinduction can be defined as the induction of the undifferentiated osteoprogenitor 
cells that are not yet committed to the osteogenic lineage to form osteoprogenitor cells. 
In other words, osteoinduction is bone formation at ectopic sites such as muscle and 
subcutis. It has been known for a long time that certain growth factors, such as Bone 
Morphogenetic Proteins have the ability to induce ectopic bone formation. Recent 
research has shown that some synthetic biomaterials, which initially do not contain Bone 
Morphogenetic Proteins, also possess the ability to induce ectopic bone growth. It is 
hypothesized that osteoinductive biomaterials are better for bone grafts than the non-
osteoinductive biomaterials. So far, the exact mechanism underlying osteoinduction by 
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biomaterials is largely unknown. Furthermore, the effect of osteoinductive potential of 
biomaterials on their performance orthotopically has not been fully investigated yet. 
This thesis had two main goals: (Ι) to investigate parameters influencing osteoinductive 
potential of biomaterials in order to unravel the mechanism underlying osteoinduction 
and (ΙΙ) to investigate performance of osteoinductive biomaterials orthotopically in 
order to get insight into their clinical relevance. 
In Chapter 2 we reviewed different in vitro models that are used in bone research in 
general, and in bone research involving biomaterials in particular. It has been shown 
that in vitro organ- and cell culture systems, which were initially developed to study 
influence of growth factors, hormones and cytokines on cell behavior, are not always 
adequate for bone research involving biomaterials. Biomaterials might interfere with 
cell culture medium, which is an undesired effect, if similar interaction is not expected to 
occur in vivo. Besides, various cell types which are used in in vitro systems are often not 
representative for the in vivo situation, in particular when complex biological 
phenomena such as osteoinduction are studied. Because of these drawbacks of 
simplified in vitro models, in the present thesis, we used in vivo models in goats to study 
mechanisms and clinical relevance of osteoinductive biomaterials. 
In Chapter 3 it was described that biomimetic octacalcium phosphate coating could be 
applied on different porous materials, independent on their chemistry, and that 
therewith the osteoinductive properties of these materials were improved. 
The main conclusion from the study described in Chapter 4 was that the presence of 
micropores, in addition to the presence of macropores, is a prerequisite for 
osteoinduction by biomaterials, and that this phenomenon is independent on the material 
chemistry. 
Chapter 5 showed that, for each type of material, there is an optimal specific surface 
area at which the osteoinductive potential is highest. We also described the influence of 
the implant size on the material osteoinductive potential, i.e. the larger the implant, the 
more bone is induced and that the same material is “more osteoinductive” 
intramuscularly than subcutaneously. Finally, in Chapter 5 it was demonstrated that, 
during implantation, on the surface of osteoinductive ceramic more dissolution took 
place, followed by the reprecipitation of the carbonated-apatite layer and possible 
coprecipitation of the organic compounds such as endogenous proteins, than on the 
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surface of non-osteoinductive ceramic. This finding might be explained by the difference 
in the specific surface area between osteoinductive and non-osteoinductive ceramic. 
Chapter 6 showed that the presence of calcium-phosphates in the form of coating on 
metallic implants or in the form of bulk ceramic had a significantly positive effect on the 
bone healing process as compared to the uncoated metal. Whether this positive effect is 
due to the fact that both OCP coating on metallic implants and BCP ceramic used in this 
study were osteoinductive is hard to conclude, as the uncoated metallic implants were 
not only non-osteoinductive, but their osteoconductive properties were limited as well.  
Finally, in Chapter 7 we demonstrated a significantly positive effect of an 
osteoinductive ceramic in a clinically-relevant critical-sized defect as compared to a 
non-osteoinductive ceramic with the same chemical composition. 
In conclusion, the results described in the present thesis shed light upon parameters 
influencing osteoinductive properties of biomaterials, which is a step forward towards 
unraveling the mechanism underlying the phenomenon of osteoinduction. Furthermore, 
this thesis demonstrates that osteoinductive biomaterials have the potency of being an 
adequate substitute for autograft in bone tissue regeneration. 
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Samenvatting 
 
De verbetering van de gezondheidszorg en daarmee samenhangende toename van de 
leeftijd heeft als gevolg dat er steeds groter wordende behoefte is aan behandeling 
van beschadigde en zieke organen die veroorzaakt worden door slijtage. Reconstructie 
van botweefsel is een belangrijke uitdaging op het gebied van orthopedische- en 
kaakchirurgie. Wervelfusies en reparatie van botdefecten veroorzaakt door trauma’s, 
tumoren, infecties, biochemische aandoeningen en abnormale skeletontwikkeling zijn 
voorbeelden van vaak uitgevoerde operaties. Voor de uitvoering van dit type chirurgie 
is er een grote behoefte aan vervangende botimplantaten. Op dit moment zijn er drie 
soorten veel gebruikte botimplantaten: natuurlijke implantaten (lichaamseigen bot, bot 
van andere (menselijke) donoren en bot van donoren van een andere soort), 
kunstmatige implantaten (metalen, keramieken, polymeren en composietmaterialen) en 
tissue-engineered botimplantaten (synthetische dragers gecombineerd met 
lichaamseigen cellen en/of bioactieve stoffen). Wegens de nadelen van natuurlijke- en 
tissue-engineered botimplantaten, zoals de extra operatie voor het wegnemen van bot 
of beenmerg, mogelijk gevolgd door chronische post-operatieve pijn, hypersensitiviteit 
en infecties, is er een grote behoefte aan kunstmatige materialen die onbeperkt 
beschikbaar zijn, niet afgestoten worden door het lichaam, gebruikt kunnen worden 
voor verschillende doeleinden en hetzelfde effect kunnen bereiken als de voornoemde 
alternatieven. Toekomstig onderzoek zou zich moeten richten op het verbeteren van 
biologische prestaties van kunstmatige materialen, die op dit moment nog inferieur zijn 
aan die van natuurlijke botimplantaten. Met andere woorden, er is behoefte aan 
volledig synthetische “intelligente” materialen die in het lichaam dezelfde prestatie 
kunnen leveren als bijvoorbeeld lichaamseigen bot. Een groep potentieel “intelligente” 
kunstmatige materialen zijn osteoinductieve biomaterialen. 
Osteoinductie kan gedefinieerd worden als de inductie van ongedifferentieerde cellen 
die nog niet gecommitteerd zijn aan de osteogene lijn om osteogene cellen te vormen. 
In andere worden, osteoinductie is het vermogen tot botvorming in een ectopische (niet-
botrijke) omgeving zoals in de spier of onderhuids. Het is al langere tijd bekend dat 
sommige groeifactoren, zoals Bone Morphogenetic Proteins (BMPs), het vermogen 
hebben om botvorming te kunnen induceren in een ectopische omgeving. Recentelijk 
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onderzoek heeft aangetoond dat ook bepaalde kunstmatige biomaterialen, die initieel 
geen BMPs of andere groeifactoren bevatten, ook ectopische botvorming kunnen 
induceren. Onze verwachting is dat osteoinductieve materialen betere botimplantaten 
zijn dan de niet-osteoinductive materialen vanwege de voornoemde eigenschap. Het is 
tot nu toe nog niet volledig bekend wat het onderliggende mechanisme van 
osteoinductie door biomaterialen is. Bovendien is het onduidelijk wat voor effect de 
mate van osteoinductiviteit van een materiaal heeft op de prestatie van dit materiaal in 
een orthotopische (botrijke) omgeving.  
Ons onderzoek had twee hoofddoelen: (Ι) het onderzoeken van de parameters die van 
invloed zijn op het osteoinductieve potentieel van biomaterialen om de onderliggende 
mechanismen van osteoinductie te ontrafelen en (ΙΙ) inzicht te krijgen in de prestaties 
van osteoinductieve biomaterialen in een orthotopische omgeving en de daarmee 
samenhangende klinische relevantie. 
In Hoofdstuk 2 hebben we een overzicht gegeven van verschillende in vitro modellen 
die gebruikt worden in het onderzoek naar bot in het algemeen en in het onderzoek 
naar biomaterialen voor botvervanging in het bijzonder. We hebben laten zien dat 
sommige orgaan- en celkweek in vitro modellen, die oorspronkelijk ontwikkeld waren 
voor het bestuderen van effecten van hormonen en groeifactoren op het gedrag van 
botcellen, niet altijd optimaal zijn voor het botonderzoek met betrekking tot 
biomaterialen. Biomaterialen gaan soms een interactie aan met het gebruikte 
celkweekmedium in een in vitro modelsysteem. Dit kan ongewenste effecten hebben 
wanneer een soortgelijke interactie niet aanwezig is in vivo. Daarnaast zijn de cellen 
die in in vitro celkweek systemen gebruikt worden niet altijd representatief voor de, 
meer complexe, in vivo situatie, in het bijzonder wanneer men complexe biologische 
fenomenen zoals osteoinductie bestudeert. Wegens deze nadelen van de in vitro 
systemen hebben we in ons onderzoek gebruik gemaakt van een in vivo model in geiten 
om de mechanismen die een rol spelen bij osteoinductie door biomaterialen en hun 
klinische relevantie te kunnen bestuderen. 
In Hoofdstuk 3 wordt beschreven dat biomimetische octacalcium fosfaat coatings 
gemaakt kunnen worden op verschillende soorten kunstmatige materialen en dat 
daardoor hun osteoinductieve eigenschappen verbeterd kunnen worden. 
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In Hoofdstuk 4 wordt beschreven dat microporiën (poriën met een diameter kleiner dan 
10 micrometer), naast de aanwezigheid van macroporiën, een vereiste zijn voor 
osteoinductie door biomaterialen, en dat deze eigenschap onafhankelijk is van de 
chemische samenstelling van het materiaal. 
Hoofdstuk 5 toont aan dat voor ieder materiaalsoort, er een optimale soortelijke 
oppervlakte bestaat waarbij de osteoinductieve potentie van een materiaal het hoogst 
is. Verder wordt duidelijk gemaakt dat de osteoinductieve potentie van een materiaal 
afhankelijk is van de grootte van een implantaat: hoe groter de implantaat, hoe meer 
bot geïnduceerd kan worden. Tevens blijkt er een verschil te bestaan in de hoeveelheid 
geïnduceerd bot afhankelijk van de plaats van implantatie: er wordt meer bot gevormd 
in een intramusculaire dan in een subcutane omgeving. Als laatste maakt hoofdstuk 5 
duidelijk dat gedurende een implantatie periode aan het oppervlak van 
osteoinductieve keramieken meer dissolutie van calcium- en fosfaat ionen plaatsvindt, 
wat weer wordt gevolgd door de reprecipitatie van een biologisch gecarboneerde 
apatiet laag en coprecipitatie van endogene organische stoffen, dan aan het 
oppervlak de niet-osteoinductieve keramieken. Deze bevinding kan worden verklaard 
door het verschil in de grootte van de soortelijke oppervlakte tussen osteoinductieve en 
niet-osteoinductieve keramieken.  
In Hoofdstuk 6 tonen we aan dat de aanwezigheid van calciumfosfaat in de vorm van 
een coating op het oppervlak van poreuze metalen of keramieken een significant 
positief effect heeft op het botgenezingsproces in vergelijking met de ongecoate 
materialen. Een belangrijk voordeel van biomimetische coatings is dat het een relatief 
eenvoudige methode is die gebruikt kan worden om biologische prestaties van 
verschillende materialen te verbeteren. 
Uiteindelijk, in Hoofdstuk 7 hebben we aangetoond dat osteoinductieve keramieken 
significant beter presteren dan niet-osteoinductieve keramieken in een botdefect van 
klinisch relevant grootte. 
Concluderend, met dit onderzoek zijn we weer een stap dichterbij het ontrafelen van de 
mechanismen die een rol spelen bij het fenomeen osteoinductie gekomen. Daarnaast 
heeft ons onderzoek laten zien dat osteoinductieve materialen de potentie hebben 
adequate vervangers van lichaamseigen bot worden. 
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Kratki sadržaj 
 
Poboljšanje životnih uslova i doslijedna prognoza dužeg života nose sa sobom povećanu 
potrebu za popravkom oštećenih i degradiranih organa i tkiva. Rekonstrukcija kostiju je 
važan izazov u ortopedskoj i stomatološkoj hirurgiji. Spajanje kičmenih grebena, 
rekonstrukcija oštećenja kostiju izazvanih ozlijedom, rakom, infekcijama, hormonskim 
poremećajima i nepravilnim razvojem skeleta su primjeri često izvedenih operacija. Za 
većinu navedenih operacija potrebni su implantati. Implantati koji se često koriste mogu 
biti svrstani u tri grupe: prirodni (kost iz sobstvenog tijela, iz tijela drugog (ljudskog) 
darodavca ili iz tijela životinje), sintetični (metalni, keramički, plastični ili mješavine) i 
“tissue-engineered” (kombinacija sintetičnih materijala sa ćelijama pacijenta ili sa 
bioaktivnim molekulama). Zbog nedostataka prirodnih i “tissue-engineered” implantata, 
kao što su dodatna operacija koja može uzrokovati hronični bol i infekcije, postoji velika 
potreba za sintetičnim materialima koji su lako dostupni, prihvaćeni u tijelu i mogu biti 
korišteni za različite namijene. Buduća ispitivanja se trebaju koncentrisati na poboljšanje 
bioloških dostignuća sintetičnih implantata, koji su još uvijek lošiji od dostignuća prirodnih 
implantata. Potpuno sintetični “inteligentni” implantati bi trebali imati dostignuće koje je 
jednako onom prirodnih implantata. Vrsta potencijalno “inteligentnih” materiala su 
takozvani osteoinduktivni biomaterijali. 
Jednostavna definicija osteoindukcije je razvoj kostiju tamo gdje koštane ćelije nisu 
prisutne (na primjer u mišićima ili ispod kože). Već je godinama poznato da su 
određene molekule, kao na primjer “Bone Morphogenetic Proteins” (BMP) u mogućnosti 
da otpočnu razvoj kostiju u odsustvu kosti i njegovih ćelija. Skorašnje istrage su 
pokazale da i neki sintetični materijali, koji u početku ne posjeduju BMP, su takođe u 
mogućnosti da otpočnu razvoj kostiju, na primjer u mišićima. Naša hipoteza je da 
materijali, koji mogu da započnu razvoj kostiju tamo gdje su kosti odsutne (u mišićima ili 
pod kožom), bi trebali omogućiti brži i veći razvoj nove kosti tamo gdje postoji 
nedostatak zbog povrede ili raka. Tačni mehanizam koji leži na osnovi fenomena 
osteoindukcije biomaterijalima je još uvijek nepoznat. Takođe nije potpuno istraženo da 
li osteoinduktivni materiali uistinu prouzrokuju bolji razvoj kostiju nego materijali koji nisu 
osteoinduktivni.  
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Glavni ciljevi ove disertacije su: (Ι) istražiti koje osobine materijala imaju uticaj na njihov 
osteoinduktivni potencijal da bismo bolje razumjeli mehanizam fenomena osteoindukcije 
i (ΙΙ) istražiti da li osteoinduktivni materijali prouzrokuju bolji razvoj nove kosti nego 
materijali koji nisu osteoinduktivni, da bismo mogli predskazati značaj osteoinduktivnih 
materijala u liječenju pacijenata sa oboljenjima kostiju.  
U Poglavlju 2 smo opisali različite in vitro (izvan tijela) modele koji se mogu koristiti za 
opštu istragu kostiju i za specifičnu istragu koja obuhvata biomaterijale. Pokazali smo 
da postojeći in vitro modeli, koji su u početku bili stvoreni za istraživanje uticaja 
hormona i drugih razvojnih faktora na ponašanje koštanih ćelija, nisu uvijek adekvatni 
za istragu koja obuhvata biomaterijale. Biomaterijali mogu reagovati sa sredstvom u 
kojem ćelije rastu, a ove reakcija je nepoželjna, ukoliko nije očekivana u tijelu (in vivo). 
Pored toga, ćelije koje se koriste za istraživanja in vitro često nisu reprezentativne za 
ono što se dešava in vivo, posebno u istragama kompleksnih bioloških fenomena, kao 
što je osteoindukcija. Zbog navedenih nedostataka in vitro modela, mi smo u ovoj 
disertaciji koristili koze kao in vivo model za istragu mehanizma i kliničnog značaja 
osteoinduktivnih biomaterijala.  
U Poglavlju 3 je opisano da sloj oktakalcijum-fosfata koji se može nanijeti na površinu 
različitih materijala bez obzira na njihov hemijski sadržaj poboljšava osteoinduktivne 
osobine biomaterijala.  
Najvažniji zaključak iz Poglavja 4 je da prisutvo mikropora (pora sa prečnikom manjim 
od 10 mikrometara) je, zajedno sa prisustvom većih makropora, preduslov za 
osteoindukciju uzročenu biomaterijalima, i da je ova osobina neovisna o hemijskom 
sadržaju biomaterijala.  
U Poglavlju 5 je opisano da, za svaku vrstu materijala, postoji optimalna specifična 
površina (u m2/g) pri kojoj je osteoinduktivni potencijal materijala najveći. Pored toga 
je u Poglavlju 5 opisano da količina nove kosti koja je započeta osteoinduktivnim 
materijalom zavisi od veličine implantata: u većim implantatima raste relativno više kosti 
nego u manjim implantatima. Količina nove kosti takođe zavisi od mjesta gdje je 
material usađen: u mišićima raste više kosti nego pod kožom. Konačno, u Poglavlju 5 je 
opisano da je, za vrijeme implantacije, na površini osteoinduktivnih materijala više 
rastvaranja kalcijum i fosfat jonova nego na površini materijala koji nisu osteoinduktivni. 
Kratki sadržaj 
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Ovi rastvoreni jonovi stoga stvaraju sloj novog, takozvanog, karbonisanog apatita koji 
je moguće odgovoran za začetak rasta kosti. 
U Poglavlju 6 je opisano da prisutnost kalcijum fosfata u obliku sloja na površini 
metalnog implantata ili u obliku keramike, poboljšava zacijeljenje defekta kosti u 
poređenju sa metalom bez kalcijum fosfata.  
Konačno, u Poglavlju 7 je dokazano da osteoinduktivna keramika uzrokuje bitno bolje 
zacijeljenje kosti nego jednaka, ali neosteoinduktivna keramika, u velikom, klinični 
važnom defektu kosti.  
U zaključku, rezultati opisani u ovoj desertaciji su pokazali nove osobine materijala koji 
imaju uticaj na njihov osteoinduktivni potencijal. Na ovaj način smo došli korak bliže 
potpunom razumijevanju mehanizma osteoindukcije. Osim toga, ova teza je pokazala 
da osteoinduktivni biomaterijali imaju potenciju postati adekvatan zamjenik prirodnih 
implantata u liječenju bolesti kostiju.  
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Chapter 2 
 
Figure 2: digital photographs of BCP1300 (A) and BCP1150 (B) after implantation in goat iliac wing defect for 12 weeks. 
(1) = ceramic, (2) = bone, (3) = fibrous tissue. 
Only a small ridge of new bone has formed along the host bone bed in the BCP1300 disc (A),  
while bone has grown deeply inside the BCP1150 disc (B). 
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Figure 3: digital photograph of histological slides of BCP1300 (A) and BCP1150 (B) after 12-week  
intramuscular implantation in goat.  
(1) = ceramic, (2) = bone, (3) = fibrous tissue. 
In BCP1300, the ceramic is extensively filled with fibrous tissue, but no signs of bone formation are observed.  
In BCP1150 (B) bone has formed in the pores of the implants, aligning its surface. 
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Figure 2: LM photographs (magnification 10x) after 12 weeks of intramuscular implantation of Ti6Al4V (A), OCP Ti6Al4V (B), HA 
(C), OCP HA (D), BCP (E), OCP BCP (F) and OCP PEGT-PBT (G). 
Ti=titanium alloy, HA=hydroxyapatite, BCP=biphasic calcium phosphate, P=PEGT-PBT, FT=fibrous tissue and B=bone. 
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Figure 7: LM photographs of BCP1150 (magnification 4x) (A), BCP1150 (magnification 20x) (B), and HA1250 (magnification 4x) (C) 
after 12 weeks of implantation. 
B=bone, FT=fibrous tissue BCP=BCP1150 ceramic, HA=HA1250 ceramic. 
The induced bone is formed in the pores of the implant, aligning its surface (A). The formed bone is normal in appearance, aligned 
with osteoblasts and with osteocytes and osteoid clearly visible (B).  
The non-inductive ceramic is filled with fibrous tissue, but no signs of bone formation are observed (C). 
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Figure 5: digital photograph of histological slides of intramuscularly implanted BCPA (A) (inset = LM photograph magnification 10x), 
BCPB (B), BCPC (C) (inset = LM photograph magnification 10x), BCPD (D), CA (E), BCPC (F),  
CA (G) and fluorochrome markers of BCPA (H) and BCPC (I). 
(1) = ceramic, (2) = bone, (3) = fibrous tissue, OTC = Oxytetracycline, XO = Xylenol orange. 
The induced bone in BCPA and BCPC (A and C respectively) is formed in the pores of the implants, aligning their surface. The bone 
is normal in appearance, aligned with osteoblasts and with osteocytes and osteoid clearly visible (insets of A and C). BCPB, BCPD 
and CA ceramics (B, D and E respectively) are extensively filled with fibrous tissue, but no signs of bone formation are observed. In 
some animals, BCPC ceramic was fragmented and mechanical degradation was observed. Note bone formation only in the non-
fragmented part of the implant (F). In some animals, chemical dissolution of CA ceramic was observed (G). Presence of both 
Oxytetracycline and Xylenol orange marker shows that the bone formation in both BCPA and BCPC (H and I respectively) had 
started before the sixth week of implantation. 
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Figure 9: LM photographs of histological slides of uncoated Ti6Al4V after 6 weeks (magnification 2x) (A) and 12 weeks 
(magnification 10x) (B); OCP coated Ti6Al4V after 6 weeks (magnification 2x) (C) and 12 weeks (magnification 10x) (D) and BCP 
after 6 weeks (magnification 2x) (E) and 12 weeks (magnification 10x) (F) of transcortical implantation. 
Ti=Ti6Al4V, B=bone, FT=fibrous tissue, BCP=ceramic. 
More bone has grown in the OCP Ti6Al4V and BCP (A and C) implants in comparison to the uncoated Ti6Al4V implant (E). Similarly, 
there is more direct bone contact between the newly formed bone in OCP Ti6Al4V and BCP implants (B and D) in comparison with 
the uncoated Ti6Al4V implants (F). 
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Figure 11: LM photographs of histological slides magnification 10x of uncoated Ti6Al4V (A), OCP coated Ti6Al4V (B) and BCP (C) 
after 12 weeks of intramuscular implantation. 
Ti=Ti6Al4V, B=bone, FT=fibrous tissue, BCP=ceramic. 
 
Selected colour figures 
 
 
 
222 
Chapter 6 
 
 
Figure 12: LM photographs of histological slides magnification 5x of the OCP Ti6Al4V after 6 weeks (A) and 12 weeks (B) of 
implantation, and magnification 20x after 6 weeks of implantation. 
Ti=Ti6Al4V, B=bone, FT=fibrous tissue, C=OCP coating; BCP=ceramic. 
In (A) there is still some coating present on the periphery of the implant after 6 weeks of implantation, in (B) after 12 weeks of 
implantation the coating is further degraded, in (C) multinucleated cells (see arrow) are resorbing  
the coating left after 6 weeks of implantation. 
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Figure 5: digital photograph (A), LM photograph (magnification 10x) of a histological slide (B) and fluorochrome markers (C) of 
intramuscularly implanted BCP1150. 
(1) = ceramic, (2) = bone, (3) = fibrous tissue, OTC = Oxytetracycline, XO = Xylenol orange. 
The induced bone is formed in the pores of the implant, aligning its surface (A). The bone is normal in appearance, aligned with 
osteoblasts and with osteocytes and osteoid clearly visible (B). The presence of both Oxytetracycline and Xylenol orange marker 
shows that the bone formation had started before the sixth week of implantation (C). 
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Figure 6: digital photograph (A) and LM photograph (magnification 10x) (B) of a histolological slide  
of the intramuscularly implanted BCP1300. 
(1) = ceramic, (3) = fibrous tissue. 
The ceramic is extensively filled with fibrous tissue, but no signs of bone formation are observed. 
 
Selected colour figures 
 
 
 
225 
Chapter 7 
 
Figure 7: digital photographs of BCP1150 (A) and BCP1300 (B) after explantation from the iliac wing defect. 
(1) = ceramic, (2) = bone, (3) = fibrous tissue. 
Bone has grown deeply inside the BCP1150 disc (A) while only a small ridge of new bone has formed along the host bone bed  
in the BCP1300 disc (B). 
 
Selected colour figures 
 
 
 
226 
Chapter 7 
 
 
Figure 8: LM photographs (magnification 10x) of the fluorochrome markers on the periphery of BCP1150 (A) and BCP1300 (B) and 
in the center of BCP1150 (C) and BCP1300 (D) discs explanted from the iliac wing defects. 
CG = Calcein green, OTC = Oxytetracycline, XO = Xylenol orange. 
On the peripheries of both BCP1150 (A) and BCP1300 (B) all markers can be seen, which shows that in both ceramics bone 
formation near the host bone bed had started before the fourth week of implantation.  
The presence of the Oxytetracycline and Xylenol orange marker in the center of BCP1150 disc (C) shows that the bone formation 
far away from the host bone bed had started before the sixth week of implantation. Absence of any of the markers in the center of 
BCP1300 (D) illustrates the absence of new bone within the first eight weeks of implantation. 
 
